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Following an introduction and review of literature
pertaining to relevant aspects of major histocompatibility systems
and a review of literature on the bovine system specifically, an
introduction to East Coast fever (ECF) and review of literature on
ECF immunology and lymphoblastoid cell line (LCL) vaccination is
g iv en.
The development and application of a technique for
selection of bovine lymphocyte antigen (BoLA) ~ defined
subpopulations within established LCLs transformed by the causative
organism of ECF (Theileria parva) is then described. The results are
discussed in the context of T.parva-preferred target cells in in
vitro transformation systems, and the possible application of the
technique in producing LCLs lacking BoLA expression is considered.
No evidence of modulation of BoLA phenotype (workshop specificities)
as a consequence of Theileria~induced transformation was found.
Two large scale LCL challenge experiments in cattle are
reported, in which degrees of compatibility between LCLs and
recipient cattle were quantified and the effect of this on the
responses to LCL inoculation and subsequent stabilate challenge,
assessed. Evidence is presented for the BoLA system being an
important factor in determining the response to LCL inoculation and
the generation of immunity to a second challenge with the homologous
parasite, when cattle are inoculated with low numbers of cells
initially.
Also presented are the results of a series of experiments
carried out to investigate the specificity of bovine alloreactive
cytotoxic cells generated _in vitro. The results suggest that BoLA
workshop specificities, as defined by alloantisera, are restrictive
in this system. The results also suggest that effects due to
expression of the products of a BoLA locus other than that coding for
the workshop specificities were being detected in some experiments.
The significance of these results for future studies of the
bovine immune system in general, and for studies of the immune
response in ECF in particular, aj& discussed.
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CHAPTER 1 Introduction and literature review
The work reported in this thesis concerns several aspects of the
bovine lymphocyte antigen system (BoLA) which is genetically coded
for by the major histocompatibility complex (MHC). Some of these
aspects relate to immunisation against East Coast fever (ECF);
specifically immunisation with Theileria-transformed lymphoblastoid
cell lines (LCL).
In this review, what is currently known of the BoLA system
is discussed. To place this in perspective a review of what is known
of the genetics, function and structure of MHCs in general is given.
The volume of literature on this subject is great and consequently an
in~depth review is not attempted. Following a brief general
introduction and review of the MHCs of the mouse and man, in so far
as they serve to introduce the BoLA system, a summary of known MHC
functions is given. Two selected aspects of the MHC are then
discussed in more detail as they are felt to have particular
relevance to the studies reported in the remainder of this thesis.
Following discussion of the BoLA system itself, a review of
literature pertaining to LCL vaccination against ECF is presented
after an introduction to the disease and a review of literature on
ECF immunity.
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1«1 The major histocompatibility complex
1.1.1 General
1.1.1.1 Introduc tlon
The immunological theory of transplantation was first
proposed by P.A.Gorer (1938) who demonstrated that antigenic
differences between mouse strains affect transplantable tumour
survival.
The MHC was originally discovered because of its role in
transplant rejection when transplantations were carried out between
individuals with differences within the complex. In species where
investigations of the MHC are advanced it has been found to consist
of a group of closely-linked genetic loci coding for cell surface
antigens and it is believed to be present in similar form in all
mammals and in some form possibly in all vertebrates (Snell, 1981).
So far an MHC has been identified in at least 12 mammalian species
(Usinger _et al., 1981).
The original work of Gorer, already cited, was carried out
in the mouse and it was the MHC of this species which, particularly
in earlier studies, received the most attention. Progress in
understanding was comparatively rapid, principally because of the
availability of inbred strains.
Little & Tyzzer (1916) and Little (1941) established that
resistance/susceptibility to transplants is influenced by multiple
genes inherited in Mendelian fashion. Further progress on the
identification of individual loci within the system came with the
identification of a blood group locus in mice and the demonstration
that this segregated with tumour susceptibility (Gorer, 1937). Gorer
page 3
was working with what he referred to as antigen II and because the
system was known to be involved with histocompatibility (H) the mouse
complex became known as H-2.
As more is known about the mouse system than any other and
as information is now rapidly accrueing concerning the human
equivalent system (IlLA) , these will be used as illustrations in an
introduction to the bovine system (BoLA); the understanding of which
is still at a comparatively incomplete stage.
1.1.1.2 The mouse histocompatibility complex - H-2
The work carried out on the structure of the H~2 system is
reviewed in detail by Snell (1981).
The H-2 system is located on chromosome 17 and is generally
divided into 5 regions, K, I, S, D, and L. The I region is further
subdivided by some authorities (Klein, 1975; Demant &
Neauport Santes, 1978; Klein, 1979) although the extent to which
this subdivision is justified is debated (Klein _et _al., 1981).
Klein (1977) suggested a classification of the loci which
is now generally accepted. The 3 classes are,
1. Class 1 regions. These are regions K, D, and L. These
products are typically serologically-defined (SD) and play
a predominant role in transplantation reactions.
2. Class 2 regions. These are the I region loci. They
are involved in immune responsiveness, reactivity in mixed
lymphocyte culture (MLC) and graft~versus~host reactions.
The antigens coded for were originally lymphocyte-defined
(LD); that is by the response of lymphocytes to coculture
with lymphocytes expressing different class II
antigens (Dutton, 1966).
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3. Class III region. This codes for or controls the level
of component C4 of the complement system and is the S
region of the H-2 system.
This general organisation probably pertains in a wide range of
species although there may be differences in the spatial arrangement
of the different loci (Bodmer, 1981). However, in most species the
MHC consists of at least one locus which codes for class I antigens
and closely-linked loci coding for class II antigens. These 2
regions are usually less than 2 centimorgans apart (Albert &
Gotze, 1977).
The class I antigens, in the process of allograft rejection
induce the formation of alloantibodies. These antibodies are used in
the characterisation of the antigens in some form of
microlymphocytotoxicity assay based on that described by Gorer &
O'Gorman (1956). The antigens are codominantly expressed and
characterised on the basis of their "private" and "public"
specificities; these being respectively determinants unique to a
particular SD entity and determinants which are present on more than
one SD entity (Klein, 1975; Ivanyi, 1978).
The class I antigens are expressed on most but not all body
cells and their density on different cell types varies
(Snell _et aA., 1973; Klein, 1975; Gotze, 1977).
Structurally these products of the class I region are
glycoproteins comprising 2 non-covalently bound polypeptides. One is
microglobulin (MWt, 12 kDa) which is present in association with
all class I antigens. The other has a molecular weight of 45 kDa and
is the variable in terms of antigenic specificity. This latter
polypeptide inserts into the cell membrane at its hydrophilic
terminal region (Schwartz et al., 1973; Klein, 1975;
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Littman _et al., 1979).
The tissue distribution of class II antigens is more
limited than that of class I antigens, being principally restricted
to B lymphocytes, some macrophage populations and a minority of T
lymphocytes (Hammerling et al., 1974). Structurally they are
distinct also, being heterodimeric glycoproteins comprising a and
subunits of molecular weights 32-35 kDa and 27-29 kDa, respectively
(Cullen _et al., 1974; Schwartz ^t al., 1977; Shackleford &
Strominger, 1980).
1.1.1.3 The human histocompatibility complex - HLA
The work leading to our present understanding of the HLA
system is reviewed by Dausset (1981). Because of the nature of the
species under study, work has of necessity proceeded in a different
way from that undertaken on the H-2 system but in many ways has more
similarities with the efforts to date to unravel the bovine system.
Dausset (1958) reported that antibodies against leucocytes
formed as a result of multiple blood transfusions may recognise
alloantigens. Van Rood _et al., (1958) and Payne & Rolfs (1958)
reported that pregnancy may also generate such antibodies.
Antibodies formed in these ways have been the basic tool in
investigations of human class I antigens. Dausset (1958), van Rood &
van Leeuwen (1963) and Payne _et al., (1964) began the process of
allele definition. Subsequently, international workshops have
enabled analysis of sera reactivities and comparisons between
laboratories resulting in a standardised approach and quite rapid
progress in the characterisation of the HLA system.
In the HLA system, 4 closely-linked regions coding for
histocompatibility antigens are recognised. These are HLA-A, HLA-B,
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HLA-C and HLA-D/DR. These regions are situated on the short arm of
chromosome 6 (Breuning et al., 1977). The first 3 regions code for
class I antigens whereas the D/DR region codes for class II antigens.
HLA-DR antigens are the most recently discovered and although they
have largely been serologically defined they are believed to be
closely related to the D-coded antigens (Bodmer, 1981). It is
becoming increasingly apparent that the D/DR region is complex and
that much remains to be done towards its definition (reviewed by Guy
& van Heyningen, 1982). Closely linked to the HLA regions are genes
coding for complement factor B and components C2 and C4.
The system shows many similarities with H-2 in that it
codes for both class I and class II antigens in a closely-linked
genetic group. The structures and tissue distributions are also
similar (Bodmer, 1981).
The fact that there is this similarity between the systems
in the 2 species so far discussed is in itself reason to suspect that
the structure of other mammalian systems, including the BoLA system,
will follow the basic principles established. Indeed, as will be
discussed, work to date on the BoLA system has not produced any
reason to believe that it will differ greatly from either H-2 or HLA.
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1.1.1.4 A summary of MHC-controlled phenomena
1.1.1.4.1 Rejection of allografts.
The antigens stimulating rejection are coded for
in the class I, and to a lesser extent, the class II
regions (K1 ein _et aT., 1981).
1.1.1.4.2 Cell-mediated lympholysis (CML).
T lymphocytes can be triggered ^Ln vitro to
transform into cytolytic cells by coculture with
lymphocytes differing in the MHC. The activated T cells
then have the capability of lysing cells of the triggering
MHC type.
1.1.1.4.3 Mixed lymphocyte reaction (MLR).
Resting T lymphocytes can be stimulated to
proliferate by coculture with lymphocytes of different MHC
type. The lymphocyte-activating determinants responsible
are coded for in the I region (or its equivalent in other
species), although there may be some involvment of class I
antigens (Dutton, 1966; Klein _et al., 1981).
1.1.1.4.4 Control of the immune response.
It is clear that the MHC is implicated in the
degree to which individuals are capable of responding to
antigen (reviewed by Benacerraf & Germain, 1978;
Zinkernagel & Doherty, 1979). The loci concerned generally
map to the I region of the mouse although such loci mapping
in the K region have been reported (Shearer et al., 1975;
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Schmitt-Verhulst & Shearer, 1975, 1976; Zaleskl &
Klein, 1977; Zinkernagel _et al, 1978b; Maron &
Cohen, 197 9).
In some instances non-response with regard to
antibody production is believed to be the result of
suppressor T cell activity. The immune suppression genes
map in the I region of the H-2 system (Klein _et al., 1981).
1.1.1.4.5 Control of T-B cell collaboration.
The antibody response to most antigens requires
the interaction of T helper cells with B cells, in the
induction phase. It is a widely-held view that such
interaction is influenced by genes mapping in the I region,
although the precise nature of I region control is unclear.
Thus Katz et al., (1975) suggested that a degree of I
region homology between interacting T and B cells was
required for optimal antibody response, a view supported by
the results of Sprent & von Boehmer (1976) and Sprent
(1978), whereas the results of Taussig _et al^., (1975) and
Heber-Katz & Wilson (1975) are at variance with this.
1.1.1.4.6 Antigen presenting cell/T helper cell interaction.
T helper cells show dual recognition in their
interaction with antigen presenting cells (APC); this
being the stage before T helper/B cell interaction.
The T helper cell recognises the antigen
presented and I region-coded MHC antigens (Erb &
Feldmann, 1978; Sprent, 1978; Ishii _et al., 1982).
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1.1.1.4.7 Restriction of cytotoxic T lymphocyte (CTL) function.
This is discussed in detail in 1.1.1.5.
CTL are effectors in the immune response to cells
rendered antigenic by infecting agents, chemical
modification, minor histocompatibility antigen differences
and male Y antigen. The effector CTL is restricted in the
sense that it can only interact when identical MHC-coded
antigens are present on both stimulator and target cell.
There does not appear to be a requirement for total
identity however, and in mouse systems, sharing of either K
or D~-coded antigens is all that is required. In this sense
the effector cells show dual specificity; that is for the
"new" antigenic determinant(s) and for the MHC~coded
antigens of the inducing cell.
1.1.1.4.8 Control of suppressor T cell function.
I region control of suppressor T cell function is
reviewed by Benacerraf (1981).
The results of recent work (Speck & Pierce, 1982)
suggest MHC restriction of antibody-specific
immunoregulation, mediated by T cells on B cells, although
results of other workers have failed to show this
(Yamauchi et al., 1981).
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1.1.1.5 MHC restriction of CTL function
Mitchison (1954) speculated that cellular immune
recognition of skin sensitising antigens occurs only when the
antigens appear on cell membranes, thus resembling foreign
transplantion antigens. Lawrence (1959) intuitively proposed that
immune cells recognise parasite antigen expressed on macrophages in
association with self antigen. Further evolution of the concept that
foreign antigen is recognised by immune T cells in association with
self antigen came with the reports of Svet-Moldavsky et al., (1967)
and Holterman & Majde (1969, 1971) which suggested that rejection of
virus-infected syngeneic cells or grafts resembles allograft
rejection.
The concept was finally crystallised when Doherty &
Zinkernagel (1974) and Zinkernagel & Doherty (1974a) reported that
CTL of mice infected with lymphocytic choriomeningitis virus (LCMV)
interact only with H—2 compatible virus—infected target cells and
thus show the dual specificity already referred to in 1.1.1.4.7.
This phenomenon was found not to solely be a feature of
virus systems when Shearer (1974) reported that it also applies to
the CTL response to trinitrophenyl—haptenated lymphocytes. As
reviewed by Doherty _e_t al., (1976) and Zinkernagel and Doherty (1979)
this phenomenon was also observed for a number of mouse virus
infections of diverse type and was extended to other species.
Furthermore, it was found to apply to the CTL response to minor
histocompatibility antigens (Bevan, 1975a) and to the male Y antigen
(Gordon et al., 1975) and has now been demonstrated in the human
Epstein-Barr virus system (Moss et al., 1981), influenza virus system
(McMichael et al., 1977; Shaw & Biddison, 1979) and for measles
virus infection (Kreth et al., 1979). Restriction in the human
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system was first shown with H-Y (Goulmy et al., 1977).
An important point concerning the MHC component of the dual
specificity of CTL is that it is the class I antigens which are
recognised (i.e., K and D~coded in mice) and further, antigens coded
for by either, and not necessarily both loci are required to be
shared between effector and target cells (Shreffler & David, 1975;
Doherty _et al., 1976). Sharing of class II antigens alone is
insufficient for successful interaction.
A further important feature of MHC restriction is that it
may be biased towards the MHC type of the environment in which CTL
effector function developes (Bevan, 1977; von Boehmer _et al., 1978;
Kappler & Marrack, 1978; Sprent, 1978; Zinkernagel et al., 1978a;
Waldman jet al., 1979). It is demonstrated in chimaeric mice and in
the classical example the chimaera is composed of F1 (P/Q) bone
marrow cells inoculated into parental strain P or Q animals. CTL
from such chimaeras respond preferentially to either P or Q target
cells, depending on the parental host strain. The organ responsible
for the bias is now known to be the thymus (Fink & Bevan, 1978;
Zinkernagel _et al^., 1978a; Miller et al., 1979;
Waldman _et al., 1979) and the phenomenon is referred to as "thymic
bending".
Of significance for an understanding of the relevance of
MHC restriction is the fact that the cytotoxic T lymphocyte is known
to be an effector in the immune response _rn vivo (reviewed by
Doherty _et a_l., 1976; Zinkernagel & Doherty, 1979). The implication
is that the phenomenon of dual specificity is not simply an
interesting observation restricted to the laboratory with no
importance in immune function, a view which may well be applied to
the allograft reaction, the CML response in coculture of
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MHC-differing cells, and the MLR response in the same situation.
Klein et al., (1981) advanced the thesis that the requirement for
simultaneous recognition of antigen and MHC products is probably the
real function of major histocompatibility systems. This view is
shared by Benacerraf (1981).
Because of the importance of the MHC restriction of CTL, a
consideration of what is understood about the mechanisms involved is
justified.
With regard to the requirement for sharing of only a part
of the genome (i.e., either K or D~coded specificities in mice) for
successful effector-target interaction, the results of the initial
work of Doherty & Zinkernagel and colleagues suggest that separate
clones of T cells evolve which in the case of the H-2 system
recognise only K or D, but not both simultaneously (Zinkernagel &
Doherty, 1974b, 1975). This means that a mouse heterozygous at both
the relevant loci could possess at least 4 clones of T cells reactive
to virus-infected cells.
There has been a great deal of discussion in recent years
concerning the molecular mechanisms involved in MHC restriction. One
view is that the driving factor in the generation and the effector
activity of the immune T cell is a response to altered self. This
so-called "altered-self" hypothesis does indeed acknowledge much of
the experimental evidence. Shortly after the demonstration of dual
recognition, Doherty et al., (1976) favoured the altered-self
hypothesis partly on the grounds that it accomodated what was known
concerning the recognition of alloantigens. This aspect of MHC
restriction is elaborated on by Benacerraf (1981), whose hypothesis
is that alloreactivity is a result of the differentiation of T cells
in the thymus that are strongly reactive with variants of self MHC
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antigens because allogeneic MHC antigens are in fact seen by the
immune system as self variants. Matzinger (1981) takes this further
in accomodating alloreactivity in the altered-self hypothesis.
Further supportive evidence for the altered-self model is
that mutations within the H-2 system can affect interaction of T
cells with virus-infected targets and at the same time leave
unaltered the interaction with TNP-modified target cells
(Doherty _et al., 1976).
A basic assumption inherent in this view is that the T cell
recognises neither foreign antigen nor self MHC-coded products, but
an antigenic entity formed by a molecular complex of the two. This
is discussed in detail by Matzinger (1981). In this respect, as
pointed out by Doherty_et aJ., (1976), the altered-self hypothesis is
immunologically more conventional than the alternative view that the
two specificities recognised are recognised as separate, distinct
entities (the dual recognition model).
A second basic assumption is that T cells are triggered to
mature or differentiate only when they bind to MHC-coded molecules on
the surface of a specialised antigen-presenting cell. T cells
binding to free antigens will not be activated, but those binding to
antigen in some association with MHC molecules will respond. As with
other theories concerning the initiation of T cell activity, some
form of tolerisation to prevent activation against self MHC alone,
and in combination with other self antigens, must occur. The
altered-self/single receptor view of CTL induction and effector
activity is consistent with many of the findings of studies
undertaken since it was first proposed as a possible explanation.
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Thus,
1. MHC restriction is not absolute, i.e., T cells capable of
recognising self combinations with foreign antigen can (although
to a much more limited degree) recognise the same antigen on a
non-self background (Peavey & Pierce, 1975; Fischer Lindahl &
Wilson, 1977; Teh _ejt al., 1978a & b) . This is explained by
similarities, as well as differences, between different MHC
molecules allowing a degree of cross-reactivity.
2. Neither free MHC-coded products nor free antigen block T
cell activity (Shearer, 1974; Plata & Levy, 1974;
Todd _et ^1., 1975; Basten ^t , 1975). Further, to be bound
by T cells, MHC molecules and antigen must be together on the
same membrane (Bevan, 1975b; Swierkosz _et al., 1977; Watt &
Gooding, 1980).
3. Alloreactivity is easily accomodated within the
altered-self/single receptor hypothesis if it is accepted that
there is no reason why a T cell reacting with a cell of foreign
MHC type cannot be induced to differentiate in just the same way
as when interacting with self cells. On the other hand, the
dual recognition model has to invoke a special case phenomenon
for alloreactivity because the separate receptor for self MHC in
this model would not be effective. Benacerraf (1981) however,
argues for cross-reactivity on this point but this again is to
invoke a concept which is not required in the interaction model
of antigen/MHC singularity. Further, the latter readily
explains the extremely strong antigenic nature of MHC antigens
which may result in activation of up to 10% of T cells
(Dutton, 1966; Fischer Lindahl & Wilson, 1977), again without
new assumptions. Thus an individual presented with foreign
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cells will see not only the foreign MHC antigens but many other
antigens in association with the MHC. Therefore response is in
fact against a large number of antigenic determinants and the
response is consequently very great. The important point here
is that many of the antigens of non-MHC type, which are
responded to in association with foreign MHC, need not be
different from their equivalents in the responding animal, but
their interaction with foreign MHC makes them recognisable to
the immune system. The recognition however, is only on this
foreign background and hence no anti-self response is involved.
An extension of this is that if alloreactive cells
only recognise MHC antigens in association, as interaction
antigens, with other cell surface molecules, purified MHC-coded
molecules of the challenge type should not block alloreactivity.
This is found to be the case (Stulting _et al., 1975;
Todd jet al., 1975). It should be emphasised that if such a view
is accepted the assumption is made that alloreactivity is not
essentially different from reactivity against self altered by
foreign antigen and does not therefore require to be viewed as a
special case.
4. Immune response genes can also be accomodated in the model
with 3 possible explanations,
a: Any given antigen may be able to form a successful
interaction antigen with some MHC-coded molecules but not with
others (Benacerraf & Germain, 1978).
b: For any given interaction antigen there may be some
determinants for which there is no T cell receptor gene
(Schwartz, 1978; Benacerraf & Germain, 1978).
c: An interaction antigen may cross-react with a self antigen
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against which, as a result of tolerance, there can be no
response (Schwartz, 1978).
The phenomenon of thymic bending poses problems for the altered~self
hypothesis in that it suggests preselection of MHC specificity prior
to foreign antigen recognition in the context of the MHC. Matzinger
(1981) however proposes that thymic bending is a result of suppressor
activity on the side of the less-preferred MHC type and is therefore
a result of negative selection as opposed to the positive selection
inherent in the dual receptor model.
It should be emphasised however that other theories to
explain the molecular basis of MHC restriction (Janeway et al., 1976;
Klein, 1977; Reinherz et al., 1983; Siliciano ^t aT., 1983) cannot
be refuted on the basis of information acquired to date, and at the
present time the mechanism involved is not known. The
altered-self/interaction model is emphasised in this review because
it has the attraction of simplicity and conceptual appeal and serves
well to illustrate the important points involved in consideration of
the phenomenon of restriction.
1.1.1.6 Polymorphism and linkage disequilibrium
The major histocompatibility systems studied in detail have
proved to be highly polymorphic; the HLA system being a good example
of this. This system is by far the most polymorphic system known in
man (Bodmer, 1972). In man, the overall average frequency of
heterozygotes across all polymorphic loci in the genome is of the
order of 15% (Harris, 1975). This is much lower than that for the A,
B, C and D/DR regions of the HLA system. The HLA A, B, C and D/DR
regions, on the basis of the number of codominant alleles so far
discovered, has several million haplotype or genotype combinations
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possible (Dausset, 1981). As Dausset points out, if one adds to
these combinations, variability (polymorphism) within the
complement-coding region and within other closely-linked loci (which
probably remain to be discovered) virtually every member of an
outbred population will have a uniquely constructed MHC.
It is clear that throughout evolution this complexity has
been preserved in a wide range of species and consequently it must be
assumed that it is of vital importance to survival. Dausset (1981)
advances the theory that the MHC is basically a self-recognition
system derived from primitive genes coding for cell surface molecules
(a view shared by others, as already discussed). Diversity within
the system would become a necessity with the development of organised
multicellular organisms, the tissues of which must co-exist and
cooperate and the cells of which cannot merge with the cells of an
organism of the same species. Recent work leading to the discovery
of a MHC in protochordates provides support for this view
( Scof ield _et al., 1982).
Maintenance of polymorph!sm within the system would be
aided by any selective advantage bestowed on heterozygotes
(D'Amaro, 1978; Bodmer & Bodmer, 1978). Some studies have suggested
heterozygote advantage on the basis of a higher degree of
heterozygosity at the A and B loci in old as compared to young
individuals (Wood & Yunis, 1972; Gerkins et al., 1974;
Macurova _et al^., 1975). The findings of another study are however at
variance with this (Bender et al., 1976).
Linkage disequilibrium is another fundamental feature of
the MHC. In the human species for example, the 4 genetic regions are
closely-linked but are sufficiently distant for relatively frequent
recombinations to occur; the frequencies being 0.8% between A and B
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and 1% between B and D/DR (Dausset, 1981). However certain
haplotypes (combinations of alleles on a single chromosome) occur
more frequently than would be expected to occur by chance. Dausset
describes it as "preferential genetic association between alleles of
several loci of the same complex".
Linkage disequilibrium is measured on the basis of the
difference between observed haplotype frequency (the frequency with
which alleles are actually found to be associated on the same
chromosome) and the product of the individual gene frequencies
(Bodmer _et al., 1966).
Dausset (1981), in his consideration of linkage
disequilibrium within the HLA system, asks whether it is a relic of
ancestral combinations when populations were isolated some thousands
of years ago, or is it a reflection of selective advantage
attributable to certain haplotypes in certain environmental
situations? These two possibilities are not mutually exclusive,
although most workers in the field would attribute greater
significance to a selection influence on both the polymorphism and
linkage disequilibrium which are such basic features of major
histocompatibility systems (Fisher, 1958; Cepellini, 1968;
Bodmer, 1972; Bodmer _et a_l., 1973; Bodmer & Bodmer, 1978).
Relevant in this regard is that in the role of the MHC in the immune
response, complementation of genes at at least 2 loci appears to
occur and this would appear to operate most efficiently when the
genes are on the same chromosome (Dorf et al., 1975; Munro &
Taussig, 1975; Dorf_et al., 1976; Benacerraf & Germain, 1978).
This could in part explain the linkage disequilibrium observed.
Indirect evidence for the importance of selective advantage
in the evolution of the system has been provided by population
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studies in which gene frequency variations between different
polymorphisms have been compared (Bodmer et al., 1973;
Cann jet al., 1973; Piazza jet al., 1973 ) .
The overriding significance of this concept, and one which
is basic to the understanding of the function of the system as it is
viewed at the present time, is that the system itself is of
indispensable importance to the organism, whether the organism is a
primitive tunicate or a primate. Beginning possibly as a mechanism
for maintaining individual organism identity, it apparently has taken
on other functions in the area of cooperation between cells within
the individual which have benefited from extreme variation, from the
point of view of population as well as individual survival. As a
result, the selective adaptation of the system has resulted in
complexity and almost bewildering diversity. An understanding of the
reason for this is vital to, and an integral part of, an
understanding of the biological role of this portion of the genome.
Additionally, the diversity within the system does make it
of considerable interest to workers not solely involved in the
unravelling of the basic genetics. It may be used to characterise
populations and discern origins and histories. Moreover, it must be
of interest to all involved in the search for genetic markers and for
a number of reasons, some of which have already been discussed,
especially to those concerned with markers of disease
resistance/susceptibiltity.
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1.1.2 The bovine MHC.
Knowledge of the bovine MHC is still in its infancy,
although studies on both the class I and class II antigens is gaining
momentum in laboratories in Europe, North America, Australia and
Africa.
Borovska & Demant (1967) reported a correlation between
lymphocytotoxic activity and the S antigen system on bovine
erythrocytes using antisera produced by whole blood immunisation.
Later, Hruban & Simon (1973) showed that the J antigen could be
associated with bovine lymphocytes.
McGary & Stone (1970), Ostrand-Rosenberg & Stormont (1974)
and Folger & Hines (1976) failed to demonstrate a relationship
between antilymphocyte activity and antierythrocyte specificity in
typing reagents, thus suggesting that distinct leucocyte antigens
were a reality.
Schmid & Cwik (1972) reported the production of 28
lymphocytotoxic sera by iso and heteroimmunisation which they
believed recognised a leucocyte-specific antigen system and
Iha _et al., (1973), using alloantisera raised against whole blood and
isolated lymphocytes, reported activity in such sera against HLA
specificities.
Following this, a number of groups independently pursued a
definition of the BoLA system. Caldwell _et al., (1977) and Caldwell
(1979) reported early attempts at serological definition. Amorena &
Stone (1978) defined 11 antigens and suggested that they were the
products of alleles at a single locus and importantly they reported
prolongation of graft survival in donor/recipient combinations
sharing these antigens. Spooner _et al., (1978) reported evidence for
a MHC in cattle, again as the result of the use of antilymphocyte
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sera. In common with other groups they demonstrated simple Mendelian
inheritance of the specificities which they were able to detect in
their study population.
Spooner _et al., (1978) also reported their methodology in
detail which demonstrates a clear difference from that employed in
HLA typing, particularly with regard to the production of
antilymphocyte sera. Whereas serological HLA typing to date has
relied on the use of sera obtained from multiparous donors, most
groups engaged in BoIA research have to a large degree worked with
sera raised by alloimmunisation, whether with lymphocytes or skin.
Further, as pointed out by Spooner et alL., absorption of such sera
with lymphocytes does not present great difficulties because of the
ease with which absorbing cells can be obtained in large numbers from
cattle donors.
Alloimmunisation results in the production of antisera
which generally are of higher titre than parous sera and which, by a
process of selective absorptions and/or careful selection of titre
level for antilymphocyte testing, can be made operationally
monospecific (Spooner _et al., 1980).
Further progress in the characterisation of the class 1
system has come as the result of an international collaborative
effort. To date, 2 international comparison tests have been
undertaken (Spooner et al., 1979; Anon, 1982). The first such test
was undertaken in Edinburgh in which 249 alloantisera to bovine
lymphocytes contributed by 9 laboratories were compared for
reactivity on a panel of lymphocytes from 130 cattle of 21 breeds.
The test used was the microlymphocytotoxicity test as described by
Spooner _et al., (1978). Eleven serum clusters were defined and given
BoLA designations. In the second test, cells rather than sera were
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exchanged and in all, 362 alloantisera originating in 9 laboratories
were tested against a panel of 144 lymphocyte samples from 7
laboratories. Ten of the 11 specificities defined in the first
comparison test were confirmed and an additional 6 specificities were
designated, 2 of which appear to be subgroups of w6 as defined in
both tests.
It is interesting to note that despite this intense effort
there is as yet no firm evidence to suggest that class I
specificities coded-for by alleles at more than 1 locus are being
detected. A further indication that there is still a considerable
amount of work to be done in characterising the system is that in the
second international comparison test, even on the basis of a single
locus model, only 66% of the alleles were identified as accepted
specificities. One must assume that those so far discovered are
either the most frequent in the cattle types studied and/or the most
antigenic specificities.
A limited amount of work has so far been reported on breed
frequencies of BoLA specificities, but it is clear that there may be
significant differences between breeds. Caldwell _et al., (1979)
reported breed differences in the frequencies of 6 antigens. In this
study, 675 cattle were tested for lymphocyte reactivity against a
panel of typing antisera. The cattle were of 5 Bos taurus breeds and
a Bos indicus/Bos taurus cross (Brahman/Hereford). Although the
authors did not claim that their results were representative of the
breeds, there were strong indications of significant differences in
frequencies between the breeds studied. Furthermore, some breeds
failed to evidence certain specificities. Interestingly, the highest
frequency of the null allele was observed in the B.indicus/B.taurus
crossbred group.
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Oliver _et al., (1981) reported a further study of BoLA
breed frequencies, and the first family studies of BoLA
specificities. This concentrated on 13 of the internationally-agreed
specificities and a regionally-defined specificity in 6 breeds of
cattle. Again, significant differences were found between breeds;
examples being the frequency of w9 which was not detected in 3 breeds
but was found to represent a gene frequency of 22% in the Herefords
studied with the next highest frequency of 2.4% in the Ayrshire
group. Specificity w6 produced a gene frequency of 46% in the
Jerseys with the next highest frequency of 16.4% in the Friesians.
It was again evident from this study that a number of alleles are
still to be detected. The frequency of the null allele ranged from
74% in 18 Charolais bulls to 10% in a group of Friesian females. In
this regard it is perhaps significant that the Friesian breed was the
largest source of antilymphocyte sera.
Relatively little work has been reported concerning
putative class II antigens of cattle. Usinger _et al., (1977) and
Curie Cohen et al., (1978) suggested that 2, and possibly 4,
determinants may be involved in mixed lymphocyte reactivity. A
further report (Usinger _et al., 1981) suggests close linkage of this
region with the BoLA A locus controlling class I antigens. In this
respect therefore, the bovine system would appear to be essentially
similar to others so far studied.
An attempt to define class II antigens serologically has
also been reported (Newman et al., 1982). In this work, cytotoxicity
of alloantisera for B lymphocytes was studied by a 2~colour
flourescence technique whereby B cells were identified by the
presence of immunoglobulin on the cell surface with an anti-bovine
Ig/flour escein conjugate and cytotoxicity was assessed by the uptake
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of ethidium bromide by dead cells. Using family studies to support
and extend cluster analysis of typing reagents, evidence was
presented for the identification of B lymphocyte-associated
specificities, expressed and inherited in an autosomal codominant
fashion. The null allele frequency in this study (53%) suggests a
high degree of polymorphism.
There was no clear evidence of multilocus control of the
specificities defined.
The restricted distribution of these antigens on blood
cells, and the probable linkage with class I, demonstrated together
with the degree of polymorphism suspected, are consistent with the
fact that class II specificities were being detected.
What is presently known of the BoLA system suggests a close
resemblance with the equivalent systems in other species. Additional
evidence for similarity is furnished by the biochemical studies of
Hoang-Xuan et al., (1982a) on class I products and
Hoang-Xuan _et al., (1982b) on class II products, which show
similarities of structure with equivalent products in other species.
1.2 East Coast fever
1.2.1 Introduction
ECF is a disease of bovids occurring in East, Central and
Southern Africa. The first description of the causative organisms
can be ascribed to several workers in the latter part of the last
century and the early 1900's (reviewed by Neitz, 1957). Prominent
among later workers in their description of the parasites are Neitz
(1957) and Barnett (1977).
ECF can be regarded as a syndrome wherein 3 types of
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disease can be distinguished on clinical, epidemiological and
parasitological grounds. The causative protozoan organisms belong to
the genus Theileria.







The 3 disease manifestations within the ECF syndrome have
in the past been ascribed to infection with 3 different forms of
Theileria. A trinomial nomenclature has been suggested (Young, 1981)
to distinguish the causative organisms. These and the diseases with
which they are associated are;
Theileria parva parva classical ECF
Theileria parva lawrencei Corridor disease
Theileria parva bovis Rhodesian malignant theileriosis
As suggested by Uilenberg (1981), this categorisation
should probably at the present time be considered as only a
convenience. It seems more likely that ECF in its broadest sense is
the manifestation of infection by any one of a variety of strains of
T.parva, which in effect are a spectrum of types producing a variety
of disease syndromes.
The T.parva group can be considered to encompass parasites
of cattle (Bos indicus and Bos taurus), the African buffalo (Syncerus
caffer) and domestic buffalo (Bubalus bubalis). Classical ECF can be
regarded as the typical disease resulting from the maintenance of the
parasite in B.indicus and B.taurus and the vector in the field with
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no involvraent of the buffalo. Corridor disease results from transfer
of the parasite into cattle from a buffalo-maintained reservoir.
Rhodesian malignant theileriosis covers disease syndromes due to
infection with types of the causative organism falling between those
responsible for classical ECF and those responsible for Corridor
disease (Uilenberg, 1981). There have been a number of reviews of
the symptomatology, epizootiology and pathology of ECF (Neitz, 1957;
Barnett, 1968, 1977). In brief, field transmission of the protozoan
parasite between mammalian hosts occurs via the tick vector
Rhipicephalus appendiculatus (the Brown Ear Tick). The vector is a 3
host tick and transmission is transtadial. Transovarial transmission
has not been demonstrated. The disease is restricted to those areas
where R.appendiculatus occurs and within these areas is a major
constraint on the cattle industry. Morbidity and mortality rates
approach 100% in susceptible cattle exposed in ECF areas when no form
of disease control is practised (Cunningham, 1977). Neitz (1957)
stated that mortality rates in calves and adult stock in South Africa
were more than 95%, but cites Lanham (1957) who gives a mortality
rate of 78%. Although not stated, it must be presumed that these
figures refer to fully susceptible populations.
The pathogenesis of the disease is covered by the reviewers
already cited. Briefly, the first evidence of the parasite in bovine
host cells is the appearance of an intracellular macroschizont in
cells of the lymphoid series, which in natural tick infections is
first seen in the parotid lymph nodes 4-6 days after tick attachment.
As the disease progresses there is a rise in body temperature,
usually occurring several days after first appearance of
macroschizonts and 10-17 days after tick attachment.
Macroschizont-containing lymphoid cells are then found in increasing
page 27
numbers in the vascular system, parenchymatous organs, and have a
widespread lymph node distribution.
Several days after the appearance of macroschizonts and
pyrexia, microschizonts are found in lymphoid cells and it is
believed that at some point, macroschizont production switches to the
microschizont production phase, but the factors which stimulate this
change are presently unknown. The microschizont eventually
disentegrates to produce micromerozoites which invade erythrocytes to
produce the piroplasms typical of theileriosis. These are infective
for the tick and represent the culmination of the mammalian part of
the parasite cycle. Death may occur 2-4 weeks following tick
attachment.
It is believed that the macroschizont development stage is
the principal pathological stage and it is the macroschizont-bearing
lymphoid cell which has been adapted for _in vitro study
(Hulliger _et jal., 1964; Malmquist et: al., 1970).
Hulliger _et al., (1964) also made the observation that the
macroschizont divides in synchrony with the host cell, so that each
daughter cell bears a macroschizont following division. This
important observation has significance for the understanding of the
immunology of the disease.
Terminally in the disease process severe leucopenia occurs
and post-mortem findings are consistent with widespread lymphoid
involvement with enlarged, moist and often haemorrhagic lymph nodes,
which on histological examination appear exhausted and show
lymphocytolysis and degeneration (De Martini & Moulton, 1973).
It is evident that in cattle, the disease is extremely
virulent. Moreover, Barnett & Bailey (1957) determined that a fatal
disease reaction can, and usually does, ensue as the result of the
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feeding of a single infected tick on naive animals.
In general terms therefore, ECF in cattle can be considered
as primarily a disease of the lymphoid system, characterised by the
intracellular proliferation of parasites of the species T.parva, the
result of which, in fully susceptible animals is the breakdown of
that system. Animals undergoing a disease episode may mount an
immune response, but in those animals suffering fatal infections the
development of this response is late in relation to parasite
development (Jarrett et al., 1966; Pearson et al., 1979;
Morrison et al., 1981).
1.2.2 Immunity to East Coast fever
1.2.2.1 Humoral immune mechanisms
As a result of the apparent failure of most, though not
all, workers to reveal a therapeutic effect of recovery serum
(reviewed by Wilde, 1967) and the universal failure to detect
colostral transfer of immunity, the possibility that humoral factors
play a part in protection against the disease has for some time been
largely discounted. Further, to date it has not proved possible
using serological techniques to demonstrate "new" antigens on the
surface of infected cells cultured JLn vitro (Duffus j2t al, 1978;
Creeraers, 1982). However it may be premature to completely rule out
a humoral factor in ECF immunity. Antibodies to the parasite are
indeed produced in challenged animals but so far these have been
found to be restricted to the intracellular schizont and piroplasm
S
stages. The development of this r^jonse is well characterised
(Burridge & Kimber, 1972; Burridge _et ad ., 1973a & b; Duffus &
Wagner, 1974; Wagner _et al., 1975). The demonstration of such
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activity in sera by the indirect fl//rescent antibody test (IFAT)
(Burridge & Kimber, 1972) is the standard method for assessing
immunity to ECF and previous exposure in epidemiological studies.
Such antibody activity however, may not play a role in
protective immunity for several reasons. First, immunity to ECF
outlasts detectable antibody to a considerable degree
(Burridge _et al., 1973b). Second, Wagner et al., (1975) in a study
of the antibody response in cattle to a severe stabilate challenge
found that animals succumbing to the challenge developed antibody
responses which were qualitatively and quantitatively
indistinguishable from the responses in those animals surviving the
infection. Moreover, in a comparison with these results and those
obtained previously following a less severe challenge (Duffus &
Wagner, 1974) it is apparent that those animals suffering the more
severe challenge developed a greater antibody response than those
undergoing more mild disease responses. As these workers pointed
out, this was probably a reflection of the greater antigenic stimulus
occurring in the heavy parasitoses.
Wagner _et al., (1974) reported on the development of the
antibody response following the inoculation into cattle of isolated
piroplasm and schizont antigen. Significantly, despite the fact that
all the cattle involved developed specific antibody to these
antigens, and to the same degree as cattle recovering from clinical
disease episodes, the animals receiving the isolated antigens all
succumbed to stabilate challenge subsequently. Emery _et al., (1981a)
also found no correlation between the antibody response to schizont
material and the level of resistance to challenge after the
inoculation of various putative immunogens.
Wagner & Duffus (1974) reported a different approach which
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involved a study of the development of antilymphocyte activity (ALA)
in sera of cattle subjected to inoculations of uninfected and
T.parva-transformed lymphoid cells. T.parva parva and T.parva
lawrenc_ei~ trans formed LCLs were used in this work. ALA was generated
in recipients of all 3 types of cell with slight differences in the
kinetics of the response. ALA was measured by the
migration-inhibition properties of post-inoculation serum samples
measured against infected lymphoblasts and uninfected lymphocytes.
Cattle receiving Theileria-transformed cells developed ALA earlier,
and ultimately to a greater degree, than cattle receiving uninfected
lymphocytes. Wagner & Duffus (1974) hypothesised as a result that
transformation resulted in increased antigenicity. It did not appear
from the results that ALA developed by individuals bore any
relationship to resistance to subsequent challenge. A further point
for comparison with the results of later work is that no ALA was
detected in this system in the sera of animals undergoing patent ECF
reactions induced by the inoculation of infected tick material, or in
animals recovered from such infections.
Should there be a humoral factor in resistance to ECF it
seems most likely that it would operate on the newly-inoculated
sporozoite or early transforming cell rather than on an established
intracellular parasite per se. This area has not been fully
investigated to date. However, preliminary results of work on the
effects of immune serum on the _in vitro infectivity for lymphoid
cells of T.annulata (causative agent of tropical theileriosis)
sporozoite preparations suggest that there is a neutralisation effect
(Gray & Brown, 1981). Neutralisation of sporozoites assayed by in
vivo infectivity has also now been demonstrated in the T.parva system
(Musoke et al., 1982). If such a system were to operate in vivo
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directly on the sporozoite, recent electronmicrograph studies of the
sporozoite/target cell interaction (Stagg _et al., 1981;
Fawcett et al., 1982) would suggest that it must be capable of
producing an effect at the time that the sporozoites are introduced
into the animal in view of the fact that sporozoites in vitro are
capable of finding and invading host cells within minutes of being
added to the cell preparation. It is not inconceivable that such a
humoral mechanism could operate in vivo and because of this, work
continues on inactivated-sporozoite vaccines, which hitherto have
been unrewarding.
1.2.2.2 Cell-mediated immune mechanisms
It has for some time been suspected that cell-mediated
immune mechanisms operate in ECF resistance and a number of workers
have proposed that cell-mediated immunity (CMI) is the principal, or
even sole factor in conferring resistance to the disease.
Aspects of CMI as measured by leucocyte-migration
inhibition tests were studied by Muhammed et al., (1974). In this
work, leucocyte migration was measured and the effect on this of
exposure to T.parva antigens assessed. Both schizont and piroplasm
antigens were used and cattle donating the PBL for the tests were
either ECF naive, recovered from tick tissue-derived infection, or
previously inoculated with killed T.parva antigen (schizont) in
combination with adjuvant. Migration inhibition of PBL from naive
animals was not induced by exposure to antigen in 4 animals tested.
Of 5 animals recovered from tick-derived infections, all showed
sensitivity to either or both antigens used in the test and in 2
cases for up to 8 months after initial infection. Nine of 12 cattle
exposed to killed parasite antigen were sensitised as assessed by the
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test when tested up to 28 days after inoculation. Of particular
interest are the results of tests on cells of 5 cattle inoculated
g
with 10 LCL cells. PBL of 3 of these cattle were sensitive to
schizont antigen in the migration inhibition test.
Care needs to be ex^ercised in the interpretation of these
results because of the possible complication of sensitisation to
cellular components rather than parasite material per se in the
cattle studied, with the exception of those cattle recovered from a
tick-derived infection. However it was the latter group which showed
the best and most prolonged sensitivity in the migration inhibition
test, which adds weight to the fact that this test was genuinely
measuring sensitivity to parasite antigen.
The immunity of the cattle studied, as assessed by
resistance to subsequent challenge was only reportedly studied in the
tick-derived infection group and these were resistant to challenge.
It would seem unlikely that the short-lived responses in the other
groups would indicate immunity because, as will be discussed in a
subsequent section, inoculation of killed parasite material is not
generally regarded as an effective means of inducing immunity to ECF.
Muhammed (1975) made a further report on migration
inhibition after exposure to T.parva antigens. In this work the
assay used assessed the migration-inhibiting properties of PBL from
ECF-immune animals on T.parva-transformed lymphoblasts. The PBL of
only 1 of 10 naive animals were capable of eliciting migration
inhibition. This was also true of 7 of 8 PBL samples from animals
7
which had received a 10 LCL cell inoculation followed by stabilate
challenge (2 of these died at 3-4 weeks following challenge). The
PBL of 2 of 4 animals successfully immunised against homologous
challenge by stabilate combined with tetracycline administration,
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inhibited lymphoblast migration. The result of the work on the
tissue-culture material immunised animals again could be complicated
by the fact that they had, prior to the test, experienced both cell
and parasite antigen and in this respect a control in the form of a
measurement of migration inhibition activity of PBL from animals
which had experienced non-infected allogeneic leucocytes would have
been informative.
If the tissue culture recipients are ignored in these
results, 2 of 4 immune cattle had a migration inhibition capability
compared with 1 of 10 susceptible cattle. Of the tissue culture
inoculated/stabilate challenge animals, 2 of these died of ECF a few
days after the PBL were shown to have the greatest migration
inhibition activity of all the cattle studied.
Summarising these results, it would seem that the migration
inhibition measured was not proven to be a good indication of immune
status, conforming with the results of the 2 other migration
inhibition assays already discussed.
The results of Emery _e£ al., (1981a) are consistent with
this overall view. In this case the development of a lymphocyte
transformation response to ultrasonicated infected cell line material
was not correlated with resistance to challenge.
Real progress in the development of knowledge of CMI in ECF
came with the results of Pearson _et al., (1979). In this study, the
antigenic nature of the surface of T.parva- trans formed cells was
studied _in vitro using the mixed-lymphocyte reaction (MLR) and
cell-mediated cytotoxicity (CMC) assays. They found that transformed
cells stimulated radio-labelled nucleotide uptake in autologous PBL
from immune and naive animals and with the same kinetics in each
case. Further, normal PBL were equally stimulated in the MLR by
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autologous and allogeneic transformed cells. Interestingly, in the
allogeneic system, transformed cells had a greater stimulating effect
than the equivalent non-transformed PBL. This suggested that the
antigenicity of the cell surface is in some way increased by
T.parva-induced transformation which is consistent with the earlier
results of Wagner & Duffus (1974) in which the ability of allogeneic
cells to induce a humoral response was reported.
Pearson _et al., (1979) concluded from their results that the
stimulation induced by T.parva-transformed cells was not simply a
response to differences in "normal" histocompatibility antigens. If
"normal" refers to MHC-coded antigens as they would appear on
norr-transformed cells there is every reason to agree with this
conclusion as this does not exclude the possibility that the
increased antigenicity of the transformed cell is due to alterations
in histocompatibility antigens. That such alterations may occur, and
indeed be solely responsible for the antigenic changes occurring in
transformation cannot, with present knowledge, be excluded.
A number of control experiments were included in this work
which strengthened the view that stimulation in MLR was due to
Theileria-induced changes, and such stimulation was only evident when
intact and viable cells were used as stimulators. Free schizonts
were not stimulatory.
When cell-mediated cytotoxicity was studied, a difference
was found between the cells of immune and non-immune donors. The PBL
of 3 immune donors, after stimulation in vitro by coculture with
autologous transformed cells, were cytotoxic for autologous
T.parva-transformed targets. A lower level of killing of allogeneic
transformed targets was also reported for these 3 immune donors.
Cells derived from 2 non—immune donors did not effect cytolysis.
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Pearson _et al., (1979) suggested that the MLR was a
reflection of the generation of helper or cytotoxic cell precursors
taking place on initial exposure to antigen and that the secondary
CMC was the result of this when the cells of immune animals were
used. However in this regard, it is perhaps significant that the
MLRs did not correlate with donor immunity. Further, the restriction
of cytotoxicity to _rn vitro systems derived from immune rather than
non-immune donors has not been repeatable in other hands (Emery &
Kar, 1983).
Eugie & Emery (1981) studied the development of a cytotoxic
cell population in the PBL of immunised animals. Immunisation was
achieved using the stabilate plus tetracycline regime
(Radley _et _al., 1975b) followed by either a stabilate challenge or
the inoculation of sporozoites in association with autologous PBL.
At intervals following this the direct cytotoxic capability of PBL
was monitored. The targets were autologous and allogeneic
T.parva-infected cells, derived from in vitro transformations, and
xenogeneic cells not infected with Theileria parva.
When immune animals were challenged with stabilate,
macroschizont—bearing cells could not be detected histologically in
the draining lymph nodes nor in efferent lymph. Further, these lymph
node cells (LNC) were unable to stimulate an autologous MLR in
cryopreserved PBL. This contrasts with the situation found in the
second week of a lethal primary infection (Emery & Morrison, 1980).
That the autologous MLR is dependent on a degree of
parasite-associated transformation, was confirmed by the fact that
some animals challenged with sporozoites in associay/ftion with cells
did show a transient intracellular parasitosis in lymph efferent from
the inoculation site draining lymph node, and blastogenesis (degree
page 36
of parasite-associated transformation) in LNC, and these elicited a
MLR. The association between parasitosis and in vitro stimulation in
MLR was also noted by Emery & Morrison (1980).
In the study reported by Eugie & Emery (1981) both forms of
challenge induced cytotoxic activity against autologous infected
cells in post-inoculation PBL taken from 10 days post-challenge.
This development of cytotoxic activity was less delayed following
subsequent challenge of immunised animals.
Cytotoxic activity was also induced by challenge with
autologous infected cells, and was also restricted to autologous
targets.
In their system, Eugie & Emery (1981) found that cytotoxic
activity of post-challenge PBL waned after peaking at about 14 days
after a primary challenge and was undetectable by approximately 21
days post-challenge.
These workers also reported some differences in their
results in a comparison with those of Pearson et al., (1979). At no
time in their immunised animals were they able to detect allogeneic
cytotoxic capability in PBL. The evidence for genetic restriction
was reinforced by an experiment on cotwins in which it was found that
cotwin cells were killed as effectively as autologous cells.
Pearson _et al., (1979) reported effective cytotoxicity in the
autologous _in vitro generation system which appeared to be
well-developed, but also reported a "low level" of allogeneic
killing.
In summary, genetic restriction was found in both systems
studied, which appeared absolute in one case, and was marked in the
other. This contrasts with the allogeneic and xenogeneic killing
seen in lethal primary infections (Eugie & Emery, 1981;
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Eugie _et _al., 1981). Eugie & Emery (1981) also reported that
cytotoxic capability was seen post-challenge in immunised cattle in
PBL which had not been prestimulated in mixed lymphocyte culture
(MLR). Pearson jet al., (1979) studied secondary CMC.
In a subsequent report Pearson _et al., (1982) presented
results of further studies on the ability of Theileria-transformed
cells to induce MLR and CMC responses in PBL harvested from immune
and non-immune cattle. This work largely confirmed their previous
findings, in that cytotoxic cells were only generated in MLR in PBL
from immune cattle. The report goes further however in a number of
respects. First, it confirms that in addition to a specific,
self-restricted cytotoxic cell response there may be a non-restricted
response following _in vitro stimulation with either autologous or
allogeneic infected cells; this again being in contrast to the
findings of Eugie & Emery (1981) where the in vivo generation system
was studied. Cold-target blocking in conjunction with
u.»
autoradiography/immune fl/*r escence characterisation suggested that
the genetically-restricted and non-restricted components are mediated
by different effector populations. The results of Emery & Kar (1983)
are consistent with this and further, suggest that the principal
difference between the in vivo and in vitro generation systems is the
component of non-restricted effector cells generated in the in vitro
system.
Interestingly, the results reported by
Pearson _et al., (1982) suggest that cell lines differ in their
efficiency as in vitro stimulators in both autologous and allogeneic
situations.
Pearson etal., (1979, 1982) and Eugie & Emery (1981)
associated the CMC response with immunity and suggested that the
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cytotoxic cells developed are a principal effector mechanism _in vivo.
Eugie & Emery (1981) interpreted the kinetics of response to mean
that unless an animal is under challenge, these cells and/or their
precursors reside in the solid lymphoid organs and are mobilised and
appear in the peripheral circulation on challenge, with repeated
challenge making the activation/mobilisation process more rapid.
Emery _et: al., (1981b) reported results of studies on the in
vivo-generated effector cell which suggest that it is of T cell type.
Very good evidence that cell-mediated immune mechanisms are
involved in immunity to ECF was supplied by Emery (1981). In this
work resistance to challenge was passively-transferred between
cotwins with thoracic duct lymphocytes. Further,
Emery _et _al., (1981a) were able to correlate the degree of lytic
activity of PBL against autologous infected cell lines, following
allogeneic cell line immunisation, with resistance conferred to
subsequent sporozoite challenge.
Eugie et al., (1981) reported initial results of a study of
the specificity of _in vitro CMC with regard to parasite isolate.
Prior to immunisation of 3 cattle with T.parva parva (Muguga), 4 LCLs
were established _in vitro infected with 4 different parasite
isolates, from PBL of each of the 3 cattle. One of the isolates was
T.parva parva (Muguga), another was cross-immunising with this in
vivo, and the remaining 2 were not completely cross-immunising with
the Muguga isolate. Following the immunisation with T.parva parva
(Muguga), PBL were assessed for lytic acivity against the 4
respective autologous lines. Good lytic activity was observed
against T.parva parva (Muguga)-infected lines and against the lines
infected with the _in vivo cross-immunising strain. PBL from 1 of the
3 cattle had no lytic activity against the 2 lines infected with the
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other strains, PBL from a second animal showed lytic activity against
1 of these other lines, and PBL from the third, showed a degree of
activity against both of these other lines. Where lysis of the lines
infected with either of the 2 non-cross-immunising strains was
observed, it was at a lower level than against the line infected with
the _in vivo immunising strain and the strain which cross-immunises
with this.
These limited results could prove to be very significant if
it can be shown that CMC does indeed reflect _in vivo resistance to
challenge. This would certainly strengthen the view that T
cell-mediated cytotoxicity is a major protective mechanism. Second,
it would show that there are significant differences between
individuals in the degree to which the immune system can respond
qualitatively and quantitatively to T.parva.
1.2.3 Immunisation against ECF with Theileria-transformed
lymphoblastoid cell lines
The potential of infected cells in a vaccine capacity was
considerably increased following the development of 2 important
techniques. First, the in vitro culture of infected bovine lymphoid
cells taken from patently-infected animals (Hulliger et al., 1964;
Malmquist et al., 1970; Malmquist & Brown, 1974).
Hulliger _et al., (1964) and Brown et al., (1978a) also reported on
the mode of multiplication of the parasite _in vitro and the fact that
the division of the parasite schizont occurs in synchrony with a
division of the hos.t cell. Such infected cells are transformed by
the parasite and in suitable conditions of laboratory maintainance,
the cell lines produced are a constant source of parasite material.
The second major step in the development of T.parva in
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vitro culture came with the work of Brown et al., (1973) who were
able to establish a technique for the in vitro infection of bovine
lymphoid tissues using tick-derived sporozoite preparations to infect
and transform cells. This technique is now routinely used in a
number of laboratories and has greatly facilitated studies of the
cell/parasite relationship, whilst at the same time making possible
the production in the laboratory of the schizont stage of parasite
isolates of varying origin and making them available for various
immunological studies.
From the time that the LCLs became available they were an
obvious subject for study with the object of establishing an ECF
vaccination system. Indeed they held great promise, with lines which
could be grown in suspension cultures yielding 1-3 x 10^ cells/ml (of
which approximately 95% contain macroschizonts), a log 10 growth rate
of 3 days and potential 4 L harvests twice weekly (Cunningham, 1977).
Early vaccination trials were carried out by Brown et al.,
(1964, cited by Wilde, 1967). It was shown in this work that the
intracellular schizont stage of the parasite could be established in
recipient animals by inoculation of infected LCLs. In addition, as a
result of studies undertaken by this group, Wilde suggested that
cattle may be able to mount an immune response to infected LCL cells
per se, and it was subsequently shown that cattle will, under certain
circumstances, generate an antilymphocyte response following
inoculation of T.parva-infected lymphoblastoid cells (Wagner &
Duffus, 1974), as previously discussed.
Wilde and coworkers also investigated the efficacy of
inactivated LCLs administered with and without 3 different adjuvants
(Wilde, 1967). They did not demonstrate the development of immunity
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to either tick-transmitted parasites or homologous tissue culture
strains following the application of these procedures.
Since this work, there has been little published on this
aspect of ECF although the later work has clarified some of the
points concerning the potential of LCLs as ECF vaccines and has
certainly produced a better understanding of the infected
LCL/recipient animal interaction. Moreover, the problems to be faced
in the production of a field vaccine based on LCLs are now more
clearly defined.
Brown et al., (1971) reported that cattle could be infected
7
by inoculating 10 or more cells infected with T.parva. In this
study, it was found that the parasite completed its mammalian cycle.
q
It was also found that high doses of cells (10 ) could produce fatal
infections and that cattle surviving various dose levels between 10
and lO-1 could be resistant to subsequent challenge.
Significant advances in the study of the LCL vaccination
system were reported by Brown _et al., (1978a). It was confirmed that
the parasite can transfer from LCL cells to recipient cells following
inoculation. On transfer to recipient cells both parasite and cells
continue to multiply. This was established by karyotypic analysis of
inoculated cells and of cells subsequently recovered from infected
animals. It should be emphasised here that it has been generally
accepted to the present time that the parasite must establish in the
cells of the recipient animal before immunity can be induced
(Emery _et al., 1981a).
Brown et al., (1978a) also reported the effect of continued
passage _in vitro of infected LCLs. They established that
infectivity, and as they inferred, immunogenicity, varied between
cell lines infected with different isolates of T.parva and between
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different passages of the same line. Two cell lines and 2 isolates
of T.parva parva were studied over a period of 3 years and 300
passages. Both parasites were attenuated by continued passage.
Inocula of 10 and 10 cells were used. With increasing passage
fewer animals were killed as a result of cell inoculation and in the
case of one line at passage 319, all animals survived LCL inoculation
and subsequent stabilate challenge. The second cell line was
effectively attenuated between passages 49 and 205 to the point where
a 10 cell inoculum did not prove fatal in any of the recipients and
87% of these were subsequently immune to challenge with the
homologous parasite isolate in stabilate form. Further passage of
the second, less virulent line, reduced its immunising efficiency in
g
that only 50% of recipients of 10 cells at passage 282 were
subsequently resistant to challenge.
This work was extended to test the immunity produced with
the less virulent line by exposing cattle immunised at an optimal
level in a tick vector-infested paddock in which 3 sequential groups
of susceptible control cattle all died. The cell line-immunised
animals proved resistant to this challenge. Brown _et al., (1978a)
concluded that "....immunisation against homologous tick-derived
challenge is possible using defined quanta of selected passages of
specific cell lines.".
The work done to this point, although showing the potential
of LCLs in a vaccine capacity, also revealed a number of problems
still to be overcome. Prominent amongst these was the number of LCL
cells required to engender immunity in recipient animals. The work
of Brocklesby et al., (1965), Jarrett jet al., (1966),
Pirie _et al.., (1970) and Brown et al., (1971 , 1978a), in particular,
had shown that in order to establish the parasite reliably in the
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majority of recipients, of the order of 10 to 10 cells were
required. These findings contrast with the results of those workers
exploring and developing the T.annulata system in which Pipano & Tsur
(1966), Sergent _et al., (1972) and Hooshmand-Rad (1973) had obtained
**■ b
reliable immunogenesis with 10 to 10 cells. Barnett (1977)
summarised the difference between the 2 systems, at which time as he
pointed out, artificial immunisation against T.annulata had been
practised for 40 years using firstly strains isolated and attenuated
by serial passage in calves and latterly, LCLs. He stated that
b
inocula as low as 2 x 10 infected tissue culture cells enjoyed a
good measure of success in immunisation of even highly-susceptible
exotic stock against tropical theileriosis. At this time LCL
vaccination against tropical theileriosis was already an established
entity and a practical field proposition and is currently
successfully applied in a number of tropical theileriosis areas
(Pipano, 1981).
This situation, if it ever can be achieved with EOF, would
still seem to be some way off. The principal problem to be overcome
at the present time is the requirement for large numbers of cells in
the T.parva system, which necessitates the use of 100-1000 ml of
tissue culture suspension for each animal vaccinated. It has been
known for some time that the inoculation of LCLs could produce a
response to these cells per se in the recipient. This was first
suggested by Wilde (1967) in the context of infected cell
inoculation. Subsequently, Wagner & Duffus (1974) reported that
anti-lymphocyte activity (ALA), as measured by migration-inhibition
and a fluorescent antiglobulin test, was induced in cattle receiving
T.parva parva and T.parva lawrencei-transformed lines.
It is clear from this work that as already stated, the ALAs
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measured in response to infected-LCL inoculation did not correlate
with immunity to subsequent challenge. However it is possibly
significant that the antigens on the LCLs inducing the ALA responses
are unknown. Importantly, in most, if not all cases it appears that
the cells used in the 2 tests for determining ALA could not have been
derived from the same source as the inoculated material. It is
perhaps also pertinent that this fact raises questions about the
meaning of the comparisons between ALA responses to parasitised and
non-parasitised cells previously discussed (1.2.2.1).
Wagner & Duffus (1974) in discussing their results, drew
attention to the possible importance of the histocompatibility system
in the LCL/recipient interaction and subsequent work also indicated
that this was indeed an area requiring study. Of particular
relevance in this context are the results of work carried out by
Brown _et al., (1978b). These workers utilised an in vitro
tick-feeding technique to produce bovine blood and its various
fractions containing infective material. They studied the effect of
inoculating this material into a variety of cattle of B.taurus type.
The parasite used was T.parva parva (Muguga). In 2 initial
experiments in which heparinised-blood tick feed pools were
inoculated into the blood donors (autologous system), and into
unrelated cattle (allogeneic system), all 11 cattle receiving their
own post-tick feed blood developed ECF. Of 9 allogeneic recipients,
none reacted and all subsequently proved susceptible to challenge.
In a further experiment, a tick feed blood pool was inoculated into
the donor, its monozygotic twin and 2 unrelated cattle. The donor
underwent a fatal ECF reaction and its twin underwent a severe
reaction. Neither of the 2 allogeneic recipients reacted and both
proved susceptible on challenge.
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In an attempt to define the transmitting factor in the feed
blood, composite feed substrates were used comprising plasma and
erythrocytes from one donor and leucocytes from another. Five pairs
of cattle were used. All 5 leucocyte donors underwent patent ECF
reactions following inoculation of the tick feed substrate and only 1
of the plasma/erythrocyte donors responded with a detectable
reaction. In the latter category however at least 1, and possibly 2
of the animals not showing obvious initial reactions, survived
challenge and so may have undergone subpatent infections following
inoculation of feed substrate.
The results of these experiments suggested two things.
First, that there is some form of self-restricion in the
LCL/recipient interaction. Such a phenomenon is not observed where
high numbers of infected LCL cells are inoculated into allogeneic
recipients and one must suppose that the parasite/cell dose in the
tick feeds used in this work (Brown et al., 1978b) was below such a
"universal take" level. Second, there was good evidence from the
results that the blood component involved is the leucocyte fraction.
It is now known that the tick-derived sporozoite becomes associated
with PBL within minutes of first contact (at least _in vitro)
(Stagg _et al., 1981; Fawcett et al., 1982), which is entirely
consistent with the hypothesis proposed by Brown _et al., (1978b) that
in an allogeneic system the infected blood fraction is treated as an
allograft and there may be allogeneic inhibition of further
development of the parasite/allogeneic recipient relationship. This
conforms with the early proposals of Wilde (1967) concerning possible
homograft rejection as a consideration in infected cell inoculation
systems.
Further evidence for self-restriction in LCL immunisation
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is reported by Morrison _et al., (1981). In this case it was shown
that in contrast to the number of cells required to effect
immunisation in most allogeneic LCL/recipient combinations (for which
BoLA typing was not available) resistance to subsequent challenge can
A
be achieved by the inoculation of as few as 10 LCL cells into
autologous recipients (cell line donors).
Evidence for "similar type" preference was reported by
Dolan _et aX_., (1982). In this work the response was monitored of
B.taurus and B.indicus cattle to the inoculation of LCLs transformed
by T.parva parva (Muguga). The transformed lines originated from
lymphoid cells of both B.taurus and B.indicus animals. Cattle
received inocula of 10 cells of the respective type. Of
significance was the finding that both cattle types were more
susceptible to infection with cells derived from their own cattle
type. Combining the results of 2 experiments, of 13 B.indicus cattle
<S
(Boran) receiving 10 cells of 1 of 2 taurine lines, parasite
development was seen in 7, a temperature response in 2 and only 1
animal succumbed to infection. All survivors were resistant to
subsequent challenge. Of 5 indicus cattle receiving 10 indicus-type
LCL cells, all 5 evidenced a disease response although all recovered.
Similarly, 5 taurines receiving 10 taurine LCL cells all developed
parasitosis. Four of these developed a temperature response and 2
died. The 5 taurines receiving indicus cells all developed a patent
disease response of which only 1 proved fatal.
There is a good indication from these results that there
was a better parasite transfer from inoculated cells of either
indicus or taurine type to recipient cattle of the same type than to
cattle of the differing type. This is further supported by the
results of the subsequent stabilate challenges (with the homologous
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parasite). There is also evidence from this work that the degree of
parasite establishment in the first instance in the recipient animal,
may be an important factor in determining the degree of immunity
produced subsequently. All the surviving taurines which had
initially developed detectable parasitoses and all but 1, a pyrexia,
were totally refractory to challenge, whereas 4 indicus animals, none
of which showed a temperature response initially, underwent mild
disease episodes following challenge. These 4 animals comprised 2
which had originally received taurine cells and 2 which had received
indicus cells.
There are at least 2 factors to be considered in these
results. There is evidence, as pointed out by the authors, for
differing innate resistances in the 2 cattle types to cell culture
challenge. This is superimposed on the self-type preference for
achieving parasite establishment in the recipient in the LCL
inoculation system. Dolan_et aT., (1982) considered that their
results were consistent with the results of previous work (already
discussed here) that histocompatibility differences could exert an
influence on LCL immunisation procedures.
Of significance in this regard was the finding by Spooner &
Brown (1980) that in vitro Theileria-transformed LCLs, in all cases
studied except one, continued to express BoLA specificities detected
on non-infected donor PBL. Moreover this was found to be the case
with one line which had been passaged more than 200 times and where
the sensitivity of the transformed cells to typing reagents was
almost identical to that of fresh PBL bearing the same specificities.
In summary, it became apparent very early in the work on
Theileria-transformed LCLs, that to achieve immunisation in even 80%
of recipients, very large numbers of cells were required in the case
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of Theileria parva cell lines. This contrasts with the relatively
small numbers required to effect T.annulata immunisation.
Evidence which suggests that the MHC may present a barrier
to this form of immunisation against ECF is available. Therefore, a
study aimed at firstly demonstrating BoLA involvement, and should
this prove possible, defining to what extent it is involved in LCL
immunisation, appeared to be of major importance in the development
of cell line immunisation procedures for ECF. Such a study is, in
large part, the subject of this thesis.
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CHAPTER 2 General materials and methods
2.1 BoLA typing
2.1.1 Materials
2.1.1.1 The BoLA typing panel
The panel of alloantisera comprised 2 groups. The first
group, with which the bulk of the initial typing in Kenya was carried
out, was supplied by Dr R.L.Spooner of the A.R.C., Animal Breeding
Research Organisation in Edinburgh. They are identified by an
Edinburgh number (ED), the number of the animal of origin followed by
the date of donor bleeding, which in turn is followed by the numbers
of the donor animals of lymphocytes used in absorptions of the
original crude serum. The sera and the working dilutions used are
listed in Table 2.1.
A number of the sera have been tested in the 2
international comparison tests carried out to date
(Spooner_et al., 1979; Anon, 1982) and have been designated defining
sera with respect to the workshop (w) specificities. A number of
other sera are considered by the Edinburgh laboratory of origin to
recognise workshop specificities (Spooner, personal communication).
The workshop specificities and the sera defining them are listed in
Table 2.2.
It should be noted that the Edinburgh panel includes sera
defining all workshop specificities presently agreed. Further, as
discussed in 1.1.2, specificities are believed to be coded for by
alleles at a single BoLA locus.




10 11 12 13 14 16 17
















































































































































































































































































































































































































































































BoLA WORKSHOP SPECIFICITIES (w) AND DEFINING SERA
w. specificity
Defining sera on
basis of comparison test(s)
Additional
sera
1 1, 8 83




6 9, 10, 66 75, 97
6.1 12, 92, 93
6.2 81, 86
7 11, 17, 67, 68
8 13, 63, 80
9 14
10 69, 71 96
11 76 73, 95a, 102
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enable better BoLA characterisation of East African zebu cattle. The
reagents are the result of alloimraunisations carried out in Kenya at
the Veterinary Research Department of the Kenya Agricultural Research
Institute (KARI), Muguga, during the course of the studies reported
here. The Kenyan sera have the prefix KM and are listed in the same
way as the Edinburgh reagents, in Table 2.3.
2.1.1.2 Hanks^ balanced salt solution (HBSS)
This was supplied in powder form by Gibco Biocult, with
phenol red. Sodium bicarbonate was added in the preparation of the
HBSS at the rate of 0.35g/L and the pH of the final solution was
adjusted to 6.8 as estimated on a Philips PW9409 pH meter, with N HC1
and N NaOH. Deionised distilled water (DDW) was used to reconstitute
the HBSS. Following preparation, the HBSS was filter-sterilised
through a 0.22 uM pore size GS type filter (Millipore Corporation),
and full, tightly-sealed half-litre bottles were stored at 4'C until
required.
Double strength HBSS (2xHBSS) was prepared in the same way
from powdered medium but with the use of half the quantity of DDW.
The pH was not adjusted.
2.1.1.3 Ficoll-Hypaque
This was prepared to specific gravity 1.069. 67.5 g Ficoll
400 (Pharmacia Fine Chemicals) was dissolved in 600 ml boiling DDW,
and the volume then made up to 750 ml with DDW.
79.8 g of Hypaque Sodium (Winthrop) was dissolved in 120 ml
DDW. After the solutions were cooled to room temperature, the
hypaque was added to the ficoll with constant stirring until a






































KENYA PANEL OF BoLA TYPING SERA
Serum
N994 26:2:81 1 4
M777 26:2:81 abs M993+S344 1 32
M639 16:2:81 abs S337+N019+M638 1 4
N023 16:2:81 abs M762+N097 1 8
7514 8:7:76 abs R128 1 4
7616 2:3:76 abs N019+M686 1 4
169 30:4:81 abs M655 1 4
169/81 30:4:81 1 4
S413 4:6:81 1 4
M655 27:5:81 abs M662 1 16
M642 10:4:81 abs M802+M778 1 4
M993 10:4:81 abs M802+M638 1 4
N770 22:4:81 abs M616+M756 1 8
7514 7:7:76 abs M810 r"4
N775 10:4:81 abs M679 i 4
o001 30:4:81 abs N774 i 16
M642 10:4:81 abs M638+M686 I 4
N546 22:7:81 abs M639+N019+N774 i 16
S333 3:9:81 abs S411 I 8
M762 25:5:81 abs M778+N023+N756+N097 i 16
S122 22:7:81 abs N042+N770+N511 i 8
7616 2: 3:76 abs M793 i 4
M781 3:9:81 abs M666 I 8
N729 3:9:81 abs N023+N913 I 16
N774 14:4:81 abs M638+N097+S48 I 8
M688 17:9:81 abs N019+M778 i 8
M666 3:9:81 abs N774+M642+N913 I 8
M681 8:6:81 abs M639+S390+N291+M685 I 4
N723 17:9:81 abs M666+N774+M639 I 16
S58 10:8:81 abs M628+M642+M685+M666 i 2
7514 7:7:76 abs R128 I 2
7616 2:3:76 abs M793 I 2
S411 4:6:81 abs N774+S413+M666 I 8
188 30:4:81 abs M802+M655+M666 I 16
M634 14:7:81 abs M642+M692+S411 I 4





The ficoll-hypaque was then autoclaved and stored frozen at
~18'C until required.
2.1.1.4 Eosln dye
Eosin powder (Koch Light Laboratories Ltd./pure A.R.) was
used to make a 5% w/v stock solution in DDW and stored at ~18'C.
For use in the microlymphocytotoxicity test a working
solution was prepared by adding 1 volume of eosin stock solution to 1
volume of DDW and adding to this, 2 volumes of 2xHBSS.
2.1.1.5 Fixative
To 95 ml of 40% formaldehyde solution was added 5 ml of
phosphate buffer prepared as a 0.15 M disodium hydrogen phosphate
solution in DDW.
The fixative was stored at 4'C until required for use.
2.1.1.6 Complement (C^)
Pooled sera from a number of rabbits served as a complement
source. Serum pools were collected by staff of the Animal Breeding
Research Organisation from a commercial slaughterer. Pools were
tested for complement potency in the lymphocytotoxicity test with
panels of typing sera and cells of known reactivity, and were also
titrated in the test in the absence of typing sera to assess inherent
cytotoxicity. Cytotoxicity in some complement pools was removable
with suitable absorptions with selected bovine spleen in powder form.
Batches of complement of sufficient potency and lacking
inherent cytotoxicity were stored at -18 or ~70'C until required in
the test.
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2.1.1.7 Non-reactive bovine serum (NBS)
Sera from young male animals were run in the standard test
at a 1/2 dilution. Those showing no cell killing were stored at
~18'C until required. NBS at a dilution of 1/16 in HBSS was included
in all typing panels to allow an estimate of baseline cell viability.
2.1.1.8 BoLA typing sera
These were stored undiluted in small aliquots at -18 or
-70'C.
2.1.1.9 Typing plates
Terasaki-type (60 well) plastic plates (Sterilin) were
prepared in batches and stored with added typing and control sera at
~18'C until required.
Typing and control sera were appropriately diluted with
HBSS to a volume of 160 ul and dispensed under liquid paraffin into
the plates using a Hamilton 1 ul multidispenser (6 channel). 1 ul of
diluted serum was added to each well.
Sera were dispensed into plates in numerical order except
that single defining sera (ED 14, 39, 47, 78, 82) were duplicated,
but not in adjacent wells.
2.1.2 Methods
2.1.2.1 Cell preparation
Cell preparation from fresh blood samples was essentially
as described by Spooner _ejt jal., (1979) with a few minor
modifications. For this, samples of blood from the jugular or caudal
veins were collected aseptically into sterile vacutainers containing
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lithium heparin (Becton Dickinson). It was found during the course
of this work that extremes of temperature prejudiced the survival of
leucocytes in these samples and so they were kept as far as possible
at an ambient temperature of 15~20'C until used. This contrasts with
the 4'C storage reported by Spooner et al., (1979) which was found to
considerably reduce leucocyte recovery and viability.
Lymphocyte separation was achieved by layering 1-1.5 ml of
blood onto 1 ml ficoll-hypaque in glass tubes (7 ml nominal volume)
followed by centrifugation at 1500 g for 15 min. The lymphocyte
layer at the plasma/ficoll^aque interface was removed with a Pasteur
pipette and added to HBSS in a second tube and mixed. The samples
A.
were then centrifuged at 400 g/5 min. Supernat^nts were poured off
and the cell pellet resuspended in the small volume of HBSS
remaining. To achieve lysis of any erythrocytes in the sample, 2 ml
of DDW was then added to the cell samples with constant mixing,
followed rapidly by 2 ml of 2xHBSS. Having filled the tubes with
more HBSS, and following several inversions, the samples were
centrifuged at 110 g/5 min. The supernat^nts were again poured off,
the cell pellet resuspended and the tubes refilled with HBSS and
inverted several times. The tubes were then centrifuged at lOOg for
5 min to leave platelets in the supernatant which was removed to
leave 0.5 ml HBSS over the cell pellet.
Following resuspension of the cells, the concentration of
viable cells was assessed by counting in a haemocytometer (Neubauer
chamber) with phase contrast microcopy (Nikon). On the basis of
these counts the volumes of the cell suspensions were adjusted to
give a final concentration of 2.5x10 cells/ml.
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2.1.2.2 Microlymphocytotoxicity test
Following thawing of test plates and their equilibration to
room temperature, 1 ul of cell suspension and 1 ul of rabbit
complement (serum diluted 1/2 in HBSS) were added to each well (to
which the typing sera had previously been added prior to storage).
Following incubation of the plates at 37'C for 80 min, 1 ul
of working eosin solution was added to each well. After a further
2-5 min at room temperature, 2ul of fixative were added to each well.
Hamilton single and multiple dipensers were used
throughout.
Such prepared plates could be stored at 4'C until reading,
which was carried out with phase contrast microscopy at a
magnification of lOOx (Nikon inverted phase contrast microscope).
The following scoring system was used throughout in the reading of
the tests;





1 O J kO
Tests showing 60% or greater cell killing were considered positive




Species and strains of Theileria parasites used in this
work are detailed in the relevant sections, although most of the work
involved the use of T.parva parva (Muguga) which is considered a
typical T.parva parva strain.
This isolate is described by Brocklesby _et al., (1961).
Cryopreserved tick-derived stabilates were the source of
all parasites. The method of cryopreservation of ground-up whole
infected ticks was a modification of the method of
Cunningham _et aR., (1973a), as described by Radley (1978).
Stabilates of T.parva parva (Muguga) were made available by
Dr A.S.Young of the Veterinary Research Department, KARI, Muguga.
Stabilates served as a source of parasites for in vivo
challenge experiments and to produce infected batches of ticks after
passage through cattle which were then used in the _in vitro
establishment of infected LCLs.
Infected ticks and stabilates were produced by Mr B.Leitch
of the Veterinary Research Department, KARI, Muguga.
2.3 Lymphoblastoid cell lines
LCLs were established from PBL and made available by Mr
C.G.D.Brown of the Centre for Tropical Veterinary Medicine, Edinburgh
and Mr D.A.Stagg of the Veterinary Research Department of the Kenya
Agricultural Research Institute. The method of _in vitro production
was that of Stagg _et; al., (1981).
The LCLs were maintained essentially as described by
Stagg _et al^., (1976).
The cell lines were initiated and maintained in either RPMI
1640 or Eagles Minimum Essential Medium with Earles salts (MEM).
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RPMI 1640 and MEM were supplied in powder form with phenol red by
Gibco Biocult Ltd., and Flow Laboratories. DDW was used to
reconstitute the media. Sodium bicarbonate was added to RPMI 1640 at
the rate of 2 g/L. Penicillin (Glaxo Laboratories Ltd.,) and
streptomycin as sulphate (Glaxo Laboratories Ltd.,) were added to the
media to a final concentration of 100 iu/ml and lOOug/ml,
respectively. After adjusting the pH to 6.8 with N HC1 the media
were filter-sterilised through 0.22 um pore size GS type filters
(Millipore Corporation) and after removal of an aliquot for sterility
testing, were stored in full, tightly-stoppered bottles until
r equired.
Immediately prior to use, foetal calf serum (FCS) of
selected batches (Gibco Biocult Ltd.,) was added to the media to a
final concentration of 17 or 20%. L~glutamine (Gibco Biocult Ltd.,)
was also added, to a final concentration of 2 mM.
FCS was filter-sterilised in the same way as the basic
media and stored in appropriate aliquots at -18'C.
Following addition of FCS and L~glutamine to the basal
media, a further aliquot was taken for sterility testing prior to use
of the complete medium in cultures.
2.4 Serology
2.4.1 The indirect fluorescent antibody test (IFAT)
This test to determine levels of antimacroschizont antibody
in cattle sera was carried out as described by Burridge & Kimber
(1972), by staff of the Veterinary Research Department, KARI, Muguga.
The antigen used was derived from the Muguga C2 cell line
which is infected with T.parva parva (Muguga).
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2.4.2 The indirect immunoperoxidase test (IIPT)
This was used to assess antibody levels in cattle sera to
cell surface antigens on inoculated LCLs. The testing was carried
out by Drs K.Cowan and C.Groocock of the Veterinary Research
Department, KARI, Muguga.
The method is described in detail by Cowan _et al., (1983,
in preparation). The relevant cell line cells attached to
poly~L~lysine~treated glass slides were used as antigen. The slides
used were clean, 8-12 well Multitest slides (Flow Laboratories) and
the poly-L~lysine (type I-B or VII-B) was supplied by the Sigma
Chemical Company. Aliquots of the LCL cells in culture medium were
taken from culture flasks 1-2 days after a 1/10 passage. The culture
material was centrifuged at 300 g/6 min and washed 3 times with Hepes
buffered KC1 saline (HBKS; 0.15M NaCl, 0.01M Hepes, 5 uM KC1, pH
7.4) containing bovine serum albumin (BSA) (fraction V bovine
albumin, Armour) to a final concentration of 0.1% (HBKS-A). After
washing, the volumes of cell suspensions were adjusted with HBKS-A to
give a cell concentration of 5 x 10 /ml.
15 ul of cell suspension was placed in each of the
multitest wells. The slides were placed in a moist chamber for
20 min to allow the cells to settle and attach to the glass after
which the fluid was gently aspirated off. A drop of HBKS containing
0.1% gelatin (HBKS-G) was then added to each well and the slides
reincubated as previously. Fluid was again aspirated off and the
wells filled with test sera at appropriate dilutions (sera were
diluted with HBKS) and the slides incubated at room temperature for
30 min.
Fluid was aspirated off the wells and the cells were washed
3 times for 3 min with HBKS-G. Rabbit antibovine-IgG (diluted
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1/200), prepared and supplied by Dr K.Cowan, was then added to the
wells and a further 30 min incubation carried out. The washing
process was repeated as above, and then the wells were filled with
goat-antirabbit-IgG coupled to horseradish peroxidase (prepared and
supplied by Dr K.Cowan). The incubation and washing procedure was
again repeated. The substrate used was 3~amino~9~ethyl carbazole
(AEC) (Sigma Chemicals Co.,) dissolved in absolute ethanol (1 mg
AEC/ml). To this was added 2 volumes of Tris-buffered saline with
hydrogen peroxide added to a final concentration of 0.01%. This
complete indicator was prepared immediately prior to use. The
indicator was added to the wells and a further 20-30 min incubation
was carried out followed by washing. 2-3 drops of 50% glycerol/0.1%
glutaraldehyde in phosphate-buffered saline (prepared from Dulbecco A
tablets, Oxoid) were added to each well and cover slips applied which
were then sealed with fingernail varnish.
Reactions were read with a light microscope at 400-1000 x
magnification.
Included in each assay as controls were known negative and
positive sera as well as conjugate and indicator controls.
2.5 Haematology
Haematological parameters of cattle on experiment were
assessed on jugular venous blood collected into bijou bottles
containing anticoagulant (dipotassium EDTA, 1 drop of 20% w/v in DDW)
Parameters routinely measured were packed cell volume
(PCV), leucocyte (WBC) count and haemoglobin (Hb) concentration.
PCV was estimated using a microcentrifuge (Hawksley)
technique. WBC counts were performed with an electronic particle
counter (Coulter ZBl/Coulter Electronics Ltd.,) and haemoglobin
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estimations were performed on a haemoglobinometer (Coulter
Electronics Ltd.,).
Haematological parameters were measured on the day of
sample collection, by staff of the Veterinary Research Department,
Muguga.
2.6 Parasitology
Giemsa-stained blood, gland and internal organ smears were
examined for evidence of Theileria parasites in experimental cattle.
The Giemsa stain was prepared by adding 2 gm Giemsa powder
(Giemsa's azur eosin methylene blue, Merck) to 108 ml glycerol (BDH
Chemicals Ltd.,) which was then heated to 60'C for 2 hr with constant
stirring. After cooling to room temperature, 168 ml methanol (BDH
Chemicals Ltd.,) was added, followed by a further 2 hr of stirring.
0.56 gm Azur II (Merck) was then added to the stain solution followed
by stirring for a further 2 days. The stain was then filtered
through a Whatman no.54 filter paper and stored for 1 week in a
stained glass bottle prior to testing and use.
Blood smears were prepared by spreading a small drop of
freshly obtained venous blood on a clean glass slide, using the edge
of a second slide, followed by rapid air drying.
Gland smears were prepared from needle biopsies of selected
glands. This involved manual immobilisation of the gland where
necessary, and the insertion of a 19G sterile disposable hypodermic
needle. After insertion of the needle, it was rotated along its axis
several times within the gland and withdrawn following closure of the
syringe attachment part of the needle with thumb or finger. The
small gland biopsy within the needle could then be expressed onto a
clean glass slide and be spread and dried as for a blood smear.
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Slides for preparation of smears were as far as possible
previously unused and were cleaned by storage in a 1/1 v/v mixture of
ethanol and ether (BDH Chemicals Ltd.,).
Prior to staining, smears were fixed in methanol for 1-5
min. Staining involved immersion in the working stain solution
prepared by dilution of the stock Giemsa with phosphate-buffered
saline (PBS) of pH 7.2. PBS was prepared from tablets (Dulbecco A,
Oxoid) and DDW.
A 5% Giemsa in PBS working stain was used. After 20 min in
the stain, the staining was differentiated by a brief immersion in
PBS. Drops of PBS were removed with blotting paper and the slides
allowed to dry prior to microscopic examination.
The microscope used for the examination of smears for
parasites was a Leitz Dialux. Examinations were made under oil at
500 and 1000 x magnifications. To establish absence of parasites or




Degrees of parasitosis were recorded on an arbitrary scale;
+ = macroschizonts or piroplasms detectable
in 1 or only a few fields.
2+ = macroschizonts visible in more than 50%
of fields examined.
3+ = more than 1 macroschizont present in most
fields examined.
As far as possible, piroplasmaemias were quantified on the
basis of the percentage of erythrocytes containing piroplasms.
The collection and preparation of samples for
parasitological examination was carried out by staff of the
Veterinary Research Department, Muguga.
The examination of the samples was shared with Dr T.T.Dolan
of the Veterinary Research Department, Muguga.
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CHAPTER 3 The use of BoLA antisera in the modulation of MHC
sub-populations in Theileria-infected LCLs
3.1 Introduction
This study was undertaken in an attempt to address a
question raised by the first reported work concerned with the
expression of MHC-coded antigens on bovine LCLs.
Spooner & Brown (1980) reported the results of BoLA typing of 19 LCLs
produced by Jui vitro infection and transformation of bovine PBL by
T.parva and T.annulata (the causative organisms of ECF and tropical
theileriosis respectively). The reactivity of the transformed cells
with a panel of BoLA typing antisera was compared with the reactivity
of fresh uninfected donor PBL and with one exception it was found
that the MHC type of the transformed lines was identical with that of
the respective donor animals' uninfected PBL. This is in accordance
with the results of work in other histocompatibility systems where
agents other than Theileria spp. have been used to transform cells
(K1 ein _et aT ., 1976).
The exceptional result reported by Spooner & Brown (1980)
was obtained on BoLA typing of fresh PBL and cells transformed in
vitro by T.parva parva (Muguga) from a steer twinned to a heifer.
Erythrocyte typing suggested that the twins could be chimaeras and
BoLA typing of the parents revealed a possible origin for the MHC
genotype of the T^parva-transformed line . The results were
therefore consistent with the possibility that the PBL in this
particular case comprised male and female cells of different BoLA
types and that the less common genotype (undetected in the BoLA
typing of the donor) had been preferentially transformed by the
parasite. Fresh PBL from the same donor, when transformed by 2
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isolates of T.annulata typed in the same way as the donor.
If T.parva had infected only a subpopulation of cells it
would be of significance for the understanding of the cell/parasite
interaction, especially in view of the recent results of other
workers which also suggest that T.parva has particularly specific
requirements with regard to target cell type (Duffus £t d., 1978;
Black et al., 1981; Pinder & Roelants, 1981; Pinder et al., 1981).
Duf fus _et jLL., (1978) suggested that the parasitised cell
is a T lymphocyte. Black et al., (1981) elaborated on this when they
suggested that the infected cell is an immature-type T cell
expressing T cell differentiation antigens, and thus having
similarities with MLR and concanavalin A~induced blast cells. Pinder
and Roelants (1981) and Pinder et al., (1981) also considered that
Theileria-infected lymphoblastoid cells are derived from a T cell
subset.
It was felt important to ascertain whether or not cells of
an hypothesised minor population (on the basis of BoLA type) within
the chimaera had been transformed in preference to those of the major
population, for two reasons. First, should such a population of
cells be shown not to exist within the donor, the implication would
be that T.parva is of itself capable of qualitatively altering the
expression of MHC-coded antigens, which would have far-reaching
implications in the field of ECF immunology. Second, a possible
interpretation should a minor population be shown to have indeed been
transformed, would be that the BoLA type of cells has an influence on
their capacity to host the parasite, again with important
implications.
Two approaches were therefore adopted. In the first
instance karyotyping of the donor and its twin was carried out to
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establish that they were chimaeras as suggested by erythrocyte typing
(Spooner & Brown, 1980). A means was also required of BoLA typing
the minor population within the chimaera. For reasons stemming from
the methodology of BoLA typing (see 2.1.2) only an overwhelming major
population would be successfully typed in any mixture of BoLA types.
Should there not be an obvious majority type, relatively large
numbers of partial reactions would be expected with clear positive
reactions only occurring in the case of shared specificities. A
minor population would at best produce a partial reaction with a
positive antiserum and if the population were small enough, unique
specificities would not be recorded at all. Such a subliminal
population, from a BoLA typing viewpoint, was postulated to exist
within the chimaeric donor and a means of making this population
available for BoLA typing was required. This could not easily be
done using standard techniques directly on donor PBL but the
possibility existed of BoLA typing such a minor population should it
coexist with a major population in a lymphoblastoid cell line. The
T.annulata-transformed cell line derived from the chimaera was
therefore studied with a view to potentiating any minor population
found to a level at which it would be detectable in the
microlymphocytotoxicity test. A method of selection of cells was
developed for this purpose.
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3.2 Materials and methods
3.2.1 Cell lines
The establishment and maintainance of LCLs is detailed in
2.2 and 2.3.
The lymphoblastoid cell lines used were 219TpM, 219TaA and
219TaH, derived from the chimaeric Ayrshire steer (number 219) and
220TaA from its female twin (number 220) as described by
Spooner & Brown (1980). 219TpM is infected with T.parva parva
(Muguga), 219TaH with T.annulata (Hissar), and 219TaA and 220TaA with
T.annulata (Ankara). Briefly, the lines were established by Jji vitro
infection of PBL with tick-derived sporozoites by the method of
Brown _et al., (1973) and these particular lines were maintained in
RPMI 1640 with 25 mM Hepes buffer and 17% foetal calf serum (Gibco
Biocult), with added penicillin (100 iu/ml) and streptomycin (100
ug/ml). The lines were established and made available by
Mr C.G.D.Brown of the Centre for Tropical Veterinary Medicine,
University of Edinburgh, U.K..
3.2.2 Karyotyping of PBL
Peripheral blood lymphocytes of the animals were karyotyped
by adding 0.3 ml of venous blood, collected into a vacutainer
containing sodium citrate (Becton Dickinson), to a 25 sq cm plastic
tissue culture flask (Nunc) containing 5 ml of medium to which had
been added 300 ul phytohaemagglutinin (PHA, Wellcome) and 250 iu
heparin (Pularin, Evans). The culture was maintained at 37'C for
72 hr after which time 300 ul of 0.01% w/v colchicine solution (BDH
Chemicals) was added. After a further incubation for 2.5 hr, cells
and medium were transferred to a plastic universal container
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(Sterilin) and centrifuged at 200g for 20 min. The supernatant was
poured off and the cell pellet resuspended in the small quantity of
medium remaining. 5 ml of 0.7% w/v tri-sodium citrate (BDH
Chemicals) was then slowly added with careful mixing and a further 25
min incubation carried out. 3 ml of Carnoy's solution (1 part
glacial acetic acid/3 parts methanol, BDH Chemicals) were then added
slowly and with thorough mixing. After a further 20 min incubation
the cells were again centrifuged and the fixative discarded and
replaced with fresh Carnoy's solution. Slide preparations of the
suspensions were made and stained with Giemsa (Merck) prior to
microscopic examination.
3.2.3 Karyotyping of cell lines
0.2 ml of colcemid (Gibco Europe) stock solution (10 ug/ml)
was added to a 25 sq cm plastic tissue culture flask (Nunc)
containing 10 ml of an actively-growing cell line (i.e., 24 hr after
a 1:10 passage). The culture was then incubated for 90 min after
which a 5 min centrifugation at lOOg was carried out in a glass
centrifuge tube. The supernatant was poured off and 5 ml of 0.7% w/v
tri-sodium citrate at 37'C was slowly added with gentle mixing.
After a further 35 min incubation at 37'C the suspension was
centrifuged as above and the pellet resuspended in 5 ml of fresh
ice-cold Carnoy's fixative solution. After 10 min at 4'C, cells were
spun down and the fixing process repeated once more.
After a final centrifugation the pellets were resuspended
in approximately 0.5 ml ice-cold Carnoy's solution and slide
preparations were made by dripping the cell suspensions onto wet,
ice-cold clean slides, followed by rapid drying. Slide preparations
were stained with Giemsa (Merck). Other than the slides all
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glassware used in the process was siliconised.
3.2.4 Cell preparation
The preparation of fresh PBL for microlymphocytotoxicity
testing was by the method of Spooner _et jal., (1979), as described in
2.1.2.1.
The preparation of LCL cells for BoLA typing was from
actively growing cultures, i.e., 24-48 hr after a 1:10 passage. 2 ml
aliquots of cell culture material were removed from the tissue
culture flasks after the cells had been resuspended by gentle
pipetting. Each aliquot was layered onto 1ml Ficoll/Hypaque, S.G.
1.069 (see 2.1.1.3), in a 7 ml nominal capacity, round-bottomed glass
tube and centrifuged at 1500g for 15 min. The layer of viable cells
at the culture medium/Ficoll interface was carefully removed with a
Pasteur pipette and then added to a second 7 ml round-bottomed tube
containing culture medium. Following topping-up of the tube with
medium, and inversion, the cells were centrifuged at 110g/5 min. The
A
supernat/nt was removed to leave approximately 0.5 ml of medium over
the cell pellet. The cells were resuspended by applying the tubes to
a Whirlimixer (Fisons, Loughborough) and aliquots removed and added
to a Neubauer chamber. Following an estimation of viable cell
concentration by viewing the chamber with an inverted phase contrast
microscope, the volume of cell suspension was adjusted with culture
medium to give a cell concentration of 10 /ml.
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3.2.5 Microlymphocytotoxiclty testing
This was performed as described by Spooner _et al., (1978)
with alterations as described in 2.1.2.2.
3.2.6 Cell selection
Selected BoLA typing sera were titrated against cell lines
in the microlymphocytotoxicity test. On this basis, antisera
positive and negative for the cell lines at a dilution of 1:4 or
greater were identified.
Selection of minor populations within the cultures on the
basis of BoLA type was accomplished by the incubation at 37'C for
30 min in sterile conditions of 1 ml of culture medium containing
2.5x10 cells with 1 ml of the appropriate positive antiserum diluted
1:4 with culture medium. 1 ml of rabbit serum diluted 1:2 in culture
medium was then added prior to a further 30 min incubation.
During incubation, the cells and medium were agitated
2-3 times. Following incubation the tubes were centrifuged at lOOg
for 5 min and the supernatant discarded. After removal of the
supernatant, the remaining cells were resuspended in 2.5 ml fresh
medium and added to a 25 sq cm plastic tissue culture flask (Nunc)
containing a confluent monolayer of IMR 31 (bison lung fibroblastic
line, supplied by Mr C.G.D.Brown of the Centre for Tropical
Veterinary Medicine, University of Edinburgh, U.K.,) from which
medium added 72 hr previously was partially removed to leave 7.5 ml.
After 24 hr the culture supernatant was centrifuged to remove cell
debris and returned to the culture flask. In this way cells
surviving the selection process in low numbers could be propagated.
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3.3 Results
3.3.1 BoLA typing of twins 219 and 220 and derived LCLs
The results of typing are shown in Table 3.1.
The workshop specificities detected in the fresh and
transformed cells are shown in Table 3.2.
These results confirm those of Spooner & Brown (1980) in
that LCLs derived from the twins typed in the same way as the
respective donor animals (BoLA phenotype, w6/wl2) with the exception
of the T.parva-transformed line derived from the steer 219 which had
the BoLA phenotype w6/wl0.
3.3.2 Karyotyping of 219 and 220 and derived LCLs
This was carried out primarily to establish the chimaeric
status of the twin cattle and to ascertain whether or not the 219TaH
LCL was a coculture of male and female cells. The results are
presented in Table 3.3.
The chimaeric status of 219 and 220 was conclusively shown.
It is of interest to note that the proportion of male and female
cells in PBL are the same in each of the twins. Further, the animals
were of predominantly female PBL type. The LCL 219TaH was also shown
to be a predominantly female cell line, whereas the 219TpM line was
overwhelmingly a male line.
The BoLA typing results together with the karyotypic
analysis supported the view that the 219TpM line could have an origin
in the minor PBL population (the male population) of the donor 219;
this population being inaccessible to BoLA typing. Further, it was
clear from the results that the 219TaH line was indeed a coculture of
male and female cells, and the attempt was therefore made to
TABLE3.1
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TABLE 3.2
BoLA WORKSHOP SPECIFICITIES OF CHIMAERIC TWINS 219
AND 220 AND THEILERIA-TRANSFORMED LCLs
DERIVED FROM THEM
w6 wlO wl2
Steer 219 + +
219TaH + +
219TpM + +









Fresh PBL 80 20
Tan p.3 80 20
TpM p.13 2 98
Heifer 220
Fresh PBL 80 20
Karyotype analysis was based on the % of
cells bearing the Y chromosome in 200
cells examined.
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potentiate the male cells in this line with a view to ascertaining
their BoLA type.
3.3.3 Selection of male 219TaH cells by suppression of female cells
in the coculture
The primary requirement for this work was a
complement-fixing antiserum which would react with the female cells
but not the male cells in the culture. Such an antiserum could then
be used for in vitro complement-dependent, antibody-mediated
cytolysis of the female cells, leaving the male component of the cell
line in a viable state to be further cultured prior to ascertaining
its BoLA type.
The Edinburgh panel of typing sera used in this work was
principally made up of absorbed sera, some of which had been absorbed
several times to give operational monospecificity. As a result many
of these sera were available in small quantities only and it was
therefore decided to titrate the original crude sera, from which sera
discriminating between the 219TpM and 219TaH lines were derived,
against these lines in order to identify a suitable selective reagent
which would be available in sufficient quantity for the work. The
crude sera used, the BoLA typing panel sera derived from them and the
results of titration in the microlymphocytotoxicity test against the
2 lines, are shown in Table 3.4.
On the basis of this result, antiserum 2273 16.9.75 was
chosen as the selective cytolytic agent. This antiserum was used on
2 occasions to treat the 219TaH line. The effect of selection on
BoLA and karotype is shown in Table 3.5.
It is clear that treatment of the 219TaH line with
antiserum 2273 had a profound effect on the karyotype composition and
TABLE3.4
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TABLE 3.5






BoLA Type Karyotype %
w6 wlO wl2 I 0*
219 TaH pi 6* + + 80
219 TpM pi 5 + + 98
219 TaH T47** + + 99
219 TaH T47 p3 + + 10 90
219 TaH pi 9 + + 83 17
219 TaH T47x2 p2*** + + 4 96
219 TaH T47 p6 6 94
219 TaH T47x2 p6 2 98
219 TaH p23 96 4
* Passage number.
** Line 219 TaH treated on one occasion with serum 2273 16:9:75.
*** Line 219 TaH treated on 2 occasions with serum 2273 16:9:75.
NB. 219 TaH pi6 was the origin of all the TaH LCL's in this study.
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apparent BoLA phenotype in that the cultured cells were completely
different from the pretreatment and control cultures in these
respects. Moreover, the essentially male line resulting from
selection of cells within the 219TaH culture had the same BoLA
phenotype, w6/wl0, as the male 219TpM line.
3.3.4 Selection for minor populations in the 219TpM and 219TaH T47
lines
A
On 3 separate occasions the 219TpM and 219TaH T47 (219TaH
previously subjected to the selective procedure detailed in 3.3.3)
lines were treated with serum 7639 7.7.76 in an attempt to select wl2
positive/wlO negative cells. On none of these occasions was it
possible to grow up any cells.
3.4 Discussion
The results are consistent with T.parva preferentially
transforming cells from a minor population of 20% or less within the
PBL of the the chimaeric donor, 219. There is no reason to suppose
therefore, that the w6/wl0 BoLA type was evolved d_e novo on
transformation. Although it cannot be concluded that no female cells
of major population type were transformed, the fact that such cells
could not be selected for may be significant. In contrast, in the
particular T.annulata (Hissar) line studied, the evidence is that the
parasite showed no preference for cells of either a particular sex or
BoLA type in the infection and transformation process. These
findings could reflect at least 3 possibilities. One could be that
the target population for T.parva parva (Muguga) is very restricted
but that for T.annulata (Hissar) is less so. The results could then
be explained by the fact that such a target subset for T.parva parva
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(Muguga) was only present at the time of infection and transformation
within the minor population of the chimaera, or if present in both
populations, more target cells had the rarer genotype than the common
genotype and the latter were overgrown during the production of the
cell line. However, the rarer genotype when transformed by
T.annulata (Hissar) was still present after more than 20 passages.
The target subset for T.parva parva (Muguga) could have been the
whole of, or only a part of the minor population; the implication
being that BoLA or karyotype per se had no influence but merely
allowed the detection of a target preference in the particular system
studied.
A second possibility is that the infection and
transformation process was directly influenced by BoLA or karyotype.
In this regard there is no evidence from previous work of sex
restriction in the sporozoite infection system either _in vitro or in
vivo. However, the possibility that certain BoLA types are more
susceptible to T.parva parva (Muguga) infection than others, remains.
Indeed links have been found in other species between MHC type and
disease susceptibility (Dausset & Svejgaard, 1977; Longenecker &
Mossman, 1981). This does not preclude the fact that such a BoLA
resistance/susceptibility connection exists for T.annulata (Hissar),
especially in view of the fact that only two genotypes were studied.
Variation in ECF susceptibility linked to BoLA type would be of
significance to the development of livestock industries in ECF areas.
A third possibility is that T.parva parva (Muguga), by
comparison with T.annulata (Hissar), is less efficient in the cell
infection and transformation process in the _in vitro system of cell
line production used. Thus in the T.parva in vitro infection system,
only very few or even one cell may transform and give rise to a
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clonal culture.
With regard to the cell selection technique itself, it is
evident that selection of certain BoLA types from within established
chimaeric lymphoblastoid cell lines is possible by the method of
suppressing other types within such lines by complement-mediated cell
killing with BoLA antisera. In this work, total suppression of the
majority karyotype was never achieved. However, it was not
established that the surviving cells of the sex which was selected
against were of the suppressed BoLA type. It is possible that they
represent one or more minor populations lacking the specificity
detected by the selecting antiserum. The limited evidence that it is
not possible to achieve a reversion of cell line type by reverse
selection suggests either that all cells are selected by the first
treatment or there are too few surviving cells of the original major
type left to grow up in the system. The results also suggest that a
line once subjected to BoLA selection is subsequently stable.
Selection for human lymphocyte antigen (HLA) variants has
also proved possible by means of suppression of non-variants, using
HLA antisera in a complement-dependent cytotoxicity system
(Pious jet al., 1973; Gladstone & Pious, 1978), and in this work the
"loss" variants proved to be stable over more than 80 cell doublings
in non-selective conditions.
The technique may have uses beyond that reported in this
limited study, particularly in the area of immunisation against ECF
by inoculation of T.parva-infected LCLs. As discussed in 1.2.3,
prior to the work reported in this thesis, there was reason to
suspect that the bovine MHC posed a barrier to this form of
immunisation. The fact that there is in reality such a barrier is
the subject of the work reported in chapters 4 and 5. One possible
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way in which such a barrier could be overcome would be to utilise
LCLs lacking expression of MHC~cod.ed antigens, analogous to the Daudi
cell line of human origin (Bodmer, 1981). Such a bovine cell line
has not hitherto been reported. However, using the technique
described here it may be possible to potentiate BoLA-negative
variants in new and existing T.parva-infected cell lines, should such
extant variants occur. The evidence from the work of
Pious & Soderland (1977), is that in their HLA system,
complement-dependent, antibody-mediated cytolytic techniques select
for pre-existing mutants rather than induce modulation in the
antigens themselves. Moreover, it may prove possible to increase the
chances of isolating such variants in the ECF system by exposure of
LCLs to chemical mutagens or ionising radiation. In the human system
the use of chemical mutagens has resulted in a 2 orders of magnitude
increase in HLA variant frequency (Pious _et al., 1977).
In summary, the work reported here has resulted in the
clarification of an anomalous T^parva-induced _in vitro
transformation, and in the development of a technique with potential
use in future studies, particularly in the area of LCL immunisation
against ECF.
Note
Aspects of the work reported in chapter 3 are the subject
of publication,
"Selection, by major histocompatibility type, (BoLA), of lymphoid
cells derived from a bovine chimaera and transformed by Theileria
parasites.",
Teale, A.J., Kemp, S.J., Young, F., & Spooner, R.L.,
Parasite Immunology, (1983, in press).
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CHAPTER 4 A study of the effect of degree of BoLA
compatibility between LCLs and recipient cattle on the response to
cell line inoculation and subsequent challenge - MHC 1
4.1 Introduction
It has been evident since the early attempts to immunise
cattle against ECF with infected tissues that the nature of the
inoculated material may have an effect on the efficiency of
immunisation. The variability in the results of various workers is
reviewed by Wilde (1967) and Cunningham (1977).
Since the development of in vitro culture techniques for
T.parva (Hulliger jet al., 1974; Malmquist _et al., 1970) and the
subsequent techniques for in vitro infection and transformation of
bovine lymphoid cells with tick-derived sporozoites
(Brown _et al., 1973; Stagg et al., 1981) the possibility has existed
of using parasite-transformed LCLs for the vaccination of cattle
against ECF. Vaccination trials have shown however, that in order to
ralinb 1 y produce immunit^in the majority of animals to the
7 Q
homologous parasite isolate LCL cell numbers of the order of 10 —10'
are required (Brown et al., 1971; Brown et al., 1978a). Even at
this dose level however, certain animals die as a result of LCL
inoculation and others may remain susceptible to challenge. It would
seen therefore, that the variability in response reported by those
workers studying the results of inoculation of tissues from infected
cattle may also pertain to the LCL immunisation system.
That the acceptability to the recipient animal, in an
immunological sense, of the inoculated material may be an important
reason for this is suggested by a number of studies carried out to
date. Wilde (1967) was the first to suggest that the inoculation of
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infected cells could result in a response to the cells themselves as
distinct from an anti-parasite response. Wagner and Duffus (1974)
drew attention to the fact that the MHC may be important in the
LCL/recipient interaction. Their important studies on the immune
response to inoculated parasitised lymphoid cells are discussed in
1.2.2.1.
Since that time, two reports have clearly shown a
"self-preference" in the LCL inoculation system,
(Brown _et al., 1978b; Morrison £t al., 1981). In the former report,
blood infected in vitro during tick feeding immunised only the
autologous blood donors, or, as in one case, the twin of such a
donor, against homologous stabilate challenge. Morrison et al.,
(1981) working with LCLs were able to show that doses as low as 10*^
LCL cells may induce immunity in autologous recipients and that doses
(o
of 10 or higher may kill such recipients. As pointed out by these
a
workers the 10 dose level, which may not result in patent infection
in the autologous recipient but is capable of inducing immunity to
7 it
subsequent stabilate challenge, is equivalent to the 10 -10 dose
level in some allogeneic recipients in these respects. There would
therefore, appear to be approximately a million-fold difference in
acceptability of LCLs between some of the autologous and allogeneic
systems.
Dolan et al., (1982) broadened this concept to one of a
similar-type preference, as opposed to a self preference, when they
reported the results of a comparison of responses of B.taurus and
B.indicus cattle to B.taurus and B.indicus-derived LCLs. In this
study, cattle evidenced a greater response to the same type cell line
than to the different type.
All these accumulated results, together with the report of
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Spooner & Brown (1980) that Theilerla-Infected LCLs express BoLA
specificities, suggested that the bovine MHC may play an important
role in the LCL immunisation system. The work reported in this
chapter, and in the subsequent chapter, was undertaken in an attempt
to determine whether or not this is the case, and if so, to quantify
the restriction on the LCL/recipient interaction imposed by the BoLA
system.
4.2 Materials and Methods
4.2.1 Cattle
Cattle were selected for the study on the basis of BoLA
type. The reactivity of their PBL with the Edinburgh, and where
relevant, the KM panel is shown in Appendix 1.1. Only cattle with no
previous exposure to Theileria parasites, as assessed by the LFAT for
serum antibody to T.parva parva (Muguga) schizont antigen, were used.
The cattle were either bred at the Veterinary Research Department,
Kenya Agricultural Research Institute, or purchased from farms in
Kenya where strict tick control was practised. Most were Friesians,
3 were Herefords and 3 were B.indicus/B.taurus crossbreds. Two were
females and the remainder were steers.
Prior to the experiment, the cattle were treated
prophylactically for babesiosis with imidocarb diproprionate
(3 mg/kg) (Imizol, Wellcome) and for helminthiasis with
oxyclozamide (15 mg/kg)/levamisole (7.5 mg/kg) (Nilzan, Cooper).
They were held in a partially covered yard during the experiment and
given hay and water _ad libitum, and a small quantity of concentrates
daily. They were dipped 3 times weekly in dioxathion (Delnav DFF,
Cooper) to control ticks.
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The cattle were generally well matched for age (1-2 years)
and weight.
4.2.2 Cell lines
Cell lines were established and maintained by Mr D.A.Stagg
as described in 2.2 and 2.3.
In vitro infections of PBL from six of the animals were the
source of LCLs. The ticks from which the sporozoites were harvested
to establish the lines had been infected by feeding on cattle
infected with T.parva parva (Muguga) stabilate 147.
The LCLs were used at low passage (<10), and were BoLA
typed prior to inoculation. The BoLA typing is presented in Appendix
1.1. In all cases LCLs expressed the same w specificities as the
donors. For the purposes of inoculation of known cell numbers, cells
in aliquots of culture material were counted in a haemocytometer
(Neubauer). Viable cells only were counted. Volumes of culture
material were adjusted as necessary with growth medium to enable
inoculation of the required number of cells in a volume of 10 ml.
Inoculations were made subcutaneously in front of the right
shoulder in the region of the right prescapular lymph node.
4.2.3 Experiment Protocol
The 24 animals subjected to LCL inoculation were allocated
to six groups of four. A cell line was established _in vitro from the
PBL of one in each group (ultimately the autologous recipient). Of
the three remaining animals in each group, one was BoLA matched with
the LCL donor as closely as possible, one was half-matched and one
was mismatched. With respect to the degree of matching, particular
attention was paid to the workshop specificities and half-matched
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animals were considered to have one workshop specificity in common
with the group LCL donor/autologous recipient, whereas the mismatched
animals did not share workshop specificities with the LCL/donor.
Matching was on the basis of sharing of two workshop specificities.
All animals in each group received an identical inoculum of
LCL cells derived from the PBL of the donor/autologous recipient in
&
the group. Three groups received 10 cells and three groups received
S
10 cells each. The groupings are summarised in Table 4.1. The "w"
prefix refers to a workshop specificity and is followed by the agreed
workshop number. The notation or "w/~" indicates that either
two or one of the workshop specificities could not be detected. This
notation is used on the assumption that the specificities represent
alleles at one BoLA locus.
4.2.4 Challenge
Animals surviving the LCL inoculation phase of the
experiment and 4 other steers selected on the basis of negative serum
reactivity in the IFAT for antibody against T.parva parva (Muguga)
schizont antigen, were challenged subsequently with 1.0 ml of T.parva
parva (Muguga) stabilate 147. The stabilate was inoculated
subcutaneously below and slightly forward of the right ear, in the




THE GROUPING, BREED AND BoLA TYPE OF CATTLE USED FOR AUTOLOGOUS
AND ALLOGENEIC LCL CHALLENGE AND SUBSEQUENT STABILATE CHALLENGE
Group Inoculum Animal Breed BoLA Type
1 103 M980 LCL cells M980 Hereford w7/w9
N894 Hereford w7/w9
S334 Friesian w6.2/w7
S866 Friesian w6/wl 3
2 103 S55 LCL cells S55 Friesian w6.2/wlO
S59 Friesian w'6.2/wl 0
N178 Friesian wlO/ -
S357 Friesian - / -
3 103 N511 LCL cells N511 x-bred w7/w8
M878+ x-bred w7/w8
S340 Friesian w7/ -
S54 Friesian w6.1/wl0
4 105 S68 LCL cells S68 Friesian wll/w20
S58 Friesian wll/w20
N170 Friesian wl 1 /wl6
S125 Friesian w5/w6.2
5 105 S48 LCL cells S48 Friesian w6/(w8)*
SI 22 Friesian w6.2/w 8
N546 Friesian w6/wlO
M645 Friesian w5/w20
6 105 N989 LCL cells N989 x-bred w6/w9/w20
N886+ Hereford w6/w9/w20





* Reacting with 2 of 3 w8 - defining sera
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4.2.5 Assessment of response to LCL Inoculation and stabllate
challeng e
4.2.5.1 Haematology
Haematology was performed as described in 2.5.
White blood cell (WBC) levels, haemoglobin concentrations
and packed cell volumes (PCV) were assessed on two occasions prior to
the experiment and then following LCL inoculation, every 2-4 days to
day 28 post-inoculation. The same parameters were measured at 1-4
day intervals from day 10 to day 28 following stabilate challenge.
4.2.5.2 Serology
Serum samples were examined by the IFAT, as described in
2.4.1, for estimation of antibody levels to T.parva parva (Muguga)
schizont antigen on two occasions prior to the experiment and then at
approximately weekly intervals to day 53 post-LCL inoculation. This
was also carried out on four occasions at weekly intervals following
stabilate challenge.
Serum samples from animals in groups 3, 4, 5 and 6 were
also examined for the development of cell membrane antibodies to the
inoculated cell line using the indirect immune peroxidase test (IIPT)




Rectal temperatures were taken daily from day 1 to day 27
post-LCL inoculation and from day 1 to day 26 post stabilate
challenge.
Rectal temperatures were recorded in the morning prior to
routine handling and sampling.
A temperature greater than 39.4'C was regarded as a febrile
response.
4.2.5.4 Parasitology
Biopsy samples of the right prescapular lymph node (RPG)
were taken daily from day 5 following LCL inoculation, and examined
for Theileria macroschizonts. A biopsy of the left prescapular node
(LPG) and a tail-tip blood smear were examined from the day following
observation of parasites in the RPG, to day 35 post LCL inoculation.
The same procedure was followed from day 3 following
stabilate challenge except that the right parotid lymph node (REG)
was used as a first indicator of parasitosis.
Smears were examined following air-drying, fixation in
methanol and Giensa staining.
Procedures were as detailed in 2.6.
4.2.5.5 Post-mortem examination
Full post-mortem examinations were carried out on the
carcasses of all animals dying during the experiment. ECF was
confirmed on the basis of the presence of large numbers of parasites
in smears of internal organs. Impression smears were routinely made
from a superficial lymph node, spleen, lung, liver, kidney and
mediastinal and mesenteric lymph nodes.
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These were fixed and stained as described in 2.6.
4.2.5.6 Recovery
Recovery was recorded on the day after the last detection
of macroschizonts following the return of the rectal temperature to
<39.5'C.
4.3 Results
The data concerning haematological parameters, IFAT
serology, parasitosis and temperature responses are presented in
Appendices 1.2, 1.3, 1.4 and 1.5 respectively.
A summary of the responses to LCL inoculation is given in
Table 4.2, and the responses to stabilate challenge are summarised in
3
Table 4.3. One autologous LCL recipient (receiving 10 cells) died
of ECF as a result of the LCL challenge. All autologous recipients
responded serologically to LCL inoculation with the development of
antimacroschizont antibodies as measured in the IFAT, and all five
which were challenged subsequently with stabilate survived without
the development of clinical signs of disease. It is notable that
3
neither of the 10 autologous recipients surviving LCL inoculation
showed any clinical signs of disease at any stage following LCL
inoculation or stabilate challenge although in both phases of the
experiment they did evidence parasitosis. The 10 autologous
recipients evidenced a disease response following LCL inoculation but
not on stabilate challenge. All three developed parasitosis
following LCL inoculation but not following stabilate challenge.
There was an indication of the development of a degree of
leucopenia in the autologous recipients during the first 14 days
post~LCL inoculation. The mean WBC level at day 14 (lowest level in
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TABLE 4.2





Matching M T R D IFAT
1 M980 M980 a 9 10 21 160
N894 103 m 12*
S334 \
N866 mis








4 S68 S68 a 10 10 15 10240
S58 105 m 10240
N170 \
S125 mis
5 S48 S48 a 8 9 16 10240
S122 105 m 640
N546 \
M616 mis




M - Days following LCL inoculation to first observed macroschizonts
T - Days following LCL inoculation to febrile response
R - Days following LCL inoculation to recovery
D - Days following LCL inoculation to death
a - Autologous recipient
m - Matched recipient
\ - Half-matched recipient
mis - Mismatched recipient










Matching M* T* R* D* IFAT
1 M980 M980 a
N894 M980 m
S334 M980 \ 7 10 17 -
N866 M980 mis 8 11 21 160
2 S55 S55 a 8 9 160
S59 S55 m 7 11 20
N178 S55 \ 6 9 23
S357 S55 mis 6 9 17
3 N511 N511 a 7 8 160
M878 N511 m 160
S340 N511 \ 7 10 17
S54 N511 mis 6 10 18
4 S68 S68 a 640
S48 S68 m 640
N170 S68 \ 6 10 19
SI 25 S68 mis 6 9 20
5 S48 S48 a 640
SI 22 S48 m 10 11
N546 S48 \ 8 10 20 160
M616 S48 mis 7 8 17
6 N989 N989 a 640
N886 N989 m 7 10 16
S121 N989 \ 7 11 21
S127 N989 mis 8 12 17
Chall¬ R608 None 7 11 17
enge S96 None 6 10 19
Con¬ SI 14 None 7 10 16
trols S170 None 7 10 17
* - See Table 4.2
IFAT - Maximum reciprocal IFAT titre achieved following stabilate
challenge
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the first phase of the experiment) for the autologous recipients was
4100/cu mm blood, having fallen from a mean value of 9533/cu mm on
the day of LCL inoculation.
Of the six matched recipients, one died at an early stage
due to causes not connected with the LCL inoculation. Results were
&
contrasting in the two remaining 10 LCL cell matched recipients in
that although neither developed anti-schizont antibody as measured by
the IFAT, M878 subsequently proved resistant to challenge and S59 did
not. It is interesting to note that following challenge M878 neither
showed evidence of parasite development or clinical signs of disease.
There was however, evidence of a limited serological response to
challenge in this animal.
The 3 matched 10^ LCL cell recipients showed varying
&
responses. As with the 10 matched recipients there was no evidence
of parasite development or disease as a result of LCL inoculation.
Two of the 3 however, developed antischizont antibody as measured by
the IFAT. On challenge two of these matched animals survived whereas
the serologically poor responder N886 succumbed. Of the two
survivors, S58, following a serological response of the same order as
the respective autologous recipient, showed no evidence of disease or
parasite development in response to challenge. S122 evidenced
parasite development but no disease signs on challenge.
Of the six half-matched recipients, none developed a
significant IFAT antibody response following LCL inoculation. All
but one of the half-matched animals succumbed to challenge. N546
survived after a severe disease episode, and even at this stage did
not produce a significant serological response until day 28 post
stabilate inoculation. N546 originally received 10 LCL cells of the
BoLA half-matched S48.
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None of the mismatched animals showed any response to LCL
cell inoculation and all succumbed to challenge.
All challenge control animals (i.e., those which had not
previously been LCL cell recipients) succumbed to challenge.
At the time of challenge, the IFAT titres of all animals
which responded serologically to, and survived LCL inoculation, were
below the peak levels previously achieved. In no case did they
regain these peak levels in response to challenge. The two animals
itfhich survived challenge without having detectable IFAT titres in
response to LCL inoculation (one matched, and one half-matched) did
respond serologically to challenge, but this response was limited.
Table 4.4 shows the serological responses of the recipients
to the cell surface antigens of the respective lines as measured by
the indirect immunoperoxidase test. None of the autologous
recipients developed a detectable response whereas 1 of 4 matched
animals, 4 of 4 half-matched and 4 of 4 mismatched recipients
responded.
Table 4.5 summarises the responses of the animals, grouped




ANTIBODY RESPONSES OF ANIMALS IN GROUPS 3, 4, 5 AND 6 TO
CELL MEMBRANE ANTIGENS ON THE INOCULATED CELL LINE
CELLS AS MEASURED IN THE IIPT
Inoculated














5 S48 S48 <5
105 S122 10 (14)
N546 20 (14)
M616 5 (20)





Figures in parenthesis denote days after cell line
inoculation on which maximum titres were first detected.





NUMBERS OF ANIMALS IN THE AUTOLOGOUS, MATCHED, HALF - AND MISMATCHED
CATEGORIES AND CHALLENGE CONTROLS SURVIVING STABILATE CHALLENGE.
Number Stabilate Number
BOLA Group Challenged Surviving
Autologous LCL recipients 5 5
Matched LCL recipients 5 3
Half-matched LCL recipients 6 1
Mismatched LCL recipients 6 0
Challenge controls* 4 0
* Not previously inoculated with LCL cells
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4.4 Discussion
It is evident from this study that the inoculation of
defined doses of BoLA-characterised LCL cells into similarly
characterised recipient cattle may result in different immune
responses in different cattle. This was even evident in the group of
six autologous recipients. One of these animals, which received only
3
10 LCL cells, suffered a fatal disease episode as a result. This
contrasts with the findings of Morrison _et al., (1981) who reported
b
fatal infections occurring following inoculation of 10 or more
autologous infected cells. However, Morrison _et al., (1981) also
studied only one or two animals at each dose level down to 1(?.
All of the autologous recipients surviving LCL inoculation
were effectively immunised against homologous stabilate challenge
effected 70 days later. There is evidence of two types of LCL dose
s
response in this group. First, the 10 recipients suffered a mild
clinical disease episode after LCL inoculation as evidenced by
temperature response, which was not seen in those animals receiving
10* autologous LCL cells. This is entirely consistent with the
"quantum of infection" hypothesis (Wilde, 1967). Second, there was
an apparent difference between the two levels of LCL inoculation in
the degree of resistance conferred to subsequent stabilate challenge.
Thus, although none of the autologous recipients showed a clinical
*
disease response to challenge, both 10 recipients allowed a
detectable degree of parasite development on challenge whereas the
s
10 autologous recipients did not. These results suggest that just
as the disease itself is a quantum-dependent phenomenon with respect
to challenge dose, immunogenesis may also be in the sense that
different degrees of priming of the immune system can be achieved
with different doses of LCL immunogen. Burridge et al., (1972),
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utilising a stabilate challenge in ECF-recovered cattle were not able
to relate the severity of primary disease to the response to
subsequent challenge. The findings of Barnett (1957) are in
agreement with this although Wilson (1950) concluded that the
durability of immunity was increased following severe disease
reactions by comparison with the immunity following mild reactions.
The results reported by Dolan jet jil., (1982) also suggest a
relationship between severity of primary disease response and
resistance to subsequent challenge. In this study the primary
challenge was with T.parva parva-infected LCLs. The differences in
these various findings may be due to the existence of a threshold
reaction, at levels above which immunity is optimally induced and
below which a relationship exists between disease reaction and
3
immunity. The two autologous 10 recipients surviving to challenge
in this work suffered mild reactions which resulted in a suboptimal,
albeit effective, immune response.
As far as the BoLA-matched LCL recipients are concerned, at
3
the 10 dose level one immunisation proved to be effective in that
the animal was subsequently totally refractory to challenge. The
lack of serological response to schizont material in this animal
prior to challenge is a point for consideration. There is a
possibility that the animal was immune to the parasite prior to the
experiment, especially as it is known that immunity may outlast
detectable serum antibodies to schizont material in the IFAT
(Burridge _et _al., 1973b). Furthermore, as reported by
Goddeeris _et al., (1982, in preparation) immune cattle may not show
an antimacroschizont antibody response when challenged. However, the
animal concerned was born and reared on a research station where
acaricidal control is practised. A more likely explanation of the
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response of this animal is that of innate resistance to infection
conferred by cross-breeding with B.indicus (Cunningham et al., 1973b;
Radley, 1978). It has further been observed that measurable
responses to LCL inoculation may be lower in B.indicus animals than
in taurines (Dolan _et _al., 1982). The second ld^ BoLA—matched
recipient showed no evidence of immunity on challenge.
Of the 1C^ LCL cell matched recipients, one succumbed to
challenge. The BoLA type of this animal N886, and the autologous
recipient to which it was matched, N989, should be considered. The
matching was based on the presence on the line and the two animals of
w6, w9 and w20. This situation is not consistent with the view that
these specificities represent alleles at one BoLA locus. It was
however thought at the inception that the specificities w6 and w9
were present and that the single serum detecting w20 (ED78) was
cross-reacting with another undefined specificity. This was possible
in view of the fact that the w20 serum was suspected to be
operationally multispecific. Subsequent absorptions have confirmed
this. However, it is now thought that both ED78 and ED14 (the
w9~defining serum) cross-react with a single third entity which is
defined by KM2. It is not known with certainty that the KM2
specificity is coded for by the first BoLA locus. If it is not,
there is a possibility that N989 and N886 were half-matched at the
first locus as a result of sharing w6. In this case, the poor
immunogenicity of the N989 line in N886 is not inconsistent with the
results in the half-matched cattle as a whole. The results of typing
large numbers of cattle with the KM panel however, suggest that in
all likelihood the KM2 specificity is first locus coded, in which
instance this result is viewed in the matched context.
Of relevance here are the serological responses to LCL cell
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surface antigens in the recipients. N886 did not respond with
detectable antibody levels to the N989 line, which is consistent with
good matching at the first locus.
Generally, the responses to cell antigen in the four groups
studied are consistent with the degrees of matching assumed at the
outset on the basis of the BoLA types as defined in these particular
cattle. As expected, there was no evidence of a response in
autologous recipients, thus strengthening the view that parasite
antigen per se on the cell surface was not being measured in this
test. This is consistent with the results of previous attempts to
demonstrate such antigens (Duffus et al., 1978, Creemers, 1982). It
seems likely that the test was indeed measuring a response to
MHC~coded antigens, and as expected, a response was detected in all
of the half-matched and mismatched recipients studied. One of 4
matched recipients however, also produced a detectable response in
4ST
the IIPT; animal S122, a 10 recipient. It is notable that in this
case, as suggested by the response to BoLA, matching was not as good
as in the other groups. S48 and S122 were matched for the w6 broad
specificity (the presence of the w6.2 subgroup in S122 but not S48
would not be expected to be significant in this context). However,
S48 and the derived cell line were positive for two of three sera
presently accepted as defining w8 (ED13 and 63) whereas S122 was
positive for these sera and the third defining serum, ED80.
Additionally, S48 and the S48 LCL are KM22 and KM25 positive whereas
S122 is not. It is known that KM22 detects an antigen related to w8
(i.e., reacts with a specificity also detected by ED13 and 63 but not
invariably ED80), but the nature of this relationship is not known.
It is clear nevertheless, that this slight difference in matching in
this group did not prevent the development of a good immune response
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following LCL inoculation into S122. Whether the BoLA difference
involves the first locus coded entity or the products of a second
putative locus is not known.
The different responses in the different groups raise a
number of questions concerning immunisation attempts with LCLs.
There are a number of possible reasons for the variability observed.
First, it could be the result of cell line factors. It is not
inconceivable that lines differ in innate aggressiveness following
inoculation. This could be the result of host cell subtype and
viability on inoculation, amongst other things. Such factors can
only be the subject of speculation at present. However, it is also
possible that the particular BoLA types involved could be implicated
in producing variability of response in recipients, in a number of
ways. Certain BoLA w specificities per se may be more immunogenic
than others and therefore result in a more effective graft response
in the recipient leading to earlier elimination of the inoculated
allogeneic cell and the parasite which it hosts. It has generally
been accepted hitherto that some degree of establishment of the
parasite in the cells of the host animal is required to induce
immunity (Emery et al., 1981a). This factor would not be expected to
pertain with LCL inoculation into BoLA matched recipients, but could
be significant with l/2~matched recipients.
The question of antigenicity of BoLA specificities can be
viewed in a second context. Thus it is possible that the parasite is
"seen" by the immune system better on some BoLA class I backgrounds
than others. This has previously been reported for other pathogens
(Doherty _et al., 1976), for haptens
(Schmitt-Verhulst & Shearer, 1976) and tissue antigens
(Zaleski & Klein, 1977). This type of BoLA limitation in LCL
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immunisation would operate at a different level from the graft
response limitation in that it would only pertain in the autologous,
matched and half-matched situations as studied here. Furthermore, it
would be expected to operate whether or not parasite transfer from
the inoculated LCL to recipient cells occurs. The implication is
that BoLA per se produces differences in degree of immunocompetence.
This also must remain speculation for the present.
The degree of matching itself might be expected to produce
the variability in response of the matched animals within the 2 dose
level groups in this study, but for reasons already outlined, this
would seem to be unlikely. However, effects due to other (putative)
specificities and the products of other genetic regions cannot be
excluded entirely.
In view of these considerations it can be reasonably
concluded from this study that the bovine MHC is a barrier to LCL
immunisation of cattle against ECF, although other factors may be
superimposed.
page 106
CHAPTER 5 A study of the effect of degree of BoLA
compatibility between LCLs and recipient cattle on the response to
cell line inoculation and subsequent challenge-MHC 2
5.1 Introduction
The study described in chapter 4 suggested that MHC
disparity between LCLs and recipients presents a barrier to this form
of immunisation against ECF. In that particular study, 6 LCLs were
used of different BoLA types and these were inoculated in each case
into the autologous recipient and a single BoLA-matched, l/2~matched
and mismatched recipient.
A second large scale experiment was carried out utilising a
different approach with 2 principal objectives. First, to confirm
the "MHC barrier" hypothesis and second to investigate the
possibility that a slightly higher dose level than those used in the
first study may be capable of inducing immunity in BoLA l/2~matched
recipients. This investigation was felt to be important because if
immunisation could be achieved in BoLA l/2~match situations the
possibility would exist of immunisation of groups of cattle with a
relatively limited number of LCLs, each of which would be required at
a feasible dose level for large scale production.
For this study therefore, a dose level of 10 LCL cells was
chosen. A single, BoLA—characterised LCL was used and the recipient
groups (grouped on the basis of their BoLA relationship with the LCL)
were made as large as the availability of suitable cattle and the
logistics of the experimentation would allow.
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5.2 Materials and methods
5.2.1 Cattle
Thirty one Friesian steers purchased from Delamere Estates,
Manera Farm, Naivasha, Kenya were used in this study. They had been
subjected to a strict dipping routine prior to purchase and were
considered to have had no exposure to T.parva parva parasites on the
basis of the results of the IFAT for serum antibody to T.parva
parva (Muguga) schizont antigen.
They were additionally selected on the basis of BoLA type
and the reactivity of their PBL with the Edinburgh panel of typing
reagents is shown in Appendix 2.1. Further, consideration was given
to the parentage of the animals as discussed in 5.2.4.
The cattle were purchased and moved directly to the
Veterinary Research Department, Kenya Agricultural Research
Institute, in December 1981 after which time acaricidal control was
continued with thrice-weekly dipping in dioxathion (Delnav DFF,
Cooper). Prior to the experiment they were treated on 2 occasions
for helminthiasis with oxyclozamide (15 mg/kg)/levamisole (7.5 mg/kg)
(Nilzan,Cooper). During the course of the experiment, those
considered strong enough were allowed to go to pasture during the
day. All cattle were kept in a partially-covered yard at night where
hay and a small quantity of concentrates were made available. Water
was given ad libitum.
At the commencement of the experiment, the cattle ranged in
age from 18-30 months.
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5.2.2 Anaplasmosls control
Anaplasmosis proved to be a recurrent problem during the
course of the experiment. Treatment and prophylaxis was undertaken
with imidocarb diproprionate (Imizole, Wellcome) at a dose rate of
3 mg/kg. This chemotherapy also serves to treat and prevent Babesia
infections.
On day -12 (day 0 being the day of LCL inoculation) animals
S806, S817 and S835 were found to be clinically affected by Anaplasma
marginale infection, and were treated. On day -5, the remaining
cattle were treated prophylactically and S817 was treated for a
second time. On day 0, all animals were considered to be free of
clinical signs of anaplasmosis and only 1 animal, S817, evidenced an
A.marginale parasitosis, but at a low level (less than 1% infected
erythrocytes).
On the day of stabilate challenge (day 29) animals S807,
S808, S820, S824, S830 and S836 were found to have A.marginale
parasitaemias; these being severe in the cases of S807, S808 and
S820 (10%, 50% and 80% erythrocytes parasitised, respectively).
These 3 animals were treated on day 29, but S808 died with acute
anaplasmosis on the same day. All remaining experiment animals were
treated prophylactically on day 30 and S834 was retreated on day 34
when it was found to have 20% erythrocytes infected with A.marginale.
5.2.3 Cell line
A single LCL was established for this*tudy by the in vitro
infection and transformation of PBL from animal S816. The ticks from
which the sporozoites were harvested to establish the line, had been
infected by feeding on cattle infected with T.parva parva (Muguga),
stabilate 147. The cell line was established by Mr D.A.Stagg as
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described in 2.2 and 2.3.
The reactivity of the LCL (S816TpM) with the Edinburgh BoLA
typing panel is presented in Appendix 2.1.
5.2.4 Experiment protocol
Thirty of the cattle were inoculated with the LCL, S816TpM.
The animal S816 served only as a souce of PBL for the establishment
of the cell line, i.e., all recipients were allogeneic with respect
to the LCL.
The 30 cattle formed 4 groups on the basis of their BoLA
relationship with the LCL. One group shared 2 workshop BoLA
specificities (w8/wll) with the line (the matched group). One group
shared the w8 specificity and a third group shared the wll
specificity (2, l/2~matched groups). The fourth group did not share
any workshop specificities with the line (mismatched group).
In an attempt to reduce the possibility of sharing by line
and recipients of inherited characteristics coded for outside the
MHC, the line was made on the S816 background. The sire of this
animal did not sire any of the LCL recipients. Further, because of
the fact that the animals were reasonably matched for age, it is
unlikely that any of the recipients had a 1/2 sib relationship with
S816 through the dam. The groups were also constructed as far as
possible to ensure genetic heterogeneity. Thus 4 bulls sired the 30
recipients and all 4 were represented through their progeny in 3 of
the 4 groups. Sire W was not represented in the w8, l/2~matched
group.
The cattle, their grouping, BoLA workshop specificities and
sires are listed in Table 5.1.
Aliquots of the S816TpM line were inoculated into the 30
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TABLE 5.1
THE LCL, RECIPIENTS, THEIR SIRES, BoLA w SPECIFICITIES AND GROUPING ON
THE BASIS OF SHARING w SPECIFICITIES WITH THE INOCULATED LCL
Group Animal no. Sire
Workshop
specificities




S830 J ' 8,11
S832 AD 8,11
























S816 TpM LCL* S816 E 8,11
* The animal number and sire refer to the animal from which the
line was derived. The workshop specificities 8 and 11 were
present on theLCL cells and the PBL of the donor animal.
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cattle on experiment, on day 0. Stabilate challenge of the 30 cattle
and 2 additional steers (ECF-naive on the basis of the IFAT) was
effected on day 29.
On day 44, a number of the cattle were treated for ECF with
halofuginone as lactate (Hoechst). The cattle not treated, and
therefore running the full course of the experiment, were all 6
matched animals, the first 2 cattle (on a numerical basis) in each of
the 3 other groups and the 2 challenge control cattle which had not
previously been inoculated with the LCL.
5.2.5 LCL inoculation
The line was utilised at passage 9.
The concentration of viable cells in the culture material
was assessed by counting dye-excluding cells in an aliquot in a
Neubauer chamber, using trypan blue (0.5% in culture medium) as a
diluent.
h
10 viable cells were inoculated subcutaneously in front of
the right shoulder of each recipient animal in 5 ml culture medium.
A 50 ul aliquot of the culture material was deposited on a
slide immediately prior to the inculations using a cytocentrifuge
(Shandon Cytospin/600r.p.m for 10 min). Following Giemsa staining of
the preparation, the following characteristics of the inoculated
material were determined,






All 30 LCL recipients and 2 additional steers were
inoculated with 1 ml of T.parva parva (Muguga) stabilate 147 on day
29. S808 died on the same day as a result of anaplasmosis.
The stabilate was inoculated subcutaneously below and in
front of the right ear, in the region of the parotid lymph node.
5.2.7 Assessment of response to LCL inoculation and stabilate
challenge
5.2.7.1 Haematology
White blood cell (WBC) levels, packed cell volumes (PCV's)
and haemoglobin (Hb) concentrations were assessed on 2 occasions
prior to day 0 and then as far as possible, every 3-4 days until day
59.
The method is detailed in 2.5.
5.2.7.2 Serology
Serum samples were examined in the IFAT (detailed in 2.4.1)
for the development of antimacroschizont antibody on 2 occasions
prior to day 0 and then weekly to day 66.
5.2.7.3 Temperature response
Rectal temperatures were taken daily from day 0 to day 56,
in the mornings as the first excercise in routine handling and
sampling.




Biopsy samples of the right prescapular lymph node (RPG)
were taken daily from day 4 to day 19 and examined for evidence of
Theileria macroschizonts.
Samples of the right parotid node (REG) were similarly
examined from day 34 to day 58. Biopsies of the left prescapular
node (LPG) and tail tip blood smears were prepared and examined from
the day first following observation of parasites in the REG on an
individual animal basis. The LPG was then examined daily to day 58.
Blood smears were examined for evidence of parasites to day 62.
Smears were examined following air-drying, fixation in
methanol and Giemsa staining.
Parasitological examinations were carried out as detailed
in 2.6.
5.2.7.5 Post-mortem examinations
Full PM examinations were caried out on all cattle dying
during the course of the experiment. The procedure followed was as
outlined in 4.2.5.5.
5.2.7.6 Recovery
Recovery was recorded on the day after the last detection




The cattle treated are given in 5.2.4 and listed in Table
5.3.
The first treatment with Halofuginone lactate was
administered on day 44.
5.2.8 Mixed lymphocyte reactivities between LCL donor and recipient
cattle
In order to assess whether or not the recipient cattle had
putative la type differences with respect to the inoculated cell line
cells of S816, MLR assays were performed utilising PBL of the
recipients as responder cells to irradiated LCL donor PBL. The
reverse MLRs using S816 PBL as responders to each of the recipients
irradiated PBL, were also carried out.
PBL were prepared from jugular venous blood collected
through 14G hypodermic needles into plastic disposable syringes
preloaded with Alsever's solution (described in 6.2.1.2). Sufficient
blood was drawn into each syringe to give a 1:1 blood/Alsever's
solution mixture. Blood collected in this way served as a source of
both responder and stimulator cells.
The separation of PBL on ficoll-hypaque and subsequent
washing procedures was as described in detail in 6.2.2.1.2. After
washing and counting of viable cells in an aliquot in a Neubauer
chamber, responder cells were suspended in complete medium at a
7
concentration of 10 /ml and 5 ml volumes were added to 25 sq cm area
tissue culture flasks (Nunc) and incubated at 37'C for 1-2 hr after
which non-adherent cells were removed with the medium. After
counting of the cells in the non-adherent fraction, the volume was
adjusted to give a cell concentration of 5x10^ cells/ml.
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Stimulator cells were prepared as responder cells but
without depletion of adherent cells. After adjusting the
concentration of stimulator cells to 5x10 cells/ml, they were
irradiated for 7.75 min in a Caesium 137 source to give a radiation
dose of 5000R.
100 ul aliquots of stimulator cell suspension were added to
100 ul aliquots of responder cell suspension in 96 well,
flat-bottomed plastic tissue culture plates (Linbro) and incubated
for 4 days in a 5% carbon dioxide/95% air atmosphere. On the fourth
day the wells were each pulsed with a 0.5 uCI dose of
Iodine 125-labelled deoxyuridine (Amersham International Ltd.).
25 ul of pulse material was added to each well after appropriate
dilution of the labelled nucleotide in culture medium.
Harvesting of the well contents onto glass fibre paper was
done on day 5 using an automated multiple sample harvester (Automash,
Dynatech). Emissions were quantified by 1 min counts of the
paper-adsorbed samples in a Gamma 5500 counter (Beckman).
Individual MLRs were established in duplicate. Background
uptake of radiolabel by responding cells was assessed in wells
containing 100 ul responder cell suspension and 100 ul complete
medium. These control wells were also established in duplicate.
Stimulation indices were calculated as,
counts/min in test wells
counts/min in medium control wells
The medium used for the work was based on RPMI 1640 (Flow
Laboratories Ltd.,) with 10% FCS, 25 mM sodium bicarbonate, 10 mM
-5"
Hepes, 5x10 M 2 mercaptoethanol, 50 ug/ml gentamycin and 2mM
L-glutamine.
The stimulation indices and background counts are presented
in Table 5.2 and are the means of duplicate assays.
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TABLE 5.2
MIXED LYMPHOCYTE REACTIVITIES BETWEEN LCL DONOR ($816) AND RECIPIENT CATTLE





Recipients count index count index
S804 6800 2.5 6600 5.5
S806 1875 37.6 6600 8.8
S807 1950 13.4 6600 2.9
S808 485 4.9 6600 11.5
S809 1350 77.8 6600 3,8
S811 8200 4.4 6600 17.2
S812 1300 17.6 1885 11.1
S813 14200 5.2 6600 7.0
S814 27500 3.5 6600 9.2
S815 855 27.5 1270 1.5
S817 6500 3.0 1885 3.4
S818 1600 25.5 1885 19.1
S819 1350 2.6 6600 4.9
S820 436 19.7 1885 6.0
S821 401 7.2 6600 6.1
S822 890 11.7 7850 4.4
S823 746 10.0 7850 2.4
S824 3080 13.7 7850 10.4
S825 650 5.1 6600 7.9
S826 830 3.0 7850 9.2
S828 3100 6.9 7850 7.0
S829 500 17.4 7850 2.6
S830 7280 3.7 7850 2.1
S831 780 10.0 7850 7.5
S832 800 4.9 7850 6.3
S834 675 12.7 7850 4.0
S835 2335 2.1 7850 3.0
S836 560 6.2 7850 ' 5.7
S996 16000 3.5 6600 2.6
S99.7 5026 4.6 1885 3.9
* "Responder" cells with medium only.
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On this basis, S816 is considered to show MLR reactivity
with respect to all recipients. Putative la-like antigen differences
are therefore considered likely between the donor and recipients.
5.3 Results
The data concerning haeraatological parameters, serological
changes with respect to response against macroschizont antigen, and
daily rectal temperature recordings are presented in Appendices 2.2,
2.3 and 2.4 respectively.
No significant changes were observed in response to LCL
inoculation in any of the animals, with the exception of a slight
degree of lymph node hypertrophy which was reflected in a blastogenic
response observed in gland smears. The observed response was maximal
on the first 2 days that gland smears were examined and had
disappeared by day 9. This response occurred in all of the LCL
recipients and was not apparently different in degree between the
groups of recipients.
The responses of the cattle to stabilate challenge are
summarised in Table 5.3. The results of daily observations on
parasitosis are presented in Appendix 2.5.
All cattle suffered a severe disease response. On day 44
(day 15 following stabilate challenge), 17 of the cattle were treated
for ECF as indicated in Table 5.3. It was considered that all of the
treated cattle were undergoing a fatal disease response. Of the
untreated cattle, 3 survived the challenge and developed a detectable
immune response as measured in the IFAT; all 3 being in the group of
6 matched LCL recipients. None of the untreated l/2~matched or
mismatched LCL recipient cattle survived the challenge, and both
challenge control cattle succumbed to infection.
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TABLE 5.3
RESPONSE TO STABILATE CHALLENGE
Group Animal
Treated
(day 15) M T P R D I FAT
Matched S811 8 12 16 29 640
S817 9 12 15 21 640
S821 10 14 15 22 10240
S828 8 9 15 20 -
S830 10 14 15 20 -
S832 10/11** 12 15 21 -
w8, | matched S812 7 10 15 17 _
S815 7 9 15 20 -
S818 + 7 15 15
S820 + 9 12 15
S824 + 8/9** 13 15
S825 + 7 12 15
S831 + 7 12 15
S836 + 7 12 15
wll, \ matched S804 7 13 12 21 _
S807 5 10 15 19 -
S808*
S813 + 7 10 15
S819 + 8 10 15
S826 + 7 12 15
S834 + 8 12 15
S835 + 9 12 15
S996 + 8 12 15
S997 + 10 12 15
Mismatched S806 7 11 16 _
S809 7 11 15 19 -
S814 + 7 10 15
S822 + 8 12 15
S823 + 7/8** 15 15
S829 + 9/10** 13 15
Challenge S590 7 13 19 _
Control S605 7 15 22 —
M - Number of days following stabilate inoculation to first
observed macroschizonts




TABLE 5.3 CONT. (2)
P - Number of days following stabilate inoculation to first
observed piroplasms.
R - Number of days following stabilate inoculation to recovery.
D - Number of days following stabilate inoculation to death.
IFAT - Maximum reciprocal IFAT titre.
* - S808 died as a result of Anaplasmosis on the day of
challenge.
** - Macroschizonts observed on the later day; biopsies
not examined on the previous day.
i
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There is evidence that the development of parasitosis was
slower in the matched group of cattle than in the other groups, as
shown in Table 5.4.
When the matched group is compared in this respect with all
the other groups on a combined basis, the time to macroschizont
detection in the matched group of 9.2 days contrasts with the mean
for all the other cattle of 7.5 days. For the purposes of these
comparisons, when parasites may have been detectable on the day prior
to first observation, should suitable material for examination have
been available, the earlier day is used in the calculations.
The delay in development of macroschizont parasitosis in
the matched group was not reflected in the time to development of
pyrexia or to the time to first observation of piroplasms.
Typically, of the parameters recorded, changes in the
levels of leucocytes were the most obvious. On day 15
post-challenge, the mean WBC counts in the matched, w8 1/2-matched,
wll l/2~matched and mismatched groups had fallen to 37%, 31%, 16% and
29% of the levels on the day of challenge, respectively.
A serological response to schizont antigen as measured in
the IFAT was observed only in the 3 surviving matched animals
(serological responses were observed in the treated cattle, but only
subsequent to treatment and these data are not recorded here).
The 3 surviving animals were still alive 5 months after
challenge, at no time having received treatment for ECF.
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TABLE 5.4
DAYS TO FIRST OBSERVATION OF MACROSCHIZONTS IN THE DRAINAGE
LYMPH NODE OF STABI LATE - CHALLENGED CATTLE
Group
Mean number of days to
macroschizont detection + S.D.,
Matched (6)* 9.2+1
w8, \ matched (8) 7.4+0.7
wll, \ matched (9) 7.7+1.4
Mismatched (6) 7.5+0.8
Challenge control (2) 7





The single LCL used in this study at the 10 dose level did
not engender protective immunity to the challenge in any of the
cattle. However, 3 of 6 animals sharing 2 workshop BoLA
specificities with the LCL survived the challenge, albeit after a
severe disease response. It is felt that the treated animals in the
1/2 and mismatched groups were undergoing a fatal disease response at
the time of treatment. If this is accepted, a survival rate of 3 of
6 in the matched group compares with 0 of 23 in the other groups. If
treated cattle are excluded, the 3 of 6 survival rate compares with 0
of 6 for the 1/2 and mismatched groups.
That a degree of immunity was engendered in the matched
recipients and not in any of the recipients in the other groups, is
supported (apart from the difference in survival rates) by the
different character of the responses in these 2 types of recipient.
Most significantly, the time taken to develop^ a detectable degree of
parasitosis in the local drainage lymph nodes was longer by 1.5-2
days in the matched group than in any of the other groups. Second,
the disease response in the matched animals was not as great as in
animals in other groups as indicated by the degree of leucopaenia
developed. This parameter is generally considered the most sensitive
in assessment of ECF disease response.
The character of the immunity engendered in the matched
group should be considered in view of the fact that it was apparently
incomplete against the challenge given. The factors of delayed
development of parasitosis and less severe leucopaenia in the matched
animals may well be connected. The outcome of an ECF disease episode
is largely dependent on the speed with which an immune response can
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be mounted relative to the speed at which the parasite is able to
propagate itself within the tissues ultimately involved in that
immune response (Pearson _et al., 197 9; Morrison et al., 1981). Thus
it is not inconceivable that a delayed early development of the
parasite in the matched animals was the major factor in enabling 50%
of them to develope a response before the lymphoid tissues were
irreversibly compromised.
It seems likely that the delay in early parasite
development in the matched group was in some way the result of the
previous inoculation of the S816 LCL. How this occurred in view of
the fact that there was no evidence of parasite transfer from
inoculated cells to recipient cells, and further, no evidence of a
detectable degree of parasite development as a result of the
inoculation in the recipients, is unclear.
The development of cytotoxic effector T lymphocytes in PBL
has been correlated with the degree of resistance to stabilate
challenge (Emery et al., 1981a) and it has been suggested that the
cytotoxic T lymphocyte is one immune effector agent in ECF
(Pearson £t al., 1979; Eugie & Emery, 1981;
Emery et al., 1981a & b). Further, it appears that the parasite, in
the process of immunisation, must be "seen" by the immune system on a
k
self ba^round (Emery _et al., 1981a); the implication being that the
immune response in ECF is, at least in some respects, MHC-restrie ted.
It is possible therefore that 1 of 2 events (or both)
occurred following LCL inoculation into the matched recipients which
did not occur in the other recipients. First, there may have been a
limited degree of parasite transfer to matched recipient cells
sufficient to induce a small effector cell population specific for
parasite-altered cell targets. The assumption is that such a low
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level transfer would not have been detected with the relatively
insensitive techniques used to detect parasitosis. The limited
transfer hypothesised could have been the result of a better survival
of inoculated cells in the matched recipients than in the other
animals, and simply a reflection therefore of a BoIA graft response
difference. This accomodates the view of absolute self-restriction
in the CTL effector induction phase.
It is also possible however, that no parasite transfer
occurred (and hence a significant degree of parasite development was
not detected) and that the difference in degree of immunity
engendered in the groups was the result of differences in BoLA
background between inoculated cells and self cells, but in this
instance not in the graft response context but in the immune
induction context. This view supposes that an immune response
(effector cell population) can be generated against a subsequent
infection on a self background (the result of tick or stabilate
challenge) directly by inoculated LCL cells providing that a degree
of BoIA compatibility exists between inoculated cell and recipient,
i.e., the inoculated parasitised cell can induce immunity in the same
way as a cell infected in vivo (autologous) without the necessity for
parasite transfer. It should be emphasised that this has never been
shown to occur in the ECF LCL immunisation system, but the necessary
studies have not been carried out to the present time.
Such an hypothesised mechanism of immune induction might
also be expected to operate in l/2~matched LCL/recipient
combinations. There was no evidence from this study of development
of immunity in the 1/2-matched recipients. However, whatever
mechanism was operative in the matched group was clearly at a low
level. If it is accepted that a clonal response to parasite/MHC
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antigens occurs (Zinkernagel & Doherty, 1974b; Doherty_et al., 1976)
it could be argued that in view of the limited response in the
matched group, it is not surprising that a response was not detected
in the l/2~matched groups.
Whatever the mechanism of induction of immunity in the
matched group, it occurred at a low level. Why this should have been
the case in this study where 10 cells were inoculated into each
recipient when in the previous study (MHC 1, Chapter 4) 2 of 3
£ 3
matched recipients receiving 10 cells and 1 of 3 receiving 10 cells
proved refractory to challenge, should be considered. Moreover the
level of immunity in the surviving matched animals in the previous
study was sufficient to prevent significant disease responses on
stabilate challenge and was apparently reflected, in 2 of the 3
animals concerned, in the development of antimacroschizont antibody
responses prior to the stabilate challenge phase of the experiment.
A number of factors are known to be different from those
operative in the first experiment (MHC 1). Principal among these is
the time to challenge in relation to LCL inculation. In MHC 1,
challenge was on day 70 whereas in this experiment challenge was on
day 29. If it is accepted that the development of a specific CTL
response is indicative of immunity, there is no reason to suppose
that the earlier challenge was itself responsible for the poorer
resistance conferred, as Eugie & Emery (1981) reported a peak in CTL
activity at 14 days after a primary challenge, which had disappeared
by day 21. However, Eugie & Emery (1981) were using a different
immunisation procedure. Nevertheless it is reasonable to suppose
that 29 days is sufficient for the development of an immune response,
whatever the immunisation protocol or effector mechanism involved.
Other immunisation procedures for ECF have proved effective when
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stabilate challenge was effected after 1 month
(Radley _et jil., 1975a).
Second, it is known that the cattle used in MHC 2 did not
share either parent with the LCL donor. It is posssible that the
matched and autologous recipients in MHC 1 were related, but because
of their diverse origin (4.2.1), this would seem unlikely.
MLR responsiveness between line donors and allogeneic
recipients in the MHC 1 experiment are not known whereas it is known
that the recipients in MHC 2 and the LCL donor were
mutually-responsive in all cases. Assuming a reasonable degree of
polymorphism at loci controlling MLR, it would not be expected that
the differences in response to LCL inoculation in the 2 experiments
would be attributable to this factor.
As far as the degree of matching is concerned, and possible
differences in this respect to MHC 1, it would appear that, if
anything, the matching was better in MHC 2 than in MHC 1 on the basis
of serological definition with the BoLA typing panel. It was however
possible to obtain a retrospective measure of compatibility between
donors and recipients in the first experiment (serological response
to cell surface antigens measured with the IIPT) which was not
possible in the second experiment. However, by using the 3 surviving
matched MHC 2 recipients and a cell line derived from a matched
animal which succumbed to challenge in a study of alloreactive
cytotoxic cell specificity (reported in detail in Chapter 6) further
definition of the w8 and wll specificities on the cells was possible.
This work confirms that at least with respect to cytotoxic cell
targetting, there are no significant differences in the w8 and wll
entities concerned, between donor and recipients in MHC 2. As
discussed in 6.4, there is some evidence of differences between
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animals of the MHC 2 w8/wll group, possibly involving the products of
a second, putative, locus. Such differences however do not correlate
with responses to LCL inoculation in MHC 2.
Of all the possible variables which could contribute to the
differences in responses to different cell lines in defined BoLA
situations, the most likely to be responsible are cell line factors
per se (also discussed in 4.4). It is conceivable that different
lines vary in performance in any given BoLA situation once inoculated
into the recipient. Innate aggressiveness (rate of multiplication,
invasiveness etc.,) may be particularly important. Another possible
factor in variability is the type of host response invoked by the
inoculated cell which could be dependent on the cell phenotype
(predominant lymphocyte subpopulation infected) in different cell
lines. Studies of such factors are in progress, and hopefully will
lead to a better understanding of the cell line/recipient
interaction.
In conclusion, the results of MHC 2 support the contention
that degree of BoLA compatibility between line and recipient is an
important factor in determining the recipient response. Undoubtedly
other factors also operate, which at the present time are unclear.
With the ability to apply BoLA typing in future experimentation,
attention can now be better focussed on these other factors,
hopefully resulting in resolution of the problems involved in the
development of LCL-derived immunogens for ECF.
The results of this work suggest that immunisation of
cattle sharing 1 BoLA w specificity with inoculated LCLs may not be
possible with "low" cell dose levels. However, for reasons discussed
here the cell line used in this study may be poorly immunogenic in
(,
all BoLA defined situations. It is possible that at the 10 dose
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level other lines may successfully immunise BoLA l/2~matched
recipients.
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CHAPTER 6 A study of target specificity of bovine
alloreactive cytotoxic cells
6.1 Introduction
As discussed in detail in 1.1.2, attempts to date to define
the bovine MHC have concentrated on the use of alloantisera raised
against BoLA specificities although there are some published results
of attempts to define putative la-equivalent (class II) specificities
using lymphocyte activation studies (MLR). There are no published
results of investigations using alloreactive cytotoxic cells.
An investigation of in vitro-generated alloreactive
cytotoxic cell specificity was felt to be of importance for a number
of reasons. First, to establish that agreed SD specificities show
homology with those of other species in being important targets for
alloreactive CTL (Klein _et al., 1981). Second, to establish the
fundamental principle of MHC restriction in a bovine system (this has
not been achieved hitherto) and by implication demonstrate that
already defined BoLA specificities are restrictive elements in
cytotoxic cell effector function. This would have relevance for any
studies of the bovine immune system which must recognise the role
played by the MHC in the immune response. Third, to establish a
system of possible use in the further definition of BoLA
specificities.
Considerations of possible MHC restriction are of
particular relevance to further studies of the immune response in
ECF. It has not been possible to demonstrate that currently
recognised humoral responses play a protective role in the ECF
syndrome (Wagner et al., 1974; Emery et al., 1981a; and reviewed by
Wilde, 1967). Further it has not been possible to demonstrate the
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presence of parasite-induced antigens on the surface of
macroschizont-infected cells with serological techniques
(Duffus et al., 1978; Creemers, 1981) and it is the intracellular
macroschizont stage of the life cycle which is believed to be
responsible for the principal pathogenesis of the disease
(Wilde, 1967).
However, evidence for the fact that cell-mediated immune
mechanisms are associated with immunity to ECF is furnished by the
results of Emery (1981). In this work immunity was passively
transferred between cotwins with thoracic duct lymphocytes.
Consistent with this, the only immune mechanism which has been
demonstrated to have some association with immunity to disease is the
CTL effector mechanism. Thus Pearson _et al., (1979, 1982) were able
to generate, in vitro, CTL for T.parva-infected LCLs, but only from
PBL of immune and not naive animals. Eugie & Emery (1981) considered
that the generation in vivo of CTL was associated with immunity and
the work of Emery et al., (1981a) suggests a correlation between in
vivo CTL generation and resistance to the disease.
MHC restriction of ECF-associated CTL function has not been
demonstrated and indeed in the absence of a BoLA typing capability it
was impossible for workers in this field to do so. It is suggested
however, by the self-restriction shown by CTL whereby in vivo
generation results in a population of effector cells restricted to
the autologous LCL when several cell lines are used as targets in
vitro (Eugie & Emery, 1981). The results of
Pearson _et al., (1979, 1982) suggest that in vitro-generated CTL also
have an autologous preference although it was not as marked as that
reported by Eugie & Emery (1981).
For these reasons, elucidation of the role played by
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MHC-coded antigens on the surface of T.parva-infected lymphoblastoid
cells in the immune response is of immediate concern. To achieve
this the antigens themselves must be definable, and in particular,
those of relevance to CTL effector function.
This study was undertaken as a first step in this
direction.
6.2 Materials and methods
6.2.1 Media
6.2.1.1 Culture medium
The medium used in this work was based on RPMI 1640 (Flow
Laboratories Ltd.). The RPMI 1640 with phenol red was prepared from
powder with DDW. To this was added sodium bicarbonate (2.5 g/L) and
Hepes (Flow Laboratories Ltd.,) to give a final concentration of 10
mM. Following adjustment to pH 6.8 with N HC1, the RPMI 1640 basal
medium was filter-sterilised through 0.22 um pore size GS type
filters (Millipore Corporation) and stored in sealed glass bottles at
4'C until required. Immediately prior to use, foetal calf serum of
selected batches (Flow Laboratories Ltd.,) was added to a final
concentration of 10%. Also added were 2 mercaptoethanol to a final
-5
concentration of 5 x 10 M, gentamycin (to 50 ug/ml) and L~glutamine
(to 2mM) (all supplied by Flow Laboratories Ltd.).
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6.2.1.2 Alsevers solution
This was prepared from DDW by the addition of,
citric acid 550 mg/L
glucose 20500 mg/L
sodium chloride 4200 mg/L
sodium citrate 8000 mg/L
The solution was autoclaved and stored at 4'C until
required.
6.2.2 Cell-mediated lympholysis
6.2.2.1 Preparation of responder cells for mixed lymphocyte cultures
6.2.2.1.1 from defibrinated blood
Venous blood (50 ml samples) from the jugular vein were
collected aseptically through sterile 14G hypodermic needles into
60 ml sterile plastic disposable syringes. These were immediately
emptied into sterile 250 ml conical flasks containing sufficient
glass beads to cover the bottoms of the flasks. 50 ml of blood was
added to each flask. The flasks were rotated manually to keep the
beads in motion until a recognisable discrete clot was formed (10-15
min agitation). The defibrinated blood was removed into sterile
plastic tissue culture flasks (Nunc).
Lymphocyte separation was achieved by layering 5 ml of the
defibrinated blood onto 5 ml ficoll 400/diatrizoate sodium with EDTA
(Ficoll-Paque, Pharmacia Fine Chemicals Ltd.,) in plastic conical
centrifuge tubes (Sterilin) of 10 ml nominal volume. These were
centrifuged at 1200g/30 min.
The leucocyte layer at, and just over, the plasma/ficoll
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interface, was harvested into plastic conical centrifuge tubes
(nominal volume 10 ml), so that each tube contained not more than 5
ml of the harvested material. Tubes were topped up with RPMI 1640,
closed, inverted several times and centrifuged at 300g/10 min.
The supernatant over the pelleted cells was poured off and
the cells resuspended by gentle pipetting in 1.5 ml RPMI 1640. The
tubes were again topped up with RPMI 1640 and the contents mixed by
repeated inversion. Following centrifugation at 150g/10 min the
supernatents were again poured off leaving the cell pellets. These
were resuspended in an appropriate volume of complete medium and
aliquots from individual donors were pooled. Viable cells in an
aliquot were counted in a Neubauer chamber following dilution in
trypan blue medium (0.5% trypan blue in RPMI 1640) and complete
medium was added to the cell suspensions to give a concentration of
5x10 /ml.
6.2.2.1.2 from non-defibrinated blood
Venous blood from the jugular vein was collected
aseptically through 14G hypodermic needles into plastic syringes
preloaded with Alsever's solution to give a 1/1, blood/Alsever's
solution mixture.
The separation of lymphocytes using density gradient
centrifugation was as for the defibrinated samples (6.2.2.1.1).
Following harvesting of the cells from the density
gradient, the tubes were topped up with Alsever's solution, inverted
several times and centrifuged at 300g/10 min. After discarding the
ft
supernatant, the cells were resuspended in 1.5 ml Alsever's solution.
The tubes were filled with further Alsever's solution, mixed and
centrifuged at 150g/10 min. The cells were resuspended and the
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process repeated twice more to remove platelets.
Following the third wash, the pellets were resuspended in
complete medium, appropriately pooled and counted and adjusted to a
b
cell concentration of 5x10 /ml, as previously described.
All cell preparation procedures were carried out
aseptically using sterile reagents and containers. Manipulations
were done at room temperature (20-25'C). Centrifugations were
carried out at 20'C.
6.2.2.2 Preparation of stimulator cells for MLC
Stimulator cells for MLC were obtained from blood collected
into Alsever's solution as described in 6.2.2.1.2.
6.2.2.3 Mixed lymphocyte culture (MLC)
Stimulator cells were irradiated with a Caesium source
(Csl37) for 7.75 min to give a radiation dose of 5000R. The culture
suspensions were placed into the radiation chamber in sterile
polythene tubes or plastic tissue culture flasks (Nunc).
1 ml aliquots of stimulator cell suspensions (SxlO^/ml)
L
were added to 1 ml aliquots of responder cell suspensions (5x10 /ml)
in 24 well (3.5 ml volume/16 mm diameter) flat-bottomed tissue
culture plates (Linbro) and incubated at 37'C in a 5% carbon
dioxide/95% air atmosphere for 6 days.
6.2.2.4 Cell-mediated lymphocytotoxicity assay (CML)
A chromium isotope (Cr51) release assay with in vitro
MLC-generated effector cells and Cr51-labelled target cells was used.
Cells in 24 well plates (2 ml cocultures, prepared as
described in 6.2.2.3) were resuspended in the wells by gentle
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pipetting, harvested, and relevant wells pooled in 50 ml polythene
tubes. These were centrifuged at 300g/10 min, the supernatant over
the cell pellet poured off, and the cells resuspended in an
appropriate volume of complete medium. Viable cells in aliquots of
cell suspensions were counted in Neubauer chambers after dilution in
trypan blue medium and complete medium was added to the suspensions
to give a cell concentration of 4, 2 or lxlO^/ml.
T.parva parva (Muguga)-infected LCLs were used as sources
of target cells. The methods of establishment and maintenance are
described in 2.2 and 2.3. Cultures were used in log phase growth
(24 hr after a 1:10 passage) when cell concentrations were
b ,
approximately 10 /ml. The contents of the culture flasks were taken
into conical centrifuge tubes and centrifuged at 300g for 10 min.
The supernat^nts were poured off the cell pellets and the cells
resuspended in an appropriate volume of RPMI 1640 with added foetal
calf serum (20%). Viable cells were counted as previously described
and the cell concentration of targets was adjusted to 2xl0^/ml. An
equal volume of isotope in medium (Cr51 as sodium chromate, Amersham
International Ltd., added to RPMI 1640 to give a 1 mCi/ml solution)
was added to the cell suspensions. Labelling was carried out in
plastic conical centrifuge tubes with a 60 min incubation at 37'C,
during which time the tubes were agitated 2-3 times.
Following incubation, the tubes were topped up with
*
complete medium and centrifuged at 300g for 10 min. The supernat^nts
were poured off the cell pellets which were then resuspended in
complete medium and again centrifuged at 300g/10 min. The washing
process was repeated twice after which the volumes of suspensions
io
were adjusted to give a cell concentration of 10 /ml in complete
medium, based on prelabelling counts.
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The BoLA types of LCLs were assessed at least once (as
described in 2.1) after passage 4 and prior to use as targets. BoLA
workshop specificities were as for fresh PBL from the respective
donors.
The basic assay was performed by adding 50 ul target cell
suspension to 200 ul effector cell suspension (4xl0^/ml for a 160/1
~7 7
effector/target ratio, 2x10 /ml for an 80/1 ratio, 10 /ml for 40/1,
5x10^/ml for 20/1, 2.5xlOfo/ml for 10/1, and 1.25xlOfc/ml for 5/1) in
individual wells of a 96 well, flat-bottomed tissue culture plate
(Linbro).
All assays were done in duplicate, i.e., each
effector/target combination at each effector/target (E/T) ratio.
50 ul of each target cell suspension was also added to
200 ul of tap water in Beckman tubes and also to 200 ul complete
medium in the plates, in triplicate in each case. In early
experiments water lysis controls were established in the plates in
triplicate.
The plates were incubated at 37'C in a 5% carbon
dioxide/95% air atmosphere for 4 hr, after which the cells and debris
were resuspended by gentle pipetting. The plates were then
Ok
centrifuged (300g/10 min) and 125 ul supernatant from each well was
taken into an individual polycarbonate counting tube.
During the incubation of the plates, the Beckman tubes
containing the targets in tap water were snap frozen in liquid
nitrogen and thawed to room temperature, twice. When incubation of
the plates was completed, the Beckman tubes were centrifuged in a
Beckman microcentrifuge to pellet debris and 125 ul of supernatant
removed for gamma counting with the supernat^nts from the plates.
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Cr51 release during the assay was assessed by counting the
emissions from the supernatant aliquots over a period of 1 min in a
Beckman Gamma 5500 gamma counter.
Percentage chromium release (and hence, degree of
cytotoxicity in the assay) was calculated as,
(cpm, test supernatant - cpm, medium control supernat/nt) x 100
" ■ ........ - *
cpm, freeze thaw supernatant - cpm medium control supernatant.
cpm = counts per minute.
6.2.2.5 Cold target blocking in CML
The method was as for the basic CML assay (described in
6.2.2.4) with the exception that effector cells were added to the
wells in 100 ul unit volumes. Cold targets (unlabelled with isotope)
at the appropriate concentration in complete medium were also added
in 100 ul unit volumes. The preparation of cold targets from tissue
culture material was as described for the "hot" (isotope-labelled)
targets with the exception of the labelling procedure which was
omitted.
Cold/hot target ratios used were 20/1, 10/1, 5/1,
2.5/1, 1.25/1. Following washing after removal from tissue culture
flasks, the concentrations of cold target cells in complete medium
were adjusted appropriately, i.e., 10^/ml for a 20/1 cold/hot ratio,
etc..
When combinations of 2 cold targets were used in individual
assays, a 20/1 cold/hot ratio implies an effective ratio of 10/1 for
each cold target and correspondingly for other cold/hot ratios.
All individual blocking assays were performed in duplicate.
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6.2.3 Study protocol
A series of 11 experiments were performed which fall into 3
groups. All involved investigations of the specificity of in
vitro-generated cytotoxic cells.
6.2.3.1 Experiments Al-6
These form the basis of the study and were designed to
demonstrate that currently-defined workshop class I BoLA
specificities are restrictive targets for alloreactive cytotoxic
c ells.
4 donor animals of responder cells (ultimately, effector
cells) were used, of different BoLA types. A variety of stimulator
PBL and targets were used although most stimulator PBL were obtained
from cattle previously used in experiment MHC 2 (described in detail
in chapter 5).
Cell lines for use as targets, with the exception of
S816TpM, were established and maintained specifically for this work
by Mr D.A.Stagg of the Veterinary Research Department, Muguga, by
methods described in 2.2 and 2.3. All were transformed by T.parva
parva (Muguga). S816TpM was an extant cell line previously studied
for its Theileria-associated immunogenicity in MHC 2. Some of the
cattle used as donors for stimulator PBL and target LCLs in this work
u
had therefore previously been inoculated with S816TpM LCL cells (10
cell inoculum).
None of the responder cell donors had previously
experienced a Theileria infection as judged by negative serology in
the IFAT for antimacroschizont antibodies (Burridge & Kimber, 1972),
or been inoculated with material, infected or otherwise, from




These experiments were performed to study cytotoxic cell
capability of effector cells generated in MLCs of BoLA-matched
responder/stimulator combinations. The BoLA matching implies sharing
of 2 workshop-defined specificities by responder and stimulator
combinations. For reasons discussed in 1.1.2 such combinations can
be considered to have identity for both BoLA-A locus alleles, as
defined by the Edinburgh panel of typing reagents which includes sera
accepted as defining at workshop level.
were both detectable in individuals of a substantial group of cattle,
most of which were survivors of previous studies (MHC 2).
6.2.3.3 Experiments CI and 2
In these 2 experiments, specificity of cytotoxic cell
cold targets matched, l/2~matched and mismatched with the respective
"hot" targets. In experiment C2, combinations of 2, 1/2-matched
targets were used to give both relevant workshop specificities on
different cell backgrounds in individual assays i.e., this
constitutes a contrived, matched blocking situation.
The experiments were again based on the w8 and wll
specificities.
The responder, stimulator and target combinations for all
experiments are summarised in Table 6.1, where the BoLA workshop
specificities are also detailed. The reactivities of the donor
cattle and LCLs with the full panel of typing reagents, are given in
The specificities studied were w8 and wll, as these alleles
cold target inhibition with a panel of
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TABLE 6.1
RESPONDER/STIMULATOR COMBINATIONS IN MLC GENERATION OF CYTOTOXIC
CELLS, AND TARGETS FOR CML ASSAYS. BoLA WORKSHOP SPECIFICITIES
(w) OF THE PBL AND LCL TARGETS ARE ALSO SHOWN
Experiment Responder Stimulator Target
A1 SI 91 w7 wlO S814 wl3 w20 S814 wl3 w20
S816 w8 wll S816 w8 wll
S821 w8 wll S821 w8 wll
A2 B487 w5 w20 S814 wl 3 w20 S814 wl3 w20
S821 w8 wll S821 w8 wll
A3 B807 wl w6 S821 w8 wll S821 w8 wll
B470 w6 w7 B470 w6 w7
A4 SI 91 w7 wlO S811 w8 wll S811 w8 wll









A5 S191 w7 wlO S811 w8 wll S811 w8 wll












A6 B470 w6 w7 S811 w8 wll S811 w8 wll










TABLE 6.1 CONT. (2)








SI 91 w7 wlO
B166 w4 wlO
B1 S995 w8 wll S811 w8 wll S811 w8 wll
•





S995 w8 wl 1 S811 w8 wll *S191 w7 wlO
S995 w8 wll S811 w8 wll *B487 w5 w20
B2 S816 w8 wll S811 w8 wll S811 w8 wll







S816 w8 wll S191 w7 wlO *S191 w7 wlO
S816 w8 wll S191 w7 wl 0 *B470 w6 w7
B3 S995 w8 wll S811 w8 wll S811 w8 wll




S823 wlO wl3 ,
S829 w!3 wl6
* SI 91 w7 wlO
S995 w8 wll SI 91 w7 wlO *S191 w7 wlO
S995 w8 wll SI 91 w7 wlO *S828 w8 wll




TABLE 6.1 CONT. (3)
Experiment Responder Stimulator Target "Cold" target





















SI 91 w7 wlO S821 S829 w!3 wl6
* Target used in assay of cytotoxicity generated in the MLC combination
specifically stated. Otherwise, within experiments all targets were




The responder cells from the S191 donor were prepared from
defibrinated blood (6.2.2.1.1). All other responder and stimulator
cells were prepared from blood collected into Alsever's solution
(6.2.2.1.2).
6.3 Results
The results of all experiments are summarised
diagrammatically in figures 6.1-6.9. The data from which these
figures are derived (counts of emmissions in assay supernatents) are
presented in Appendix 3.2.
6.3.1 Experiment A1
Results are summarised in fig. 6.1.
The responder S191 was used in 3 MLC situations. Two
stimulators were matched to each other at the BoLA-A locus (w8/wll)
and one was of a different BoLA type (wl3/w20).
In this experiment a control in the form of culture of S191
responder cells with no allogeneic stimulator cells was included (MLC
established with S191 cells plus medium alone). These cells were
assayed for effector function subsequently, together with the
allostimulated S191 responder cells. LCLs from all 3 stimulator
donors were used as targets for all responder populations.
It is clear that the cytotoxicity generated distinguished
the w8/wll cells from the wl3/w20 cell, and there was absolute
cross-reactivity between the w8/wll cells. Significant cytotoxicity
was not generated in the absence of stimulator cells.
Although maximum cytotoxicities are recorded as 100%, they
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control was replaced by a freeze/thaw control in subsequent work.
6.3.2 Experiment A2
Results are summarised in fig. 6.1.
A second responder, B487 (w5/w20) was used with a single
w8/wll and the wl3/w20 stimulator used in Al. The responder was
1/2-matched through the w20 specificity with one stimulator.
Cytotoxicity again clearly distinguished the 2 stimulator
cell types.
6.3.3 Experiment A3
Results are summarised in fig. 6.1.
A third responder of a third BoLA type was used, again with
a w8/wll stimulator and with a third BoLA type stimulator (w6/w7).
In this latter case, there was sharing of the w6 allele by the
responder and stimulator.
The stimulator types were distinguished, and the
cytotoxicity in the l/2~match MLC situation was as good as that in
the mismatch situation.
6.3.4 Experiments A4 & A5
Results are summarised in figs. 6.2 and 6.3.
The responder S191 was cocultured with 2 stimulator cells,
both of w8/wll phenotype. The MLC-generated cytotoxicity in the 2
populations was assayed on a panel of w8/wll, w8 1/2-matched, wll
1/2-matched and mismatched targets. The l/2~matched targets were
used in A5 and the full panel of w8/wll targets in A4.
The results show that,
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apparent with all w8/wll and 1/2~matched targets.
2. Cytotoxicity generated in the S191/S821 MLC was greater on
all matched and l/2-~matched targets (mean 66%) than cytotoxicity
generated in the S191/S811 MLC (mean, 52%), with one exception.
3. Both responder populations gave greater cytotoxicity with
wll l/2~matched targets than w8 1/2-matched targets. Thus the
mean cytotoxicities were 40% and 44% with the S191/S811 and
S191/S821 combinations respectively on w8 l/2~matched targets,
and 59% and 83% with wll targets. The difference was clearly
greater with the S191/S821 population than with the S191/S811
population.
4. The cytotoxicities achieved on wll l/2~matched targets
approached closely those achieved on w8/wll targets and in some
individual cases, exceeded the cytotoxicity achieved on the S811
target with both effector cells. Mean cytotoxicities in A5 on
w8/wll targets were 70% and 88% with the S191/S811 and S191/S821
effector populations respectively, and on the wll l/2~-matched
targets, these were 59% and 83% respectively.
These results again reflect the better recognition of
wll l/2~matched targets by S191/S821 effectors than S191/S811
effectors.
5. Of 8 mismatched targets used in the 2 experiments, there was
no significant cytotoxicity in 7 cases. The exception was the
B166 target in both experiments. Mean cytotoxicities on the
B166 target in A4 and A5 were 31% with the S191/S811 effector
and 22% with the S191/S821 effector. It is interesting to note
that exceptionally, the S191/S811 effector produced greater
cytotoxicity in both experiments on this target than the
S191/S821 effector.
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B166 is unique among the mismatched targets in having
reactivity for panel sera ED13 and ED63 (2 of the 3 w8~defining
sera).
The degree of cytotoxicity was somewhat less than with
the l/2~matched targets.
6.3.5 Experiment A6
Results are summarised in figs 6.4/1 and 6.4/2.
This experiment used essentially the same panel of targets
(differing in only 1 mismatch target) and the same stimulators as A4
and A5; the responder in this case being B470, replacing S191. One
target, S818 was l/2~matched at the w6 allele with the responder.
The results show,
1. Matched and l/2~matched targets were clearly distinguished
from mismatched targets.
2. In all cases, cytotoxicity was greater with matched than
l/2~matched targets. The B470/S811 effector gave a mean
cytotoxicity of 87% on matched and 59% on 1/2-matched targets.
The B470/S821 effector gave 85% and 51% respectively.
3. There was no significant difference between the 2 effectors
in degree of cytotoxicity developed with matched targets
although it was slightly greater with the B470/S811 effector
(70%, as opposed to 64% with the B470/S821 effector).
4. Cytotoxicity on the B166 target was not significant. This
contrasts with the situation in A4 and A5 with the S191
responder.
5. The only mismatched target to give a significant
cytotoxicity was S814TpM. This was significantly less than that
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6. There was no significant difference between the wll and w8
l/2~matched targets although the tendency was for a slightly
greater cytotoxicity with wll than w8, shown by both effectors
(mean 58% for wll and 53% for w8).
6.3.6 Experiment B1
Results are summarised in fig. 6.5.
The aim of the B series of experiments was to study
cytotoxicity should it be developed, resulting from coculture of
cells matched for both the w8 and wll specificities.
It is clear that cytotoxicity can be developed in this
situation.
In the first experiment of the series, using 2 effector
populations resulting from coculture of S995 with S811 and S817, the
pattern of cytotoxicity produced by the 2 effectors was the same.
Significant cytotoxicity (mean, 52%) was produced with w8/wll targets
S811, S817 and S828 with both effectors. There was no cytotoxicity
with the w8/wll targets S816 or S821 or with mismatched targets S191
and S829.
A limited degree of cytotoxicity (15%) was recorded with
mismatched target B487 (w5/w20).
6.3.7 Experiment B2
Results are summarised in fig. 6.6.
Using responder S816 (w8/wll) and stimulators S811 and
S821, it is clear that the S816/S811 effector gave the same pattern
of cytotoxicity on matched targets as seen with both effectors in Bl.
Thus, mean cytotoxicity with targets 811, 817 and 828 was 96%.
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85%. There was no cytotoxicity with the S816/S811 effector on the
S821 target (the S816 target not being used in this experiment).
The S816/S821 effector produced no significant
cytotoxicity.
With the exception of B487, all mismatched targets gave low
or insignificant levels of cytotoxicity.
6.3.8 Experiment B3
Results are summarised in fig. 6.7.
Levels of cytotoxicity generated in this experiment were
low. However, it is felt that some of these were significant in view
of the clear differences in cytotoxicities achieved by the different
effectors on identical targets.
S811 and S821 were used as stimulators for the matched
responder, S995. The patterns of cytotoxicity produced by the 2
effectors were distinct. Thus the S995/S811 effector is cytotoxic
for w8/wll targets S811, S817 and S828 and not for targets S816 and
S821. This is the same pattern as seen in B1 with the S995/S811 and
S995/S817 effectors and in B2 with the S816/S811 effector.
The S995/S821 effector gave significant cytotoxicity with
the autologous S821 target and possibly with the S191 target (w7/WlO)
only.
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In this first cold target blocking study, results are
recorded and considered for the 40:1 effector target ratio (the
highest used) and for cold/hot ratios of 10:1, 5:1, 2.5:1 and 1.25:1.
The effector was from the S191 responder/S816 stimulator combination
and results in inhibition assays are based on the autologous S816
target. In the unblocked situation, a 38% cytotoxicity was achieved
which compares with a 5% cytotoxicity on the mismatched S814 target.
The levels of cytotoxicity in the unblocked and blocking
situations (cold/hot ratio of 10:1) are summarised in fig. 6.8. The
percentage levels of blocking at all cold/hot ratios are summarised
in Table 6.2.
It is evident that,
1. No significant blocking was achieved with the mismatched
S829 cold target.
2. The w8/wll cold targets produced more blocking at all levels
than l/2~matched cold targets.
3. There was no significant difference between the w8/wll cold
targets in the degree of inhibition produced. At 3 levels
however, the matched cold target S821, gave more blocking than
the autologous cold target.
6.3.10 Experiment C2
In this cold target inhibition assay, the same responder
was used as in CI with a different stimulator, S821, but of the
w8/wll type as previously. A larger range of cold targets was used,
i.e., 5 matched, 2 of each l/2~-match, and 2 mismatch. Additionally,
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EXPERIMENT CI: INHIBITION OF CYTOTOXICITY OF Cr51 LABELLED TARGETS
(HOT) BY UNLABELLED TARGETS (COLD) AT AN EFFECTOR/TARGET
RATIO OF 40:1, EXPRESSED IN PERCENTAGES
Cold Target
Cold/Hot ratio S816 S821 S836 S834 S829
10:1 92 92 53 66 5
5:1 76 76 32 66 0
2.5:1 50 66 26 45 0
1.25:1 32 47 8 26 0
% inhibition = % Cr release
_ % Cr release
in control assay with cold target ^qq
% Cr release in control assay
Hot Target - S816
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wll-bearing cells.
Cold/hot ratios of 20:1, 10:1, 5:1 and 2.5:1 were used with
an effector/target ratio of 80:1. In combinations of 1/2-matched
blocking cells, each cell was added to the assay at 1/2 the cold/hot
ratio stipulated.
Table 6.3 summarises inhibition levels and fig. 6.9
represents diagrammatically the levels of cytotoxicities achieved in
the unblocked and blocking situations at the 20:1 cold/hot ratio.
The results reflect and extend those obtained in CI.
Thus,
1. At all levels, inhibition was greater with matched targets
(mean value) than with l/2~match targets (mean value).
2. Significant levels of inhibition were achieved with all
matched targets.
3. The wll l/2~matched targets at all levels, resulted in
greater inhibition than the w8 l/2~matched targets, giving on
average 22% greater blocking and therefore approximately twice
the inhibitory effect. These figures correlate closely with
those in CI.
4. The l/2~match combinations of cold targets resulted in
degrees of inhibition very close to those achieved with matched
cold targets. At the 20:1 cold/hot ratio the combinations gave
greater inhibition than the mean level for the matched targets.
5. A reflection of the result reported in 3 above, is that in
certain circumstances, the wll l/2~match targets gave greater
inhibition than individual matched cold targets.
6. There were clear differences between cold, matched targets
in the degree of inhibition produced, with the highest level of
inhibition occurring in the autologous situation.
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TABLE 6.3
EXPERIMENT C2: INHIBITION OF CYTOTOXICITY OF Cr51 LABELLED TARGETS
BY UNLABELLED TARGETS AT AN EffECTOR/TARGET RATIO OF
80:1 EXPRESSED AS PERCENTAGES
Cold Target
Cold/Hot ratio 821 811 816 817 828
20:1 80 63 59 59 78
10:1 63 54 41 61 70
5:1 72 48 39 52 61
2.5:1 35 48 28 37 43
Cold Target




20:1 67 61 33 50 84 74
10:1 54 46 27 27 59 52
5:1 46 28 26 9 35 43
2.5:1 46 24 15 27 26 28
For calculation of I inhibition, see Table 6.2
Hot Target - 821
wu 90 80 70 60
50 40 30 20 10 get )LA+ )LA+ get
+
FIG.6.9 ExptC2











In the first series of experiments, 4 responding cells were
used of 4 different BoLA phenotypes which between them expressed 6
different BoLA workshop-specificities of the currently-recognised 15.
Five stimulator cells were used of 4 BoLA phenotypes representing 6
BoLA specificities. In 2 responder/stimulator combinations, there
was sharing of 1 BoLA specificity by the cocultured cells in the
cytotoxic cell generation.
All the BoLA phenotypes of stimulator cells were clearly
«-
i
discerrylble on the basis of susceptibility to cytotoxic cell activity
generated in all responder cells. Further, it would seem that only
partial differences between responder and stimulator cells, in the 2
cases studied (with the w7 and wl3 specificities not shared), does
not prejudice the generation of a cytotoxic cell population, and in
such cases the level of cytotoxicity developed is of the same order
as that produced in mismatched combinations.
The results of experiments A4, 5 and 6, in which targets
sharing a single w specificity with stimulator cells were used,
suggest that populations of cytotoxic cells are generated in this
system which require recognition of only single w specificities on
target cells for effect. This is consistent with the clonal response
reported in other systems where cytotoxic cells are generated against
autologous and allogeneic transformed lines bearing virus antigens;
the responding clones being specific for single MHC-coded
specificities and virus antigen (Zinkernagel & Doherty, 1974b, 1975)
and thus showing dual recognition and classical MHC restriction.
The development of techniques for establishing cloned
cytotoxic T lymphocyte lines in human and mouse systems has now
placed beyond doubt the fact that a clonal response with respect to
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MHC specificity occurs. This work has been done using virus-infected
(Townsend _et al., 1983) and hapten-modified autologous cells
(Siliciano _et aT., 1983) and allogeneic, "unmodified" cells
(Teh _et al., 1978a; von Boehmer & Turton, 1983) as stimulator and
target cells where the _in vitro generation has been both primary and
secondary.
It could be argued that the cytotoxic cells generated in
the experiments reported here may have been specific for the
stimulator specificities on the basis of requiring recognition of
stimulator specificities either singly (but both being recognisable)
or together. The evidence agaist this is based on the cytotoxicity
result with the 1/2-matched targets. In this instance, levels of
cytotoxicity are almost invariably less than with matched targets.
The most likely explanation for this is that fewer cells are acting
in an effector capacity in the 1/2 match than in the full match
situation. This is strongly supported by the results of the cold
target inhibition experiments in which l/2~matched cold targets, in
most instances, result in a lower level of blocking in any given
defined situation than fully-matched cold targets.
In all these experiments, the target specificities were w8
and wll, and the evidence is that at least 2 populations of effector
cells are generated against w8/wll cells by mismatched responders.
The possibilty that more are generated against such cells cannot be
exclud ed.
The question of the existence of 1 or more other loci
controlling cytotoxic cell specificity may be considered in the
context of the results reported here. All of the matched and
l/2~matched animals used in these studies originated from the same
source. A degree of haploidentity in this group cannot be excluded.
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However the group was the progeny of 5 sires, and certainly a larger
number of dams. Three of the 5 sires are of the wll/wl3 phenotype, 1
is w8/wl3 and the fifth (siring only S816) is w8/wll, w8/wx or
wll/wx. There is no correlation in the A and C series of experiments
between sire and susceptibility to cytotoxicity or cold target
inhibitory activity. This fact, allied with the unlikelihood of any
significant haploidentity in the group for reasons of parentage,
suggests that the w8 and wll specificities are recognised as discrete
entities in these studies. It does not exclude the possibility that
specificities coded for at other putative loci are recognised in the
same way. It would seem however, that the responders S191 and B470
used in this work generated cytotoxicity principally against the w8
and wll specificities on all 3 w8/wll stimulator cells used (having 3
different sires) and if against other specificities, only in a minor
way.
There would appear to be quantitative differences between
the responders S191 and B470 in their responses to different w8/wll
cells and to the 2 specificities. Thus S191 evidenced a clearer
"preference" for S821 cells over S811 cells as stimulators on each
occasion studied. This was not so apparent with the B470 responder.
Both responders produced greater degrees of cytotoxicity against the
wll specificity than the w8 specificity, although again this was more
obvious in the case of S191. The apparently greater antigenicity of
wll over w8 with S191 was clearly reflected in the cold target
inhibition assays from which it would appear that there was a
two-fold greater effect with wll than w8. The possibility of effects
of other loci again cannot be excluded, but for reasons already
outlined, would seem to be unlikely. In addition to this, the
results of combination blocking with different w8 and wll cells are
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not consistent with effects at other loci. In this instance the
stimulator for S191 derived neither haplotype from the same source as
any of the l/2~-matched blockers.
A qualitative difference in the response of S191 and B470
is evidenced by the different cytotoxic effects on target B166
following stimulation with w8/wll cells. A degree of recognition of
B166 was achieved by S191 but not B470. B166 expresses some
serologically detectable cross-reactivity with w8. Why this should
be recognised by one responder and not another is not clear, although
such results do suggest that this system may offer a particularly
sensitive way of further defining BoLA class I specificities. It is
apparent that in other systems cytotoxic T lymphocyte clones are
indeed capable of exquisite specificity (Krangel _et a^., 1983). It
would be expected that cloning would greatly facilitate studies in
this area in the bovine system.
The results of the B series of experiments lend support to
the view that _in vitro-generated cytotoxic cells may have a use in
antigen definition in the bovine system. In these experiments w8/wll
matched stimulator/responder combinations were used to generate
cytotoxic cells and in these circumstances there is some reason to
believe that a second locus may be controlling cytotoxicity, when it
is generated. The results suggest that 3 of the w8/wll animals form
a group distinguishable from the other w8/wll cattle; the 3 being
S811, S817 and S828. Cytotoxicity generated by both S995 and S816
was apparent with these 3 but not with S821 or S816 (S995 was not
used as a target). Further, this cytotoxicity was also evident with
the B487 target (w5/w20).
The fact that cytotoxicity generated in w8/wll-matched
situations is evident with the w5/w20 target as well as with some,
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but not all, w8/wll targets, is perhaps the strongest evidence for
non BoLA~A locus control in these circumstances. It is reasonable to
suppose that a public component on w8 or wll would be shared by other
w8/wll cells as well as cells of different A locus type.
To investigate this further, a number of approaches could
be adopted which include identifying the haplotypes involved in the
w8/wll animals by using 1/2-matched targets where the shared
haplotypes are of common origin with respect to the haplotypes in the
S811, S817, S828 group (these are the progeny of 3 different sires).
Second, other w5/w20 targets could be used with effectors produced in
the appropriate matched-generation system, and third, a larger panel
of other mismatched BoLA types could be used.
Cross-immunisations between the different w8/wll "types"
might enable serological definition of the differences observed with
the alloreactive cytotoxic cells.
For reasons already discussed, in those mismatch
responder/stimulator combinations studied, cytotoxicity generated
appeared to be directed against the products of the A locus alleles
with no detectable activity directed against the products of other
MHC regions. It is possible that had B487 been used as a target in
these circumstances, cytotoxicity would have been detected. However
it is also possible that in mismatch generation combinations in the
system studied, immunodominance of A locus products over the products
of other putative loci occurs, and that such second locus products
are only stimulatory to a detectable degree where A locus products
are shared by stimulator and responder.
Finally, it can be concluded that the objectives of this
study as outlined in 6.1, have been achieved and the opportunity now
exists to extend this work to further definition of the bovine MHC
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and for further studies on the cell-mediated immune response in
cattle, with a sound BoLA-orientated approach. This will obviously
greatly benifit from the establishment of cloned cytotoxic cell lines
in the bovine system, which is the logical next step in furthering
this line of research.
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CHAPTER 7 Summary and conclusions
The work reported in this thesis in large part involved the
application of a BoLA typing capability to two related problems in
the field of ECF immunisation with Theileria parva-infected
lymphoblastoid cell lines. Discussion of immunisation against, and
chemotherapeutic control of, ECF in general terms places the LCL
approach in context.
Until relatively recently it has not been possible to
roliably and oafoly treat infected cattlg^ Chemotherapeutic agents
are however now becoming available (reviewed by Dolan, 1981) and will
undoubtedly have a role to play in ECF control. As with most
chemotherapeutic agents with most infections, they will not control
the infection on every occasion and this may even be the case when
multiple treatments are effected. Further, in an ECF outbreak,
particularly in an extensive livestock rearing situation, which is
frequently the norm in East Africa, the disease is likely to take a
toll not only in terms of deaths directly attributable to T.parva
infection, but also in terms of lost production even when
chemotherapy is instituted optimally and at the first sign of
disease. Not infrequently treated and recovered cattle are severely
checked for a considerable period (personal observation). By the
time cattle show clinical signs the infection process is well
advanced and as a result, in the absence of access to laboratory
diagnostic facilities, chemotherapy on a whole herd basis must be
considered which is not only expensive in terms of antibiotics but
also in terms of the associated effort involved.
The chemotherapeutics have, and are being used as
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components of certain immmunisation regimens (the so-called
"infection and treatment" methods, reviewed by Radley, 1981). In the
original system, cattle are infected by inoculation with
cryopreserved infected tick material and simultaneously inoculated
with the chemotherapeutic agent (long-acting formulations of certain
tetracyclines). This method has been shown to induce immunity to the
homologous parasite isolate in a high proportion of cattle although
5the incidence of breakthroughs , i.e., where the chemotheradbutia
does not prevent the development of frank disease resulting from the
parasite inoculation, is a slight cause for concern.
The newer chemotherapeutic agents, particularly of the
quinone and quinazolinone types, may find applications in "infection
and treatment" approaches and as a result of their better
anti-Theilerial activity, may prove safer than the tetracylines.
They may also be administered several days following infection rather
than on the same day and one can speculate that as a result,
immunogenesis may be improved.
As discussed in detail in 1.2.3, LCL-based immunisation
systems have been the subject of a considerable research effort from
the time that in vitro culture of infected cells was first reported.
Despite this, a field-applicable technique is not available and among
the reasons for this, and probably the most important at the present
time, is the requirement for very large numbers of cells to achieve
immunisation in the majority of recipients and an unacceptably high
death rate directly attributable to cell line-induced infections at
these dose levels.
Interest in Theileria-infected LCLs has however been
maintained despite disappointing results in immmunisation trials and
the fact that infection and treatment has greater
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field-applicability, for several reasons. First, there is as yet no
ideal means of vaccinating against the disease. Second, and related
to the first reason, presently available immunisation systems
necessarily rely on inducing infection with field isolates. This
gives rise to a number of problems, the most important of which is
the induction of the carrier state and other dangers inherent in any
system which can potentially produce the disease.
The production of a non-infective immunogen would be a
major advance in ECF control. There is no single obvious candidate
at the present time. Inactivated sporozoite preparations are a
possibility but despite efforts to produce an effective vaccine based
on non-infective tick-derived material of this type, the vaccine has
not so far been forthcoming.
The other principal possible source of non-infective
immunogens is the infected lymphoid cell. As discussed in 1.2.2,
parasite-associated antigens are induced on these cells although
nothing is known of their nature at the present time. Their
existence is confirmed by the ability of infected cells to induce
lymphocyte activation _in vitro and a cytotoxic cell response _in vitro
and in vivo. Moreover, there is limited evidence that the generation
of CTL is correlated with resistance to subsequent challenge. It is
for these reasons that the surface of infected lymphoid cells may be
expected to eventually yield effective immunogens in preparations
devoid of infective parasite material.
The third reason for continued interest in the
Theileria-infected LCL is that it provides a useful subject for use
in studies of the bovine cell-mediated immune response per se. The
genus Theileria offers transforming agents for bovine cells which are
readily available and with the appropriate technology, relatively
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easy to apply.
In chapters 4 and 5 of this presentati/on, results are
reported of experiments in which a BoLA typing component was
introduced into studies of response to cell line inoculation and
subsequent challenge. This was a direct attempt to define the role
played by histocompatibility antigens in cell line immunisation
procedures. An hypothesis had been evolved on the basis of the
results of work going back to the early part of the century and
culminating in the study of Brown _et al., (1978b), that an immune
response to histocompatibility antigens on the surface of inoculated
infected cells was at least in part responsible for the requirement
for large numbers of cells in the inoculum. The results of the work
reported here support this hypothesis. As discussed however in 4.4
and 5.4, other factors almost certainly contribute, but nevertheless
the results of inoculations in autologous and matched donor/recipient
combinations suggest that if the "BoLA barrier" to LCL immunisation
could be overcome, the other factors may be relegated to a position
of little significance. This is paticularly evident when the
difference in cell number requirements of autologous and mismatched
recipients would appear to be of the order of 1 million fold.
How the BoLA barrier might be overcome is not within the
scope of this discussion and a number of possibilities have already
been raised in the relevant chapters.
The work reported in chapter 3 has relevance to all studies
of the cell line immunisation system. An accepted view in cell line
immunisation research is that Theileria-transformed cell lines
express histocompatibility antigens, particularly since the report of
Spooner & Brown (1980). The implications, should it occur, that the
transformation process can qualitatively alter BoLA antigens (as
page 173
detected by current serological defining procedures applicable to the
uninfected cell) would be far-reaching, and indeed of considerable
interest to ECF imraunologists. Spooner & Brown (1980) reported a
particular transformation, the product of which appeared to differ in
its reactivity with a BoLA typing panel with respect to uninfected
donor PBL. With the development of a cell selection technique based
on the use of BoLA antisera, the anomalous transformation could be
explained without the need to invoke the concept of parasite-induced
modulation of histocompatibility antigens. Moreover, the technique
developed may have uses in the production of BoLA-negative variants
for future immunisation studies (one possible approach to the BoLA
barrier problem).
The third area in which the involvement of bovine
histocompatibility antigens was studied was in the target specificity
of alloreactive cytotoxic cells resulting from primary _in vitro
generation (chapter 6). This was of interest for a number of
reasons, but principally the objective was to further an
understanding of the BoLA system per se.
It is felt that this was achieved in that the results are
entirely consistent with BoLA~A locus-associated restriction of
cytotoxic cell effector function and the demonstration that of the
serologically-defined antigens, at least those studied are also
lymphocyte definable. This latter fact clearly strengthens the view
that the workshop specificities examined, which are in essence the
result of the application of statistical analyses to the results of
assays of serological activity, are real entities in functional
terms. Furthermore, limited evidence suggestive of the existence of
a second locus controlling cytotoxic cell effector function was
found. Despite considerable efforts, good evidence for a B locus
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(class I) has not been forthcoming using other techniques. It cannot
be concluded with certainty however, that the products of a second
class I locus, rather than class II, were being detected, although it
is reasonable to assume that this would be the case in the
circumstances described.
The definition of target antigens in the ECF immune
response is of immediate concern not least because this may shed some
light on improved approaches to vaccination. As discussed in 1.2.2
and 6.1, there is evidence that the only response with any
association with protection is MHC-restricted. An obvious candidate
for further studies is therefore the cell surface of parasitised
lymphoid cells and in this work, the bovine MHC may not be ignored.
The application of cloning techniques in the generation of cytotoxic
cells specific for membrane antigens of parasite-transformed cells
may prove to be a particularly rewarding area for further study. The
work reported in chapter 6 indicates that the serologically-defined
specificities may be restrictive elements in the targeting of such
effector cells, or have a close association with them. It is
possible that parasite transformation may induce alterations in the
histocompatibility antigens themselves, particularly in the event
that some form of interaction antigen is formed. Clear definition of
the MHC antigens in the non-transformed state is therefore a
prerequisite for meaningful studies on transformation-associated
changes.
There are a number of other possibilities as far as
parasite-induced changes on the cell surface are concerned, but
nevertheless, BoLA definition will be required in their
investigation.
Definition of the changes induced by parasitisation and the
page 175
involvment of histocompatibility antigens in these changes is also
particularly important in the context of the BoLA barrier to LCL
immunisation. Separation of parasite and host cell surface antigenic
components of transformational changes, may or may not prove possible
(which is of interest in its own right for the insight it offers into
basic immunological processes). Should it prove possible however, a
step towards avoiding the barrier associated with host cell/recipient
histoincompatibility, may have been made.
It is clear that the opportunities for further studies of
ECF immunology with an immunogenetics component are legion, and the
potential rewards in terms of an understanding of fundamental immune
processes are great. However, the most pressing problem is that
faced by the East African farmer and his stock in an ECF outbreak and
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MrruMUiA I.
BoLATYPINGOFMHC1EX ERIMENTALCATTLEA DLCL's ED&KM(wherestat d)codesoferagivingpositiveReact o(60%k ll)
WorkshopSpecificityDefin ngAdditionalReactions
11,17,67,68/14 11,17,67,68/14 11,17,67,68/14 11,17,67,68/9,10,66,75 13,63,80/5,16 9,10,66,75,81,86/69,71 9,10,66,75,81,86/69,7 9,10,66,75,81, 6/69,7
/69,7 /69,7"










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































N989 N886 SI21 SI27
17700 4100 7100 12100
20800 1100 5900









R608 S96 SI14 SI70
15600 7900 9800 5900
11100 5100 10300 6600














M980 N893 S334 N866 S55 S59 N178 S357 S68 S58 N170 SI25 S48 SI22 N546 M616 N511 M878 S340 S54 N989 N886 SI21 SI27
30 37 25 30 33 36 35 31 33 33 28 37 37 37 42 33 29 29
30 27 38 22 32 39 33 36 44 33 36 33 32 36 39 38 37 39 36 40 38 30
28 24 32 27 33 37 33 33 34 39 36 31 36 31 38 42 39 43 44 37 40 38
31 28 33 30 32 29 35 33 35 32 34 30 38 37 37 44 43 38 36 26 28
35 28 34 29 31 36 24 31 32 32 30 31 30 30 33 32 33 42 35 31 46 35 27 33
28 27 34 28 32 34 27 36 28 31 33 36 28 34 37 37 36 43 42 38 43 35 31 34
33 30 26 31 36 27 36 23 33 30 30 28 34 36 36 33 39 37 36 33 37 31 31
24 31 26 30 33 25 35 24 30 33 30 24 30 31 33 30 39 34 40 33■ 33 28 33
27 34 30 30 37 33 40 27 37 32 34 28 33 40 42 36 43 42 39 31 42 30 32
34 31 33 38 29 38 27 30 30 33 28 32 41 36 33 42 39 38 31 37 27 33
33 28 30 27 36 27 31 28 23 21 27 33 37 32 40 37 36 31 42 27 28 fr-mf
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S55 S59 NT78 S357
38.7 41.2 40.8 41.5
38.6 40.5 41.1 40.7











N511 M878 S340 S54
38.5 38.8 41.0 40.6
38.1 38.3 39.3 40.8











S68 S58 NT70 SI25
28.6 38.9 41.1 40.5
37.4 38.6 40.6 39.8
38.0 38.8 41.0 39.5
38.4 38.5 41.3 40.8









S48 SI22 N546 M616
39.0 38.5 40.5 39.7
38.5 38.9 40.8 37.7











N989 N886 Si21 S127
38.2 39.2 41.4 40.8












R608 S96 SI14 SI70
38.9 40.5 40.7 41.3






MHC 2 : BoLA TYPING AND SIRES OF MHC2 EXPERIMENT CATTLE AND LCL
Sire w.specificitiesj ED codes of non w defining sera
816TpM 8/11 30 72 74 91 95a 102 105
E S816 8/11 30 72 74 85 91 95a 99 102 105
W S811 8/11 72 74 85 95a 99 102
AD S817 8/11 30 72 74 85 91 95a 99 102
J S821 8/11 30 72 74 91 95a 99 102
N S828 8/11 30 72 74 85 91 95a 99 102
J S830 8/11 30 72 74 85 91 95a 99 102
AD S832 8/11 30 72 74 91 95a 102
AD S812 w8/wl3 28 72 74 88 101 104
J S815 w8/wl3 28 72 74 88 102 105
N S818 w8/w6/81,100 72 74
N S820 w8/w6 12,97,100 72 74
N S824 w8/w20 30 72 74
J S825 w8/wl3 28 30 72 74 88 91
N S831 w8/w20 72 74 101
AD S836 w8/wl3 28 • 72 88
J S804 wll/wl6 30 72 74 91 95a 102 105
AD S807 wll/wl3 28 30 72 74 85 88 91 95a 99 102
N S808 wll/wl3 28 30 72 74 85 88 91 95a 99 102
J S813 wll/w6 100 30 72 91 95a 99 101 102 105 109
AD S819 wll/wl6 30 72 91 95a 99 102 105
J S826 wll/w6 100 30 72 95a 99 102
W S834 wll/w6 100 72 91 95a 101 102 105
J S835 wll/w6,93,100 30 72 85 91 95a 99 101 102 105
AD S996 wll/wlO 30 72 85 91 95a 99 105
AD S997 wll/wl6 30 72 85 91 95a 99 102 105
AD S806 w6/wl3 28 72 74 88
N s809 w6/wl3 28 30 72 74 88 91
W S814 wl3/w20 28 72 74
J S822 w6/wl3 28 72 74
W S823 wlO/wl3 28 72 74 85 105
AD S829 wl3/wl6 28 30 72 74 91 105
SI 20 wl6/- 28 30 72 85 88 91 102 105 109
S167 w20/- 85 88 105
SI 95 w6/- 30 102 109
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APPENDIX 2.2
MHC 2 HAEMATOLOGY : WBC COUNTS/mm3 PRIOR TO AND
FOLLOWING LCL INOCULATION ON DAY 0
Date 3/5 10/5 14/5 17/5 21/5 24/5 28/5 31/5 4/6 7/6
Day -8 -1 3 6 10 13 17 20 24 27
S804 10800 11300 9600 9900 11800 10600 12500 11700 12300
S806 6700 10200 4800 5700 6200 7300 7300 9100 7800 8800
S807 6100 6300 6100 8700 7900 6800 7800 5200 6000
S808 6300 6600 5600 6900 5500 4800 8100 6600 5500
S809 6000 6600 4700 6200 6800 5300 7500 6000 6100
S811 7800 7900 5700 6500 7900 7500 13100 9600 9800
S812 7900 8700 7000 10300 7100 9200 15100 12000 9400
S813 6900 7000 5000 6000 7200 6800 7200 5900 6900
S814 7500 7200 4700 7300 7100 7400 10800 11400 16700
S815 9200 7300 8200 7800 11900 9600 13200 11800 9300
S817 9900 14200 21400 14700 4800 5400 6300 7900 8100
S818 8100 7500 7600 8000 138000 8200 10900 8000 5900
S8I9 10400 10600 7900 8100 6400 9200 9800 10600
S820 15900 16500 10700 9700 15800 14700 19800 11500 15600
S821 4700 5100 5500 7500 6300 4200 6400 6100 6500
S822 8600 8900 5500 7700 7000 7500 9900 8300 9200
S823 10900 9100 5900 7700 9800 9200 11700 13200 8500
S824 10700 7700 5300 9800 10100 7600 10900 10100 10100
S825 8200 7400 7100 8900 8200 7400 9900 8900 11500
S826 7700 9300 11000 9300 8900 7800 9000 8400 9100
S828 7800 6500 6700 10000 6400 6600 8000 7900 8500
S829 6100 4900 4400 5200 4900 4100 4100
S830 8900 10700 7800 11800 10800 8000 11800 10000 9000
S831 6400 8100 5600 6900 7800 6900 8300 8300 8100
S832 4800 5400 3700 4000 4000 3700 5800 6200 6800
S834 7300 89000 5500 8300 9200 7200 9700 10000 12200
S835 7100 8200 7100 7600 8100 7300 11700 11300 11900
S836 7400 5200 6100 5600 7200 8800 8400 9100
S996 13200 9700 7200 7600 11100 10300 9300 7300 9600




MHC 2 HAEMATQLOGY : WBC COUNTS/mm3 FOLLOWING
STABILATE INOCULATION ON DAY 29
Date 11/6 14/6 18/6 21/6 23/6 25/6 28/6 2/7 5/7 9/7
Day 31 34 38 41 43 45 48 52 55 59
S804 11000 11200 5800 1600 1500 1800
S806 10900 9500 11900 4800 750 1900
S807 7600 6200 6700 3400 1900 1320
S808
S809 7600 7200 10100 7100 1100 960 2900
S811 10300 13800 9400 7700 3500 3400 5500 6600 12800 12500
* S812 10400 9300 7300 4900 1400 860
*S813 9100 10000 11800 5100 630
*5814 12500 12100 11700 4100 690
S815 11200 8300 6500 4700 1100 663 645
S817 8800 8800 5700 4200 1400 840 11300 3500 5200 9100
S818 5600 7300 9200 7500 3000
*S819 11400 8100 5200 1300
*S820 10200 7200 6700
S821 6800 6400 6100 5700 4500 2300 3300 6900 13600 4900
*S822 14300 10200 7800 12000 4700
*S823 7700 9500 8100 4900 4500
*S824 7900 11200 9100 7400 2800
*S825 14700 8600 7500 6100 3600
*S826 11100 97PP 7900 6300 2000
S828 15200 6800 5700 5500 1900 1400 1400
*S829 5100 12600 6900 7200 5000
S830 9100 6400 7700 8600 3700 672 652
*S831 11300 8700 7400 4500 1800
S832 11900 6900 6900 2000 703 926
*S834 12700 14500 10200 5600 990
*S835 11600 11300 10800 4800 1000
*S836 6800 9300 9000 7500 1600
*S996 14700 11300 8300 6300 2800
*S997 7300 8300 10100 5800 1500
S590 7500 7000 11000 4000 1700 545 695
S605 19100 17800 18900 8500 1800 1600 1202




































































































































































































































































MHC 2 HAEMATOLOGY ; HAEMOGLOBLIN LEVELS (mgm %)
FOLLOWING STABILATE INOCULATION ON DAY 29
Date 11/6 14/6 18/6 21/6 23/6 25/6 28/6 2/7 5/7
1
9/7
Day 31 34 38 41 43 45 48 52 55 59
S804 11.2 11.8 11.1 11.0 10.0 9.6 8.8
S806 8.9 10.1 10.1 8.9 8.5 9.3
S807 6.6 6.5 7.3 6.5 5.7 5.8
S808
S809 6.4 9.8 9.9 9.1 8.8 8.6 11.4
S811 11.5 11.6 11.0 10.2 8.7 9.2 8.1 8.1 7.1 7.0
S812 10.2 9.7 9.6 8.1 7.3 7.3
*S813 8.3 8.4 9.6 9.7 8.4
*S814 7.3 7.4 8.7 8.7 7.7
S815 10.3 9.7 9.6 9.4 8.9 9.1 8.4
S817 6.7 8.2 8.4 8.6 7.3 7.3 6.2 5.9 4.9 4.5
*S818 10.6 4.9 10.4 10.6 10.6
*S819 10.1 - 10.8 9.3 8.6
*S820 2.9 6.4 6.6 6.4
S821 9.6 9.6 10.1 10.2 9.5 8.3 7.9 8.3 7.8 6.9
*S822 11.6 10.5 11.2 10.8 9.7
*S823 5.4 5.2 6.6 6.0 4.4
*S824 9.5 10.6 10.2 9.5 8.9
*S825 11.2 11.2 11.2 10.5 8.7
*S826 12.3 11.9 12.0 11.2 9.8
S828 11.5 10.4 9.9 10.8 8.4 8.0 6.7
*S829 5.1 4.2 5.9 5.9 4.4
S830 9.2 8.1 8.0 9.4 7.8 8.6 7.3
*S831 11.3 10.1 10.7 9.9 8.8
S832 10.8 11.1 9.4 9.0 8.3 8.0
*S834 7.6 5.2 7.2 7.2 6.6
*S835 9.6 9.2 9.8 8.7 7.2
*S836 9.4 9,5 9.8 9.0 •
*S996 12.5 12.0 11.6 10.3 8.4
*S997 6.9 5.8 6.9 7.0 6.7
S590 11.1 12.5 10.7 10.1 9.1 9.5 9.6
S605 11.7 11.2 11.1 9.8 8.9 10.5 8.9




MHC 2 HAEMATOLOGY : PCV LEVELS PRIOR TO AND FOLLOWING
LCL INOCULATION ON DAY 0
Date 3/5 10/5 14/5 17/5 21/5 24/5 28/5 31/5 4/6 7/6
Day -8 -1 3 6 10 13 17 20 24 27
S804 27 30 34 30 33 32 33
S806 21 28 28 29 30 31 30 27
S807 25 28 30 27 33 29 30
S808 29 33 29 30 30 30 32
S809 28 30 29 32 33 30 33
S8I1 29 31 32 30 33 30 33
S812 29 30 30 27 30 31 33
S8I3 25 30 28 26 28 27 30
S814 28 29 30 29 21 29 33
S815 29 31 30 27 30 30 30
S817 15 19 20 21 25 25 27
S8I8 26 30 30 30 32 30 31
S8I9 30 30 30 30 30 32 33
S820 27 30 28 28 28 28 28
S82I 28 27 30 27 30 29 30 LU LU
S822 29 30 27 29 31 29 30 O
2
O
S823 24 27 27 25 27 28 29
o Q





S825 31 30 28 30 31 31 32
2
S826 32 34 36 33 36 33 36
S828 26 30 29 28 33 29 33
S829 28 29 29 27 29 28 -
S830 25 25 28 29 32 28 35
S831 27 30 29 30 34 30 30
S832 25 28 27 25 30 28 30
S834 29 30 30 29 30 30 31
S835 24 28 27 27 30 30 25
S836 26 30 30 31 36 33 33
S996 33 30 32 30 33 34 36




MHC 2 HAEMATOLOGY : PCV LEVELS FOLLOWING STABILATE
INOCULATION ON DAY 29
Date 11/6 14/6 18/6 21/6 23/6 25/6 28/6 2/7 5/7 9/7
Day 31 34 38 41 43 45 48 52 55 59
S804 31 34 30 30 28 25
S806 26 31 29 26 26 28
S807 18 21 20 18 17 16
S808
S809 28 28 28 26 26 25 33
S811 33 33 30 28 26 27 24 24 21 20
S812 20 28 29 23 21 22
*S813 25 26 28 25
*S814 21 22 25 24 22
S815 28 30 28 27 26 25
S817 20 25 25 23 21 23 19 18 15 13
*S818 30 29 28 30 31
*S819 30 30 27 25
*S820 10 20 19 20
S821 28 29 30 30 27 25 23 24 24 20
*S822 32 30 31 30 27
*S823 15 15 20 18 14
*S824 28 30 29 28 26
*S825 33 33 32 26 25
*S826 35 34 33 30 28
*S828 33 29 27 28 23 23 21
*S829 14 13 20 17 14
S830 28 23 23 27 23 25 23
*S831 33 29 30 28 25
S832 31 31 27 26 25 24
*S834 22 15 22 20 21
*S835 29 27 28 25 22
*S836 26 27 27 25 26 •
*S996 36 35 33 30 25
*S997 21 16 20 20 20
S590 31 34 30 28 25 27 28
S605 33 31 30 26 25 32 26
* Treated on day 44 (day 15 post stabilate inoculation)
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APPENDIX 2.3
MHC 2: RECIPROCAL TITRES IN THE IFAT TO T.PARVA SCHIZONT
ANTIGEN PRIOR TO AND FOLLOWING LCL INOCULATION ON DAY 0
AND STABILATE CHALLENGE ON DAY 29
Day -4 3 17 24 31 38 45 52 59 66
Date 7/5 14/5 28/5 4/6 11/6 18/6 25/6 2/7 9/7 16/7
S804 <40 <40 <40 <40 <40 <40 <40
S806 II II II II II II II
S807 II II II II II II II
S808 II II II II - -
S809 II II II II II II II
S811 II II II II II II II 640 640 640
S812 II II II II II II II
*S813 II II II II II II II
*S814 II II II II II II II
S815 II II II II II II II
S817 II II II II II II II 640 640 640
*S818 II II II II II II II
*S819 II II II II II II II
*S820 II II II II II II II
S821 II II II II II II II 10240 2560 10240
*S822 II II II II II II II
*S823 II II II II II II II
*S824 II II II II II II II
*S825 II II II II II II II
*S826 II 40 40 40 II II II
40S828 II 40 <40 <40 40 II
*S829 II <40
II
II II <40 II <40
S830 II II II II II II
*S831 II II 40 II II II II
S832 II II <40 II II II II
*S834 II II II II II II II
*S835 II II II II II II II
*S836 II II II II II II II
*S996 II II II II II II II
*S997 II II II II II II II
*S590 II II II 40 II II II
S605 II II II <40 II II
II
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gamma counts E/T % Cr^ release









S191/S814 3800 40:1 100
4327
x 4064
S191/S816 973 40:1 21
928
x 951
S191/S821 648 40:1 11
664
x 656
SI 91/medium 364 40:1 2
403
x 384







S191/S814 904 40:1 19
787
x 845
S191/S816 3147 40:1 100
3399
x 3273
SI91/S821 2624 40:1 75
2400
x 2512
S191/S816 356 40:1 2
330
x 343


















S191/S814 915 40:1 10
884
x 900 •
S191/S816 4887 40:1 100
4965
x 4926
S191/S821 4075 40:1 78
3994
x 3870
SI 91/medium 370 40:1 0
318
x 344








B487/S814 4572 75:1 87
4382
.X 4477
B487/S821 864 65:1 10
911
x 888








B487/S814 787 75:1 21
989
x 843










gamma counts E/T % Cr^ release








B807/S821 2401 80:1 76
2234
x 2318
B807/B470 477 80:1 8
545
x 511







B807/S821 606 80:1 4
593
x 600
B807/B470 2607 80:1 75
2545
x 2576
























gamma counts E/T % CR^ release
1173
x 1224
S191/S811 5329 80:1 50%
6009
x 5669











S191/S811 3814 80:1 46%
3808
x 3811
S191/S821 4624 80:1 63%
4638
x 4638








S191/S811 3764 80:1 63%
3985
x 3875 '
SI91/S821 4050 80:1 71%
4182
x 4116














gamma counts E/T % CR51 release
x 2079
S191/S81I 3115 80:1 36%
2969
7 3042
S191/S81 3414 80:1 48%
3357
x 3386








S191/S811 1216 80:1 0%
1012
x 1114
SI91/S821 1087 80:1 0%
1160
x 1124























S191/S811 505 . 80:1 0%
Cont.
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E/T % CR^ release
557
x 531
S191/S821 584 80:1 0%
694
x 639








S191/S811 484 80:1 0%
487
x 486
S191/S821 405 80:1 0%
442
x 424








S191/S811 1887 80:1 34%
1634
x 1761












S191/S811 1732 160:1 60%
1894
x 1813









gamma counts E/T % CR^ release








S191/S811 3336 160:1 79%
3661
x 3499
S191/S821 4266 160:1 100%
- 4613
x 4440







S191/S811 1861 160:1 38%
233
x 2047
S191/S821 2303 160:1 47%
2435
x 2369








S191/S811 1351 160:1 27%
1412
x 1382
S191/S821 1757 160:1 36%
1675
x 1716




















S191/S821 1257 160:1 41%
1397
x 1327







S191/S811 1776 160:1 54%
1907
x 1842
S191/S821 1756 160:1 52%
1773
x 1765







S191/S811 1741 1:160 49%
1780
x 1761
S191/S821 2292 * 1:160 67%
2180
x 2236








S191/S811 1343 160:1 54%
1312
x 1328
i— ' - -
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APPENDIX 3.2 CONT. (9)
Responder 1 minute
% CR^ releaseExperiment Target stimulator gamma counts E/T
S191/S821 1690 160:1 77%
1805
x 1748








S191/S811 1912 160:1 64%
1945
x 1929
S191/S821 2485 160:1 87%
2443
x 2464








S191/S811 1709 160:1 69%
1761
x 1735
SI91/S821 2322 160:1 100%
2526
x 2424









S191/S811 701 160:1 9%
663
x 682









gamma counts E/T %CR^ release







S191/S811 485 160:1 6%
530
x 508
S191/S821 546 160:1 8%
573
x 560







S191/S811 543 160:1 28%
510
x 527
S191/S821 534 160:1 25%
451
x 493








B470/S811 2692 160:1 80%
2837
x 2765
B470/S821 2948 160:1 83%
2798
x 2873















gamma counts E/T %CR^ release
x 416
B470/S811 3267 160:1 100%
3390
x 3329
B470/S821 3118 160:1 100%
3201
x 3160








B470/S811 2013 160:1 93%
1917
1965
B470/S821 1896 160:1 87%
1819
x 1858








B470/S811 4878 160:1 80%
4737
x 4658
B470/S821 4618 100:1 77%
4332
x 4475








B470/S811 2916 160:1 if?o00
3218
x 3067









gamma counts E/T %CR^ release








B470/S811 2176 160:1 47%
2115
x 2146
B470/S821 1885 160:1 44%
2184
x 2035






B470/S811 x 2313 160:1 35%
2259
x 2286












B470/S811 2217 160:1 76%
2226
x 2222
B470/S821 1723 160:1 58%
1864
x 1794

















B470/S811 2836 160:1 68%
2911
x 2874
N470/S821 2554 160:1 56%
2398
x 2476








B470/S811 3393 160:1 70%
3548
x 3471
B470/S821 3215 160:1 62%
3019
x 3117







B470/S811 2085 160:1 43%
1940
x 2013
B470/S821 1836 160:1 40%
1985
x 1911

















gamma counts E/T %CR^ release
B470/S821 2040 160:1 48%
2144
x 2092







B470/S811 3213 160:1 72%
2992
x 3103
B470/S821 2847 160:1 66%
2913
x 2880








B470/S811 1561 160:1 19%
1557
x 1559
B470/S821 1839 160:1 26%
2035
x 1937









B470/S811 1173 160:1 13%
1338
x 1256







APPENDIX 3.2 CONT. (15)
Experiment
Responder/ 1 minute %CR^ releaseTArget stimulator gamma counts E/T








B470/S811 468 160:1 0%
551
x 510
B470/S821 510 100:1 0%
500
x 505








B470/S811 1052 160:1 5%
1165
x 1109
B470/S821 1355 160:1 11 %
1515
x 1435









B470/S811 373 160:1 5%
317
x 345
B470/S821 324 160:1 6%
390
x 357






APPENDIX 3.2 CONT. (16)
Experiment
Responder/ 1 minute




S995/S811 4136 80:1 51%
3911
x 4024
S995/S817 2872 80:1 '34%
2879
x 2876








S995/S811 5380 80:1 58%
5119
x 5250
S995/S817 3824 80:1 40%
4050
x 3937








S995/S811 467 80:1 0%
382 -
x 425
S995/S817 382 80:1 0%
408
x 395








S995/S811 787 80:1 2%
Cont.
Page 255





gamma counts E/T %CR^ release
819
x 803
S996/S817 855 80:1 2%
892
x 874








S995/S811 3928 80:1 74%
3660
x 3794
S995/S817 3066 80:1 56%
2898
x 2982








S995/S811 409 80:1 0%
367
x 388
S995/S817 421 80:1 0%
353
x 387 ■







S995/S811 818 80:1 0%
835
x 827
B1 B487 Freeze/thaw 8763
Cont.
Page 256























S816/S811 3193 160:1 00oo
3349
x 3271
S816/S821 776 160:1 14%
773
x 775








S816/S811 680 , 160:1 0%
754
x 717
S816/S821 885 160:1 2%
831
x 858








S816/S811 5800 160:1 98%
Cont.
Page 257






gamma counts E/T %CR51 release
5043
x 5422
S816/S821 1216 160:1 11%
1216
x 1216








S816/S811 3858 160:1 100%
3731
x 3795
S816/S821 836 160:1 0%
836
x 836








S816/S811 1360 160:1 18%
1501
x 1431
S816/S821 1493 160:1 19%
1450
x 1472
S816/S191 1348 160:1 17%
1458 '
x 1403


















gamma counts E/T %CR^ release
S816/S821 1053 160:1 14%
1054
x 1059








S816/S811 3299 160:1 85% •
3421
• x 3360
S816/S821 1395 160:1 23%
1313
x 1354








S816/S811 930 160:1 22%
789
x 860
S816/S821 678 160:1 13%
686
x 682









S816/S191 2488 160:1 60%
2498
x 2493












gamma counts E/T %CR^ release
206
x 216
S995//S811 524 80:1 16%
458
x 491
S995/S821 357 80:1 7%
320
x 339





















S995/S811 178 80:1 0%
214
x 196 .
S995/S821 225 80:1 0%
319
x 272


















gamma counts E/T %CR^ release
S995/S821 449 80:1 0%
472
x 461








S995/S811 608 80:1 22%
712
x 660
S995/S821 310 80:1 3%
271
x 291
S995/S191 336 80:1 3%
226
x 301








S995/S811 268 80:1 3%
324
x 296
S995/S821 428 80:1 7%
374
x 401







S995/S811 188 80:1 0%
247
x 216
S995/S821 338 80:1 0%
Cont.
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gamma counts E/T %CR^ release
364
x 351
S995/S191 468 80:1 3%
420
444








S995/S811 557 80:1 2%
617
x 587
S995/S821 817 80:1 14%
101
x 929



























































S816 S821 10:1 S191/S816 380
458
40:1 3%
i>816 S821 5:1 S191/S816 592
617
40:1 9%
















S816 S821 5:1 S191/S816 975 40:1 20%
974
x 975
S816 S836 10:1 S191/S816 900 40:1 18%
951
x 926
S816 S836 5:1 S191/S816 1141 40:1 26%
1077
x 1109
S816 S836 2.5:1 S191/S816 1221 40:1 28%
1200
x 1211
S816 S836 1:25:1 S191/S816 1295 40:1 35%
1494
x 1395




S816 S834 5:1 S191/S816 706 40:1 13%
827
x 767
S816 S834 2.5:1 S191/S816 1101 40:1 21%
911
x 1001 «
S816 S834 1.25:1 S191/S816 1241 40:1 28%
1157
x 1199
S816 S829 10:1 S191/S816 1424 40:1 36%
1458
x 1441
S816 S829 5:1 S191/S816 1624 40:1 44%
1683
x 1654
S816 S829 2.5:1 S191/S815 1623 40:1 40%
1496
x 1560
S816 S829 1.25:1 S191/S816 1604 40:1 42%
1615
x 1610




APPENDIX 3.2 CONT. (26)
Cold Cold/ 1 minute %CR51






S191/S821 745 80:1 11%
722
x 734








S191/S821 2632 80:1 46%
2695
x 2664
S821 S821 20:1 S191/S821 768 80:1 9%
998
x 883
S821 S821 10:1 S191/S821 1290 80:1 17%
1224
x 1254
S821 S821 5:1 S191/S821 1012 80:1 13%
1100
x 1056
S821 S821 2.5:1 S191/S821 1953 80:1 30%
1877
■ x 1915
S821 S811 20:1 S191/S821 1271 80:1 17%
1261
x 1266
S821 S811 10:1 S191/S821 1585 80:1 21%
1304
x 1445
S821 S811 5:1 S191/S821 1745 80:1 24%
1462
x 1604
S821 S811 2.5:1 S191/S821 1498 80:1 24%
Cont.
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S821 S807 20:1 S191/S821 1186
x 1186
80:1 15%












































S821 S834 20:1 S191/S821 1193 80:1 18%
Cont.
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S821 S834 10:1 S191/S821 1458
1532
x 1495
80:1 22%
S821 S934
S836
5:1 S191/S821 1688
1748
x 1718
80:1 26%
S821 S834
S836
2.5:1 S191/S821 2174
1918
x 2046
80:1 33%'
